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ABSTRACT 
The broad range of diseases controlled by transcription factors (TFs) and their potential abilities 
to modulate gene expression have led to an emerging interest in the development of small 
molecules that target TF-DNA complexes. Still, there is only a limited number of types of designed 
small molecules that show strong and sequence-specific binding to DNA along with good cellular 
uptake properties for therapeutic use. Most of the successful nuclear stains or therapeutic agents 
that bind non-covalently in the minor groove of DNA are AT specific. Synthesis of novel 
compounds to better target the mixed AT/GC base pair (bp) sequences with a broad range of 
applications like targeting TF is a daunting task.  
Our novel heterocyclic cation, DB2277, contains the aza-benzimidazole group (aza-BI) 
that specifically recognizes the single GC bp interspersed between AT bp sequences in the minor 
groove of DNA. NMR spectroscopy revealed the presence of major and minor binding species in 
the DB2277 complex with AAAGTTT type of DNA. NMR exchange dynamics have shown that 
the exchange between major and minor species is much faster than the compound’s dissociation 
from the complex, as determined using surface plasmon resonance (SPR). To understand the 
molecular basis of recognition of mixed bp sequences and to acquire ideas to design new sequence-
specific compounds, structural information of the DB2277-DNA complex is essential. 
Experimental structure of the unique and selective binding orientation of DB2277 with 
“AAGATA” binding site of DNA has been obtained using high-resolution NMR and molecular 
dynamics (MD) simulations, which suggests the involvement of two specific and strong H-bonds 
in recognition of the central GC bp. Extended MD calculations have shown dynamic water-
mediated H-bond contacts between amidine of DB2277 and the bases at the floor of the minor 
groove and 180° rotations of the phenyl linked to a flexible linker (OCH2) in a bound compound 
for the first time. Therefore, designing additional compounds with the ability to recognize a vast 
array of biologically important DNA sequences is essential for extending the use of new 
heterocyclic compounds in therapeutic applications in the future. 
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1 
1 INTRODUCTION  
1.1 Overview  
DNA (Deoxyribonucleic Acid) was used as a target for the discovery of anticancer drugs even 
before the structure of DNA was discovered (1). For many years, scientists have shown empirically 
derived compounds with anticancer, antibacterial and anti-parasitic activities which either target 
DNA directly or inhibit the enzymes involved in gene regulation (2-4). DNA, as a central 
component of cellular machinery, is involved in a broad range of biological functions inside the 
cell. Therefore, such compounds with the ability to target DNA and their role in regulating the 
gene expression, have the potential for far-reaching applications in therapeutic development (5). 
DNA is a stable storage unit of all the genetic information and transfer of the genetic information 
in biological systems is explained through the central dogma (a term coined by Francis Crick in 
1958) in molecular biology (6, 7). It describes the one-way flow of genetic information from DNA 
to RNA to proteins (Figure 1.1). In order to decode the DNA, the transcription process is used to 
copy DNA to information carrying RNA intermediary molecules which leads to the production of 
the protein molecules (8) (Figure 1.1). Transcription and translation processes serve as a major 
molecular “on/off” switch for the genetic expression (9). 
1.2 Structural Characteristics of DNA  
DNA, a secret of life that contains all the information required by any cell in the body to thrive, 
was first identified by Friedrich Miescher in the late 1860s. Watson and Crick concluded in 1953 
that the DNA molecule exists in the form of a three-dimensional double helix (6). Erwin Chargaff 
explained the additional details of the structure of DNA (10). Two major conclusions found by 
Chargaff in 1950 are: 1) nucleotide composition of DNA varies among species. 2) All DNA 
follows the Chargaff's rule, in spite of its varied composition, the total amount of purines (A + G) 
2 
are essentially equal to the total amount of pyrimidines (C + T). Watson and Crick model 
represents the following features of DNA, also outlined in Figure 1.2: 1) DNA is a double-stranded 
helix, with the two strands connected by hydrogen bonds. Adenine base is always paired with 
thymine, and cytosine is always paired with guanine. 2) Most DNA double helices are right-
handed. Only one known type of DNA, called Z-DNA, is left-handed. 3) The DNA double helix 
is anti-parallel, which means that the 5' end of one strand is paired with the 3' end of its 
complementary strand and vice versa (Figure 1.2).  Nucleotides on the same strand are linked to 
each other by their phosphate groups, which bind the 3' end of one sugar to the 5' end of the next 
sugar. This antiparallel arrangement of the two backbone strands of DNA gives rise to another 
structural feature of the molecule i.e. the major and minor grooves, opposite to each other, also 
shown in the Figure 1.2.  4) The outer edges of the bases are exposed and available for potential 
hydrogen bonding as well. Through these H-bonds, other molecules including proteins can have 
access to DNA.  
The minor groove of B-form DNA is narrow and shallow with the width of only about 10 
Å whereas the major groove is deeper and wider, 24 Å width approximately. The major groove 
serves to provide more specific hydrogen bond donor and acceptor sites compared to the minor 
groove, therefore most of the DNA-interactive proteins bind in the major groove (3, 11). However, 
most of the small molecules less than 1000 Da with antibiotic and anticancer properties bind in the 
minor groove of DNA primarily.   
1.3 Recognition of the minor groove of DNA by small molecules 
Targeting the minor groove of nucleic acids through binding of small molecules helps in regulation 
of a wide variety of biological processes, therefore is an emerging field of interest. Typical small 
molecules that bind the DNA minor groove are heterocyclic dications and polyamides, for 
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example, netropsin, berenil, pentamidine and distamycin as shown in Figure 1.3. Natural Minor 
Groove Binders (MGB) include netropsin and distamycin. These compounds preferentially bind 
to the AT rich regions in the minor groove (12). Netropsin binds in the minor groove as a monomer 
whereas distamycin and its analogues, usually bind as a dimer in a widened minor groove, face to 
face and antiparallel (13-15). Synthetic compounds need proper curvature and positive charge to 
bind to the minor groove of DNA (16). In order to expand the sequence recognition capabilities 
and surpass the classical AT specific agents to include more mixed base pair (bp) sequences, re-
designing of the small molecules is essential. 
Designing of such sequence-specific small molecules may provide a powerful tool that can 
be directed towards production of valuable therapeutic agents. Some of these designed synthetic 
dicationic compounds are clinically used as therapeutic agents against a number of diseases (17-
20). For example, pentamidine (bis-amidine) shown in Figure 1.3 has been used for antiparasitic 
therapy since the 1940s (21, 22) but like many others among these compounds, it has several 
toxicity issues including provocation of hypoglycemia and renal and hepatotoxicity. The potent 
DNA binding capability of DAPI, a fluorescent compound, makes it an important stain in cellular 
microscopy and shows antitrypanosomal activity (23). Hoechst dyes which belong to the bis-
benzimidazoles class of compounds are also strong minor groove binders with fluorescent 
properties depending upon the attached substituents (24). For example, Hoechst 33258 is very 
effective as a human topoisomerase I poison, yet it failed in phase II trials after passing human 
phase I clinical trials for pancreatic cancer (25, 26). Several analogues of Hoechst 33258 and a 
large number of hybrid molecules were synthesized based on netropsin and distamycin (Figure 
1.3) with improved selectivity and specificity and with reduced side side-effects (27, 28).  Study 
of the small molecule-DNA complexes also provides insight into the structural and thermodynamic 
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characteristics of the complexes (29, 30). Based on wide-ranging experience in design of minor-
groove agents for AT recognition, an approach to rationally design the compounds which can bind 
strongly to mixed base pair DNA sequences is quite attractive (31-34).  
Hydrogen bonding, electrostatic interactions along with the strong van der Waals 
interactions helps to stabilize small molecule-DNA complexes. Highly structured water molecules 
also play an important role in mediating the interactions of ligands in the minor groove of DNA 
without any loss in binding affinity (35-37). Targeting the nucleic acids through small molecules 
is still a challenge due to low specificity of DNA binders and high rate of their failure in clinical 
trials. Therefore, progression in the discovery of new small molecules requires further 
development of structural biology and other related technologies.  
1.4 NMR Spectroscopy in small molecule-DNA complexes 
To understand the biological importance of nucleic acid complexes, various biophysical, 
biochemical and spectroscopic methods have been used to provide atomic level descriptions of 
such recognition. NMR spectroscopy is a well proven method for elucidation of high-resolution 
structures and dynamics of the biomolecular complexes including many other systems which 
cannot be solved by X-ray diffraction studies (38, 39). In addition, NMR can also directly provide 
valuable experimental data on small molecule-DNA complexes, for example, quantitative and 
qualitative binding information can be obtained through changes in NMR parameters. Binding site 
of small molecule in the complex can also be obtained through change in chemical shift of the 
assigned NMR signals of the complex.  
The development of [1H, 1H] nuclear Overhauser effect spectroscopy (NOESY) has made 
it possible for NMR spectroscopy to evolve as an alternative approach to X-ray crystallography in 
the determination of protein and nucleic acid conformation in solution (40). In NOESY 
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experiment, short (< 5 Å) inter-nuclear distances between hydrogen nuclei can be measured and 
directly used to probe the conformation of a molecule in solution. NMR techniques have been 
widely used to study the interactions of small molecules in the minor groove of DNA in solution 
(41). NMR has also been able to provide high-resolution structures of small molecule-DNA 
complexes in solution in conjunction with molecular dynamics simulations. In the early days, 
structures were solved for quinoxaline antibiotics nogalamycin, actinomycin, and the 
anthracyclines and they were in close agreement with the structures solved by X-ray diffraction 
(42-47).  NMR has also provided a wealth of information about various minor groove binding 
compounds including oligopyrrole ligands such as netropsin, distamycin and bis-benzimidazoles 
related to Hoechst 33258, bisquaternary ligands and bisamidine ligands related to pentamidine 
(48-50). Moreover, NMR studies on these complexes have also revealed internal binding kinetics 
such as exchange rate calculations (51-53) and the dynamic information provided by NMR also 
helps to further clarify intermolecular interactions. Information obtained from NMR on small 
molecule-DNA complexes also depends upon the small molecule concentration in the solution, 
which is often limited by its solubility and aggregation, i.e. around 0.5-2.0 mM. Several 
computational methods and force fields have also been significantly improved which have helped 
in designing novel small molecules targeting nucleic acids.   
1.5 Outline of Chapters and Goal of the Research  
This dissertation is primarily focused on DNA and its complexes with small molecules. Much of 
the research work described in this dissertation elaborates the recognition of mixed bp sequences 
by novel heterocyclic diamidine molecules. The approach used here also provides substantial 
information on the highly efficient, sequence-specific, and dynamic nature of minor groove 
binding agents. The following three chapters are mainly focused on determining the structural and 
6 
dynamic aspects of DB2277, a novel heterocyclic diamidine, binding in the minor groove of DNA. 
Chapter 2 explores the binding affinity and dynamic aspects of DB2277 binding in the minor 
groove using over-thirty mixed base pair DNA sequences with the help of NMR, thermal melting 
and SPR techniques. Chapter 3 is focused on the determination of the first high-resolution NMR 
structure of the binding of heterocyclic cation compound, DB2277 that selectively recognizes 
mixed AT/GC bp DNA sequence in a 1:1 complex. Molecular features describing the recognition 
mechanism of both A/T bp and G/C bp are represented in this chapter in detail. Chapter 4 is aimed 
in looking at the phenyl ring rotation of the DB2277 molecule bound to the DNA by conducting 
multi-microsecond molecular dynamics simulations. This chapter also illustrates how a rotation of 
a phenyl group can occur in the bound state as well as how mixed base pair recognition can occur 
for monomer compounds in the bound state. The fundamental goal of all the research work shown 
here, is to expand the recognition capabilities of the newly designed sequence-specific heterocyclic 
compounds to recognize the vast array of biologically important and mixed bp DNA sequences. 
Modification in heterocyclic compounds that belong to the classical type minor groove binders is 
an approach to expand the applications of minor groove binders. 
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Figure 1.1 Central dogma. 
Central dogma includes two processes, transcription and translation which provide the 
information about genetic flow in the cell.      
 
 
 
 
Figure 1.2 A) Base pairing in DNA. B) Major and minor grooves in DNA. 
Two hydrogen bonds connect T to A; three hydrogen bonds connect G to C.       
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Figure 1.3 Typical DNA minor groove binding small molecules. 
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2.1 Abstract 
Sequence-specific binding to DNA is crucial for targeting transcription factor-DNA complexes to 
modulate gene expression. The heterocyclic diamidine, DB2277, specifically recognizes a single 
G•C base pair in the minor groove of mixed base pair sequences of the type AAAGTTT. NMR 
spectroscopy reveals the presence of major and minor species of the bound compound. To 
understand the principles that determine the binding affinity and orientation in mixed sequences 
of DNA, over thirty DNA hairpin substrates were examined by NMR and thermal melting. The 
14 
NMR exchange dynamics between major and minor species shows that the exchange is much 
faster than compound dissociation determined from biosensor-SPR. Extensive modifications of 
DNA sequences resulted in a unique DNA sequence with binding site AAGATA that binds 
DB2277 in a single orientation. A molecular docking result agrees with the model representing 
rapid flipping of DB2277 between major and minor species. Imino spectral analysis of a 15N-
labeled central G clearly shows the crucial role of the exocyclic amino group of G in sequence-
specific recognition. Our results suggest that this approach can be expanded to additional modules 
for recognition of more sequence specific DNA complexes. This approach provides substantial 
information about the sequence specific, highly efficient, dynamic nature of minor groove binding 
agents.  
2.2 Key words 
Nuclear Magnetic Resonance; Minor groove binders; Minor groove recognition; Mixed DNA 
sequences, Selectivity 
2.3 Abbreviations 
NMR, nuclear magnetic resonance; bp, base pair; hp, hairpin; SPR, surface plasmon resonance; 
RU, response unit from SPR; Tm, thermal melting; EXSY, exchange spectroscopy; NOESY, 
nuclear Overhauser effect spectroscopy; FPLC, fast protein liquid chromatography; B3LYP, 
Becke three-parameter hybrid functional combined with Lee-Yang-Parr correlation functional; 
DFT, density functional theory. 
2.4 Introduction 
Targeting transcription factor-DNA complexes for regulation of gene expression, is very attractive 
for the treatment of a number of diseases (1-3). This could be done by targeting the transcription 
factor (TF) or the DNA binding site (4). It has proven difficult to target TFs directly and they are 
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frequently considered “undruggable” (5). The alternative of targeting the DNA binding site of the 
TF with designed small molecules is, thus, gaining increasing attention (6-8). A barrier to this 
approach for control of gene expression in cells is that only a limited variety of small molecules 
bind strongly and sequence-specifically to DNA (9,10). The modification of heterocycles in 
classical type minor groove binders is an approach to expand the applications of minor groove 
binders (11,12). 
The greatest variety of A•T specific minor groove binding compounds such as netropsin, 
DAPI, pentamidine, furamidine and Hoechst 33258 and its analogs are a complement to the highly 
sequence-specific hairpin polyamides (13). Many of the A•T specific compounds are taken up by 
cells and have a unique variety of therapeutic as well as biotechnology applications (14,15). Non-
covalent binding minor groove agents have been used in therapeutic targeting of DNA in various 
types of cells with successful application all the way to clinical trials (16,17). As described above, 
many minor groove binding compounds are highly A•T specific (18) but it is essential to be able 
to better target mixed, A•T and G•C base pair (bp) sequences (19,20). Such novel compounds 
would be useful for a new class of potential drug molecules that can target promoter DNA 
sequences to modulate transcription factor binding (21-23). In order to expand past the pure A•T 
specific compounds, new types of compounds must be designed (24-26). These modified 
compounds still require the correct curvature and charge to match the minor groove but they will 
also need functional groups that have H-bond acceptors for favorable interactions with the G-NH2 
group that projects into the minor groove and presents a steric block to strong binding by A•T 
specific minor groove binders (27,28).  
Our understanding of G•C bp recognition by small molecule minor groove binders is very 
limited, and for use of the DNA minor groove for new drug design and development we need a 
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more detailed understanding of compound-DNA complexes (29-31). Compounds with aza-
benzimidazole H-bond acceptors have initially been designed for G•C recognition (32). DB2277 
(Figure 2.1) is a novel example with strong binding to an AAAGTTT binding site (32,33). 
Evaluation of an analog of DB2277 without the CH2O linker, for example, indicated the 
importance of flexibility in strong, sequence-dependent binding at mixed DNA sequence (32). To 
fully appreciate the binding of DB2277 to its target DNA sequence, structural information is 
required. NMR, in conjunction with molecular modeling, is uniquely suited to study the molecular 
interactions and dynamic behavior of DNA-ligand complexes (34-38). An initial NMR experiment 
for a DB2277 complex with an AAAGTTT sequence, however, revealed the surprising result that 
two species are present, even in a 1:1 complex. Interestingly, these two species were not observed 
in other high-resolution biophysical experiments (32,33). To understand these multiple binding 
species and their importance for compound design, we have investigated the DB2277 complex 
with numerous hairpin DNA duplexes. 
2.5 Results 
 Proton NMR Spectra 
The chemical shifts of DNA protons of the A•T and G•C bp have been used to monitor the binding 
of DB2277 with DNA. Numerous changes in the chemical shifts for DNA imino protons have 
been observed upon complexation with DB2277, particularly in the central region of the hairpin 
DNAs. We have investigated over thirty DNA sequences and results for six G-hp DNAs that 
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illustrate different modes of sequence-specific binding of DB2277 to DNA are shown here (Table 
2.1). 
 G-hp1 (AAAGTTT Binding Site) 
The G-hp1 DNA sequence gives well-resolved spectra with six A•T and four G•C bp signals and 
a broad upfield band for the unpaired T loop bases (Figure 2.1). Assignment of the imino proton 
signals of free DNA shown in the Figure 2.1 was done using 1D-NOE experiments. Titration of 
G-hp1 with DB2277 revealed both upfield and downfield chemical shift changes. The addition of 
DB2277 to G-hp1 at the ratio of 1:0.5 (DNA:DB2277) shows both free DNA and complex 
resonance peaks in the spectra indicating slow exchange on the NMR timescale. No significant 
chemical shift changes were observed for DNA imino peaks of the terminal bp of the duplex 
indicating their minimal contribution to binding with DB2277. The appearance of an unexpected 
additional peak at 11.3 ppm was observed with the addition of DB2277. This additional peak was 
not observed in 1D NMR spectrum of free DB2277 and the assignment of this peak which belongs 
to the bound DB2277 is discussed in detail below. No significant changes were observed after 
reaching a 1:1 ratio of DNA:DB2277. At ratios above 1:1, slightly broadened peaks are probably 
due to some non-specific, electrostatic interaction of the excess DB2277 cation with the anionic 
DNA backbone. No unbound G-hp1 peaks are observed at the binding ratio of 1:1 (DNA:DB2277) 
suggesting a tight binding of DB2277 with the G-hp1, in agreement with SPR results (33). 
For DB2277 binding with G-hp1 as a single species, six imino proton resonance peaks are 
expected for A•T bp at a 1:1 binding ratio. The imino proton spectra (Figure 2.1), however, reveal 
that all complex signals are doubled, even though the stoichiometry of binding is 1:1. The two sets 
of signals clearly indicate two binding modes for DB2277 with G-hp1, a major and a minor binding 
species based on signal intensity (39,40). Interestingly, other biophysical methods such as surface 
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plasmon resonance, mass spectrometry, circular dichroism and isothermal titration calorimetry 
also indicated a 1:1 complex between DB2277 and G-hp1 (33) but these methods were unable to 
show any evidence of two binding orientations of DB2277. The local symmetry (similar A•T bp 
sequences on both sides of the central G•C bp) of G-hp1 may result in the two orientations of 
DB2277 with similar energy. The two modes suggest complexes with reverse orientations in the 
AAAGTTT sequence (Figure 2.1) as previously observed for the polyamide minor groove binder, 
netropsin, in all A•T sequences (40). 
In order to understand the origin of the two bound species and to facilitate study of structural 
details of the DB2277-DNA complex a more detailed analysis of DB2277 binding to different 
DNA sequences was undertaken. It is important to understand the origin of the different compound 
orientations and how they can be modulated by DNA sequences. It seemed possible that formation 
of a unique complex could be achieved with DNA sequences that are less symmetric than the 
AAAGTTT motif in G-hp1. 
 G-hp2 (AAGTTT Binding Site) 
A 5’ A•T bp in G-hp1 (G-hp2) was removed to give a less symmetric binding site. The question 
to be addressed is whether changes of this type will give a single DB2277-DNA species with good 
binding affinity. Imino proton spectra of G-hp2 show one less A•T bp resonance peak (Figure 
2.2). At a 1:1 binding ratio of DNA:DB2277, the fraction of the minor species was reduced, but 
not eliminated relative to the G-hp1-DB2277 complex. The largest differences in chemical shifts 
between the major and minor species are observed for A4 and T6 imino protons which are adjacent 
to the central G. The chemical shift of T6 signal for the major species is downfield of A4 signal. 
It is very interesting that the minor species T6 signal is the most upfield while the minor species 
A4 is very downfield. In other words, the protons shift position is in an opposite way for these 
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major and minor species, in agreement with an opposite orientation of the DB2277 for two species 
evident in the flipping exchange model (Figure 2.1). In addition, the chemical shifts for the major 
binding species are similar to the major species in G-hp1 complex but with one less A•T bp signal. 
The less symmetric binding site reduces the amount of minor species. This result indicates that the 
less symmetric binding site in G-Hp2 relative to G-Hp1 is an advantage for obtaining a single 
species. While this may seem obvious for asymmetric sites, not all asymmetric sequences are 
advantageous for yielding a single binding species. 
Assignment of exchangeable protons of the G-hp2-DB2277 complex was done using 1D-
NOE and 2D NOESY experiments (Figures 2.3, 2.4, and 2.5). The ambiguity with the imino 
proton assignment due to exchange peaks was resolved by performing 2D EXSY experiments 
(Figure 2.6, 2.7 and 2.8). 2D EXSY experiments are similar to very short mixing time 2D 
NOESY. They are useful to define which 2D cross peaks are due to exchange. Intense exchange 
cross peaks in the EXSY experiment showing exchange between major and minor species and 
NOE-build up from adjacent bp in NOESY experiment are clearly discernible in Figure 2.6. 
 G-hp3 (AAAGTT Binding Site) 
Since the removal of a 5’ A•T bp in G-hp1 improved the imino proton spectra, in the next step a 
3’ terminal T•A bp was deleted from G-hp1 to remove sequence similarity in a different way. 
Despite similar imino proton spectra of free G-hp2 and G-hp3 DNA, their titration spectra with 
DB2277 were quite different (Figures 2.2 and 2.9 respectively). Surprisingly, the change at the 
3’ end of the binding site in G-hp3 resulted in sharp peaks with a significant increase in signal 
intensity of the minor species as compared to the G-hp2 complex. Clearly, the 3’ TTT side of the 
binding site is critical for the major species while the minor species is more sensitive to the 5’ 
AAA sequence. These observations show that the amount of the minor species is very sequence-
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dependent, even for two asymmetric sequences, AAGTTT and AAAGTT. Thus, the binding of 
DB2277 is quite sensitive to the A•T bp sequence flanking the central G•C bp. 
 G-hp4 (AACTTT Binding Site) 
A different possible method to improve the results for G-hp2 is to invert the central 5’ G•C bp, 
again with the goal of reducing the minor species. It is surprising that this change in the central 
G•C bp causes the minor species to significantly increase relative to the G-hp2 complex (Figure 
2.10) These results indicate that the DB2277 complex is also very sensitive to the orientation of 
the central G•C bp. The NMR results with G-hp1, 2, 3, and 4 with DB2277 illustrate the extreme 
sensitivity of the complex to the DNA sequence.  
 G-hp5 (AAGATA Binding Site) 
The 3’ TTT sequence clearly has a major role in directional binding with DB2277 since the 
removal of the T in G-hp3 causes large changes in the spectra. In G-hp5, the 3’ TTT was changed 
to ATA and this change yielded a single set of peaks for the complex at a 1:1 ratio. Examination 
of several 3’ modifications that reduce the local symmetry in the central region in different ways 
(data not shown) helped to pave the way towards a 3’ ATA change. At the binding ratio of 1:0.5 
(DNA:DB2277), double imino resonance peaks for the five A•T bp imino protons reveal the 
occurrence of one binding species and the free DNA. The almost equal intensity of these binding 
species shows two equally populated states. Single bp resonance peaks in the imino spectral region 
in the G-hp5-DB2277 complex at the 1:1 binding ratio show one selective binding orientation 
(Figure 2.11). The imino proton assignment of the G-hp5-DB2277 complex was done using a 2D 
NOESY experiment (Figure 2.12). The G-hp5-DB2277 complex at the ratio of 1:1 provides 
selective binding as desired.  The reduction of minor species in G-hp2 and single binding species 
in G-hp5 is clearly seen in the spectral comparisons in Figure 2.13. Decrease in intensity of the 
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peak at 14.5 ppm can be used as a probe to observe the reduction of the minor species from the G-
hp1 complex to G-hp5 complex.  
 G-hp6 (AACATA Binding Site) 
As observed with G-hp4, inversion of the central G•C in G-hp5 again results in the appearance of 
significant minor species signals in the spectra of DB2277-DNA complex (Figure 2.14). 
Therefore, the AAGATA binding site (G-hp5) sequence is the only one among over thirty oligomer 
hairpin duplexes investigated that provided very selective binding with DB2277. The success with 
G-hp5 relative to G-hp1 is due to two sequence changes. Removal of a 5’ A base to give a less 
symmetric binding sequence clearly reduces the minor species. The reason for the decrease of the 
minor form when the 3’ TTT is changed to ATA is less clear. Subtle changes in DNA 
microstructure, base substituent position and fit of DB2277 to the minor groove must be 
responsible for an enhancement of the major species. The DB2277 complex with the AAGATA 
sequence is now being used for high resolution NMR analysis of the structural details of the 
selective DB2277 complex. 
 15N-labeled central G in G-hp5 
To assign the peak at 11.5 ppm, a G-hp5 sequence was synthesized having the central G fully 
labeled with 15N. The proton spectra of 15N-labeled G-hp5 show five A•T bp imino proton peaks, 
as with the G-hp5 spectra (Figure 2.15). Splitting of the G5 imino proton resonance at 12.5 ppm 
is observed in the 15N-labeled spectra due to 15N-1H coupling (88 Hz) whereas a singlet is seen for 
G5 in the unlabeled DNA. Splitting of the G5 proton peak reverts to a singlet upon decoupling of 
15N (Figure 2.16). 
On addition of DB2277, the additional peak emerges at 11.5 ppm as observed in all other 
G-hp-DNA complexes. However, this peak shows no effect of 15N-labeling, which indicates that 
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this peak does not belong to G5. The aza-benzimidazole NH signal of DB2277 is generally 
downfield and exchanges with water. A strong H-bond of this proton to DNA should cause an 
additional downfield shift of the NH signal (41) and this signal should not be affected by 15N 
coupling. Moreover, in the molecular model of the G-hp1-DB2277 complex (Figure 2.17), the 
aza-benzimidazole NH of DB2277 is observed to form a strong H-bond with the carbonyl oxygen 
of an adjacent T base. Therefore, in this case, the signal at 11.5 ppm, not affected by 15N coupling, 
most likely represents the aza-benzimidazole NH of DB2277. Support for this assignment is also 
provided by NMR studies done by Leupin and coworkers (41) on Hoechst 33258 with A•T 
sequences. In this model, the benzimidazole NH proton faces into the minor groove and forms an 
H-bond with the carbonyl oxygen of a T base. The chemical shifts for the labile protons of 
benzimidazole NH are 11.3 and 12.3 ppm in the AATT complex (41), in general agreement with 
an observed signal between 11 and 11.5 ppm in Figures 2.13 and 2.15. 
 UV-Vis Thermal Melting 
Thermal melting experiments were performed on over thirty G-hp DNA sequences by monitoring 
DNA unfolding at 260 nm to screen the complexes based on their relative binding affinity with 
DB2277. The addition of DB2277 to the hairpin oligomers in this study resulted in Tm increases 
(∆Tm) of 10-14 °C. The DB2277 strongly stabilizes the G-hp1-5 as clearly indicated by their ∆Tm 
values (Table 2.3) whereas, reversing the central G•C bp in G-hp6 decreases the thermal stability 
of the complex (∆Tm value is 8.7 °C). 
 Surface Plasmon Resonance 
Biosensor-SPR methods provide a quantitative estimation of the interaction of small molecules 
with DNA and other biomolecules (42). Very fast association and slow dissociation rates make 
DB2277 a very strong binder for single G•C-containing mixed sequences. SPR data (Figure 2.18) 
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reveals that DB2277 binds strongly with the single G•C bp sequence in both AAGTTT (KD = 1.3 
nM) and AAGATA (KD = 4.4 nM). This represents a small difference in ∆G° for binding to these 
two oligomers (∆(∆(reveals that DB2277 binds strongly with the single number of factors. 
Certainly, the increased number of species for G-hp2 contributes to the more favorable ∆G° for 
binding. DB2277 forms a 5-fold weaker monomeric complex with AAGATA which has DB2277 
bound in one orientation. 
 Dynamics of Bound DB2277 
At a 1:1 binding ratio, only bound DNA is observed with separate peaks for the major and minor 
species. 2D EXSY provided clear evidence for the exchange between major and minor species of 
bound DB2277 and allowed evaluation of the exchange rate between both species. Strong cross 
peaks observed in EXSY spectra of the G-hp2-DB2277 complex shows the chemical exchange 
between species (Figures 2.6, 2.7 and 2.8). Exchange cross peaks observed in this short time 
experiment are not due to NOE from the adjacent bp, but due to the chemical exchange for nuclei 
in different environments. The exchange rate between the major and minor species is 6.8 s-1 at 303 
K and 2.8 s-1 at 285 K. The exchange rate was calculated by considering the chemical exchange 
between major and minor species for A•T bp imino protons (A4, T6 and T7 at 303 K and A4 and 
T8 at 285 K) which show sufficiently resolved signals (Table 2.4 and 2.5) (43,44). The exchange 
rate calculated from the EXSY spectrum at 50 ms mixing time, is in close agreement with the 
exchange rate calculated at 150 ms mixing time. 
2D EXSY also provided information about the exchange of the aza-benzimidazole NH 
proton of DB2277. The aza-benzimidazole NH interacts with G-hp DNA in two different chemical 
environments as reported previously (41). A clearly visible exchange cross peak has been observed 
for the labile NH proton of aza-benzimidazole of DB2277 in the EXSY spectrum (Figure 2.7). In 
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addition, 1D-NOE differences in the spectra clearly show the change in signal intensity at the 
central G and adjacent T base on irradiating the NH proton signal of the aza-benzimidazole moiety 
of DB2277 resonating at 11.25 ppm (Figure 2.2). The exchangeable NH proton of aza-
benzimidazole in different environments characterizes the major and minor binding species and is 
at 11.3 ppm and at 12.7 ppm in complex spectra, respectively (Figure 2.2).  
An interesting comparison between macroscopic dissociation rate constants from SPR data 
with the total exchange rate constant from 2D EXSY for DB2277 binding with G-hp1 is shown in 
Table 2.2. The apparent half-life for the exchange between different species is around 100 ms by 
NMR whereas the half-life for the bound DB2277 with G-hp2 and G-hp5 is in the range of 30-60 
s by SPR. Thus, the exchange between the major and minor species is much faster than the 
macroscopic dissociation of DB2277 from the complex. The long dissociation half-life of the 
complex compared to half-life of the exchange between species shows that DB2277 can flip 
rapidly between major and minor species while remaining bound to minor groove of DNA. Such 
microscopic exchange between two orientations of bound DB2277 is clearly represented in the 
model shown below. In addition, the free energy change for exchange of major to minor species 
can be calculated using intensities of resonances originating from the different species (∆G˚ = - 
RT ln [(IM)/(Im)] where [(IM)/(Im)]  = Keq) . The free energy difference between major and minor 
species is 0.95 ± 0.03 Kcal/mol at 303 K and 0.97 ± 0.03 Kcal/mol at 285 K (Table 2.5). The 
configurational entropy change associated with different orientations of the major and minor 
species is 0.4 kcal/mol⋅K using Boltzmann's entropy formula, S = kB ln (W) where kB is the 
Boltzmann’s constant and W is the number of possible configurations. Both dynamic amidine 
moieties and the –CH2O linker (as shown in the model in Figure 2.17) provide flexibility in the 
minor groove of G-hp2. This flexibility contributes to the ability of DB2277 to adopt a favorable 
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conformation and make optimum contacts with the minor groove structure. Removal of the CH2O 
linker, for example, results in a loss of both selectivity and affinity (32). From the clustering 
histogram of 200 Autodock runs (Figure 2.19), it has also been observed that the conformer in 
Figure 2.17 (A) is the most populated and most favorable with the lowest binding energy. 
The rapid, microscopic dynamics of DB2277 and netropsin (40) suggest that such 
dynamics may be a common feature of minor groove binding compounds, even those with quite 
low KD values. The flipping motion of DB2277 in different orientations is seen in the model in 
Figure 2.17 and is surprising for a compound bound to a DNA sequence. 
 Molecular Modeling of G-hp1-DB2277 Complex 
DB2277 fits quite well into the minor groove of the AAAGTTT binding site with an optimum 
curvature to follow the groove shape. Models of the two possible orientations (Figure 2.1) 
represented in Figure 2.17, are in general agreement with the experimental results and predict the 
observed strong binding of DB2277 into this sequence. The flexible -CH2O- linker is essential for 
the aza-benzimidazole moiety to track along the minor groove curvature and predicts a strong H-
bond with the exocyclic G-NH2 that projects into the minor groove of the binding site. The H-bond 
distance of aza-N with G-NH2 is 1.9 Å and 2.2 Å in conformers represented in Figure 2.17 (A) 
and (B), respectively. The NH of the aza-benzimidazole moiety also nicely projects towards the 
minor groove of the binding site and can form H-bonds with the carbonyl group of 5' T7 on the 
same strand and 3' T5 on the complementary strand as shown in Figure 2.17 (A) and (B) 
respectively (T=O---H-N distances are 2.0 Å and 1.9 Å, respectively). By van der Waals 
interactions, the two phenyl groups adequately stack parallel to both sides of the minor groove 
walls and provide an extended binding interaction with the flanking bases. Both amidine groups 
fit into the minor groove and dynamically form strong H-bonds with both N3 of A and O2 of T at 
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the flanking side of mixed DNA sequences (Figure 2.17). The inherent dynamic nature also allows 
the amidines to form H-bonds to deoxyribose O and the negatively charged phosphate backbone. 
The -CH2O- linker of DB2277 molecules in this model is serving primarily to add needed 
flexibility and appropriate distances to the groups of DB2277 to allow optimum DNA interactions. 
2.6 Discussion 
An imino proton NMR investigation on different single G•C bp-containing DNA sequences with 
an aza-benzimidazole compound, DB2277, revealed that rationally designed diamidine molecules 
can act as very sequence-specific probes at the minor groove of mixed sequences of DNA. The 
strong binding efficiency and highly dynamic binding nature of DB2277-G-hp complexes allow 
the ligand to form two reversed oriented microstructures in the minor groove of G-hp sequences. 
A key finding here is that the large dissociation off-rate of G-hp2 complex allows the DB2277 to 
microscopically rearrange in the complex without its complete dissociation from target DNA. The 
study also illustrates the different orientation preferences of DB2277 in G-hp DNA due to different 
microstructures and base substituent positions and how well the nature of the minor groove can 
mesh with the functional groups of the DB2277. Another major finding of a DNA sequence with 
a single species orientation for DB2277 with good binding affinity is essential for detailed NMR 
structural studies of the DB2277-DNA complex. The examination of binding spectra of DB2277 
with 15N-labeled G5 clearly shows the pivotal role of the exocyclic G-NH2 in H-bonding with the 
aza-benzimidazole moiety of DB2277. This research has provided exciting information about 
sequence specificity and exchange behavior of DNA minor groove binders which will help expand 
the scope of rationally designed molecules for DNA minor groove recognition.  
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2.7 Experimental protocol 
 Sample Preparation 
Sequences for selected hairpin DNAs are provided in Table 2.1 (Integrated DNA Technologies, 
Coralville, IA, USA). The heterocyclic diamidine, DB2277, was synthesized as previously 
described (32). 15N-labeled central G in G-hp5 was synthesized with 15N-labeled phosphoramidites 
using a 391 DNA synthesizer and then desalted by FPLC using an AKTA purifier. The purity of 
DNA was checked using denaturing gel electrophoresis. The DB2277 was prepared as 2 mM stock 
solution in double distilled water (ddH2O) and its concentration was calibrated against a known 
concentration of DSS (4, 4-dimethyl-4-silapentane-1-sulfonic acid), being used as an internal 
standard.  
 NMR Experiments 
1D and 2D NOE data were collected. Water suppression in NMR spectra was obtained using 1-1 
pulse sequence. In 1D-NOE difference experiment, selective imino proton resonances are pre-
irradiated to observe the NOE build up at proton resonances in proximity. Phase-sensitive NOESY 
spectra were recorded with 2048 × 400 data points in the two dimensions at different mixing times 
(150 ms and 50 ms). The spectral width was set at 24 ppm and 1 s relaxation delay was used for 
experiments in H2O. Both dimensions were acquired with cosine bell functions (SSB = 2). From 
2D Exchange Spectroscopy (2D EXSY), total chemical exchange rate is calculated for a two-site 
exchange using the following equations (Table 2.2): 
k = (1 / tm) ln ((r + 1) / (r - 1)) 
r = 4 XM Xm ((IM + Im) / (IM-m + Im-M)) - (XM - Xm)2 
The term r corresponds to unequal populations of the major and minor species. IM and Im are the 
diagonal peak intensities of major and minor exchangeable resonances in the EXSY spectrum and 
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IM-m and Im-M are the intensities of the exchange cross peaks, tm is the mixing time. XM and Xm 
are the mole fractions of the major and minor species (43, 50). 
 Surface Plasmon Resonance 
As the Biosensor-SPR approach responds to mass, it is an excellent method for comparative studies 
of dications that have very large differences in properties and equilibrium binding constants (K). 
The SPR experiments were performed at 25 °C in degassed and filtered Tris-HCl buffer (50 mM 
Tris-HCl, 100 mM NaCl. 1 mM EDTA, pH 7.4). Steady-state binding analysis was performed with 
multiple injections of compound concentration as previously described (33). Kinetic analysis was 
performed by globally fitting the binding results for the entire concentration series using a standard 
1:1 kinetic model with integrated mass transport-limited binding parameters as described 
previously (42, 45). The signal at saturation of binding sites allows direct determination of 
stoichiometry. 
 Molecular Modeling and Docking 
The center of the macromolecule is the grid center with a grid size of 72 Å×68 Å×108 Å and a 
grid spacing of 0.375 Å. Docking runs were performed using the Lamarckian genetic algorithm 
(LGA) with no modifications of docking parameters. LGA was used because of the existence of 
rotatable bonds in the ligands and to evaluate the correct conjugate DNA conformation, as it is 
known to reproduce various experimental ligand−DNA complex structures. Initially, we used a 
population of random individuals (population size of 150), a maximal number of 2500000 energy 
evaluations, a maximal number of evaluations of 2700, and a mutation rate of 0.02 fs. Two hundred 
independent flexible docking runs were conducted for each ligand, and then the lowest-energy 
dock conformation obtained from the Flexible docking was resubmitted for rigid docking to 
29 
remove the internal energy of the ligand (steric clashes) and retain the hydrogen bonding 
interaction with ds-DNA bases. 
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Figure 2.1 Shifts in the imino spectral peaks at different G-hp1:DB2277 ratios at 285 K. 
 
The major and minor binding species of DNA-DB2277 complex are represented by “ ” and “ ” 
labels, respectively. A schematic model showing two possible orientations of the DB2277 
complex with G-hp1 is at the top. The NMR sample consisted of 100 µM DNA at pH 6.9. 
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Figure 2.2 Shifts in the imino proton peaks at different G-hp2:DB2277 ratios at 285 K. 
 
The major and minor binding species of the DNA-DB2277 complex are represented by “ ” and 
“ ” labeled peaks respectively along with the exchangeable protons of aza-benzimidazole NH 
that are assigned from 1D-NOE and 2D NOESY shown in Figure 2.3 and 2.7. The NMR sample 
consisted of 100 µM DNA at pH 6.7. 
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Figure 2.3 Sequential assignment of imino protons of G-hp2 complex with DB2277 using 1D-
NOE difference spectra. 
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Figure 2.4 Sequential assignment of imino protons of G-hp2 complex with DB2277 using 
several 1D-NOE difference spectra in conjunction with 2D NOESY experiments. 
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Figure 2.5 Imino proton region of 2D NOESY spectrum of G-hp2-DB2277 complex using a 
150 ms mixing time at 285 K. 
Both NOE and exchange peaks (in circle) are visible. 
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Figure 2.6 Overlay of imino proton region of the NOESY spectrum (in blue) at 285 K and the 
EXSY spectrum (in red) at 303 K of G-hp2-DB2277 complex. 
EXSY experiment conducted at short mixing time 50 ms whereas NOESY experiment was 
conducted at 150 ms mixing time). Red cross peaks show exchange between major and minor 
species. Shifts in imino proton peaks of NOESY and EXSY are due to the temperature difference. 
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Figure 2.7 Imino proton region of EXSY spectrum of G-hp2-DB2277 complex at 285 K. 
2D NOESY recorded at short mixing time of 50 ms. Exchange cross peaks are marked with 
circles. 
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Figure 2.8 Imino proton region of EXSY spectrum of G-hp2-DB2277 complex at 303 K. 
EXSY spectrum was recorded at a short mixing time 50 ms. Exchange cross peaks are marked in 
circle. 
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Figure 2.9 Shifts in the imino spectral region peaks at different G-hp3:DB2277 ratios at 285 
K. 
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Figure 2.10 Shifts in the imino spectral region peaks at different G-hp4:DB2277 ratios at 285 
K. 
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Figure 2.11 Shifts in the imino spectral region peaks at different G-hp5:DB2277 ratios at 285 
K. 
Unique and selective binding species of the DNA-DB2277 complex are represented by the 
labeled peaks. The NMR sample consisted of 100 µM DNA at pH 6.7. 
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Figure 2.12 Imino proton assignment of G-hp5-DB2277 complex using 2D NOESY at 150 ms 
mixing time. 
Exchange cross peaks are marked in circle. 
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Figure 2.13 Comparison of imino proton peaks of G-hp DNA-DB2277 complexes at 285 K. 
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Figure 2.14 Shifts in the imino spectral region peaks at different G-hp6:DB2277 ratios at 285 
K. 
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Figure 2.15 Shift of imino proton peaks at 308 K in 1H NMR spectra of 15N labeled G-hp5. 
Splitting of imino proton of G-5 bp is highlighted along with the emergence of a new peak at 
11.5 ppm. The NMR sample consisted of 100 µM DNA at pH 6.7. 
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Figure 2.16 a) Splitting of G•C (5) imino proton peak due to 15N-1H coupling in the imino 
spectral region  of  1H  NMR spectrum at 308 K. b) Splitting of G•C (5) imino proton peak 
reverts back to singlet upon decoupling of 15N. 
a) Splitting of G•C (5) imino proton peak due to 15N-1H coupling in the imino spectral region  of  
1H  NMR spectrum at 308 K. b) Splitting of G•C (5) imino proton peak reverts back to singlet 
upon decoupling of 15N. 
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Figure 2.17 Minor groove views of the docked conformations of DB2277 with the AAAGTTT. 
(A, B) The stick in green-blue-red-yellow represents DB2277 ligand. The DNA backbone is 
represented as a tube form in orange, DB2277 interacting bases are in stick with grey-blue-red-
yellow and other bases are in stick with orange. (C, D) Important H-bond interactions between 
aza-N- with the exocyclic G6-NH2 and aza-benzimidazole NH either with N3 of A or the carbonyl 
group of T at bases flanking the central G. 
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Figure 2.18 Representative SPR sensorgrams for DB2277 binding to G-hp2 and G-hp5. 
Inset, the increase in the concentration of DB2277 as injected on immobilized DNA sequence. 
The solid black lines are best-fit values for the global kinetic fitting of the results with a single 
site function. 
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Figure 2.19 Clustering Histogram of multi-member conformations found out of 200 
Lamarckian Genetic Algorithm docking runs. 
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Figure 2.20 Shifts in peaks at different G-hp7-:DB2277 ratios in imino proton spectrum at 
285K. Spectra show significant minor form. 
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Figure 2.21 Shifts in peaks at different G-hp7-:DB2277 ratios in imino proton spectrum at 
285K. Spectra show significant minor form. 
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Figure 2.22 Shifts in peaks at different G-hp9:DB2277 ratios in imino proton spectrum at 
285K. In this sequence context the minor form is suppressed. 
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Table 2.1 Selected mixed-sequence hairpin DNAs. 
 
 
 
 
 
 
 
Table 2.2 Kinetic and equilibrium parameters calculated using SPR and NMR. 
 
 
a determined from SPR. b determined from NMR at short mixing time (50 ms) at 303 K (40). 
 
 
 
 
 
 
 
 
  
Abbrev. Sequence Abbrev. Sequence 
 
G-hp1 
AAAGTTT 
  
G-hp4 
AACTTT 
 
 
G-hp2 
AAGTTT 
  
G-hp5 
AAGATA 
 
 
G-hp3 
AAAGTT 
  
G-hp6 
AACATA 
 
Complex ka (M-1s-1) a kd (s-1) a KD (nM) a 1/kd (s) a kex (s-1)b 1/kex (s)b 
 
G-hp2-
DB2277 
 
(1.4 ± 0.8) × 107 
 
0.02 ± 0.01 
 
 
1.3 ± 0.1 
 
55.5 
 
 
6.8 ± 1.3 
 
0.15 
 
 
 
G-hp5-
DB2277 
 
(0.6 ± 0.4) × 107 
 
0.03 ± 0.02 
 
 
 
4.4 ± 0.3 
 
 
33.5 
 
- 
 
- 
6 
5' C C A A A G T T T G T 
3' G G T T T C A A A C C 
C 
T 
5' C C A A G T T T G T 
3' G G T T C A A A C C 
C 
T 
5 
6 
5' C C A A A G T T G T 
3' G G T T T C A A C C 
C 
T 
5 
5' C C A A C T T T G T 
3' G G T T G A A A C C 
C 
T 
5 
5' C G A A C A T A G T 
3' G C T T G T A T C C 
C 
T 
5 
5' C G A A G A T A G T 
3' G C T T C T A T C C 
C 
T 
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Table 2.3 Tm results of DNA hairpin oligomers and their complexes with DB2277 are reported 
within ± 0.5 °C. 
 
Hairpin DNA  
Native DNA Tm (°C) ∆Tm (DNA-DB2277 complex) (°C) 
G-hp1 68.5 13.5 
G-hp2 68.1 13.8 
G-hp3 68.5 12.0 
G-hp4 68.1 11.9 
G-hp5 65.2 10.3 
G-hp6 66.9 8.7 
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Table 2.4 Intensity and molar fraction of major and minor well-resolved peaks at 303 K and 
285 K. 
 
 
 
 
 
 
  
Peak 
No. 
A•T bp 
(303 K) 
Intensity 
Major 
peak 
IM 
Intensity 
Minor peak 
Im 
Intensity 
Major to 
minor peak 
IM-m 
Intensity 
Minor to 
major peak 
Im-M 
Molar 
fraction 
XM 
Molar 
fraction 
Xm 
    
     4 
2.38E+09 
2.42E+09 
2.29E+09 
 
3.13E+08 
3.25E+08 
3.22E+08 
 
9.02E+07 
9.36E+07 
8.96E+07 
 
9.83E+07 
1.09E+08 
9.83E+07 
 
0.88 
0.88 
0.88 
 
0.12 
0.12 
0.12 
 
 
     6 
1.97E+09 
1.93E+09 
1.93E+09 
 
4.68E+08 
4.09E+08 
4.59E+08 
 
9.79E+07 
9.95E+07 
9.95E+07 
 
8.47E+07 
8.09E+07 
8.51E+07 
 
0.81 
0.81 
0.81 
 
0.19 
0.19 
0.19 
 
 
     7 
2.04E+09 
2.05E+09 
1.91E+09 
 
5.65E+08 
5.95E+08 
5.46E+08 
 
1.43E+08 
1.40E+08 
1.35E+08 
 
1.65E+08 
1.67E+08 
1.67E+08 
 
0.78 
0.78 
0.78 
 
0.22 
0.22 
0.22 
 
Peak 
No. 
A•T bp 
(285 K) 
Intensity 
Major 
peak 
IM 
Intensity 
Minor peak 
Im 
Intensity 
Major to 
minor peak 
IM-m 
Intensity 
Minor to 
major peak 
Im-M 
Molar 
fraction 
XM 
Molar 
fraction 
Xm 
 
    4 
8.72E+08 
8.72E+08 
8.25E+08 
 
1.16E+08 
1.17E+08 
1.16E+08 
 
1.43E+07 
1.33E+07 
1.43E+07 
 
9.61E+06 
9.61E+06 
9.61E+06 
 
0.89 
0.89 
0.88 
 
0.11 
0.11 
0.12 
 
 
    8 
8.63E+08 
9.86E+08 
1.03E+09 
 
2.16E+08 
2.14E+08 
2.52E+08 
 
2.50E+07 
2.66E+07 
3.64E+07 
 
2.38E+07 
2.51E+07 
2.51E+07 
 
0.80 
0.82 
0.80 
 
0.20 
0.18 
0.20 
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Table 2.5 Exchange rate calculation of G-hp2-DB2277 complex from EXSY at 303 K and 285 
K. 
aThe reported errors are calculated using standard deviation from three repeated measurements 
on the same sample. 
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3.1 Abstract  
The high-resolution NMR structure of the first heterocyclic, non-amide, organic cation that 
strongly and selectively recognizes mixed AT/GC bp sequences of DNA in a 1:1 complex is 
described. Compound designs of this type provide essential methods for control of functional, non-
genomic DNA sequences and have broad cell uptake capability, based on studies from animals to 
humans. The high-resolution structural studies described in this report are essential for 
understanding the molecular basis for the sequence-specific binding as well as for new ideas for 
additional compound designs for sequence-specific recognition. The molecular features, in this 
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report, explain the mechanism of recognition of both A•T and G•C bps and are an interesting 
molecular recognition story. Examination of the experimental structure and the NMR restrained 
molecular dynamics model suggests that recognition of the G•C base pair involves two specific H-
bonds. The structure illustrates a wealth of information on different DNA interactions and 
illustrates an interfacial water molecule that is a key component of the complex.  
3.2 Key words 
DNA, minor groove binder, NMR spectroscopy, mixed base pair recognition, solution structures. 
3.3 Abbreviations 
Deoxyribonucleic acid (DNA); Nuclear Magnetic Resonance (NMR); Minor groove binder 
(MGB); Molecular Dynamics (MD) Simulations; Solution Structure 
3.4 Introduction 
Most known, non-polyamide minor groove compounds that bind reversibly to DNA are AT 
sequence specific (1,2). These include reference standards such as netropsin, stains such as 
Hoechst dyes, DAPI and others, and therapeutics including many heterocyclic cations (3-5). While 
these compounds have been quite successful in modulating specific biological functions, they are 
also quite limited for many applications by their lack of diversity in the sequence specific DNA 
recognition (6,7). As one approach to widen the sequence recognition of these compounds, we 
have introduced H-bond accepting modules to A•T recognizing groups to explore G•C (bp) 
recognition in the context of heterocyclic cation structures (8-10). 
The first step in this process, adding an H-bond accepting module for recognition of a G•C 
bp with flanking A•T bps, has been successfully accomplished with several quite different, new 
compound designs. One new design contains a central pyridine H-bond acceptor, DB2120 (Figure 
3.1 (inset)). The compound covers essentially a full turn of the double helix, and specifically and 
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strongly recognizes a single G•C bp with flanking A•T sequences (8,11). An N-methyl 
benzimidazole (N-MeBI) module has also been used as an H-bond acceptor when paired with a 
thiophene to create a sigma-hole structured interaction. This module also gives strong and selective 
recognition of a G•C bp (12). 
The compound investigated in this report contains an aza-benzimidazole (aza BI) H-bond 
accepting group, DB2277, (Figure 3.1). This molecule also recognizes a single G•C bp with 
flanking AT sequences (13-15). In order to extend the compound design efforts for single G•C bp 
as well as for extending the recognition to two or more G•C bp in more complex sequences, 
structural information on mixed sequence complexes is essential. Since we have not been able to 
obtain diffraction-quality crystals of DB2277-DNA complexes, high-resolution NMR experiments 
have been used in the structural analysis. A number of NMR studies of benzimidazole (BI) 
derivatives of Hoechst 33258 have been done with A•T binding sites and they show strong binding 
in the minor groove with much weaker binding at sites with G•C bps (16-19). Other minor groove 
binders, pentamine, berenil and SN6999, also bind strongly to AT minor groove sequences (20-
22). They all form H-bonds to acceptor groups on the A•T bp edges and fit the shape and width of 
the minor groove quite well. To this time, however, no previous NMR structural studies have been 
reported for heterocyclic cations with a G•C bp containing sequence. Since these non-amide 
compounds have excellent cell uptake and biological activities, there is a compelling need to 
develop analogs with broad DNA sequence recognition (23,24).  
A sequence that has been found to bind DB2277 strongly and in a single orientation has an 
–AAGATA– binding site (Figure 3.1B). This sequence has been used in the high-resolution NMR 
investigations of the DB2277–AAGATA complex structure reported here. Both 1D and 2D 1H and 
31P spectra were collected in H2O and D2O (buffer solution). The NMR results were used in 
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restrained molecular dynamics (rMD) calculations to determine the structure of the DB2277 
complex. Examination of the structure indicates that the aza BI group forms two strong H-bonds 
with the G•C bp. Based on the NMR restrained molecular dynamics model the complex is 
extensively hydrated and one amidine is linked to the DNA base pairs at the floor of the minor 
groove through a water interface. The other amidine forms a direct H-bond to the bases. The most 
dynamic part of the bound DB2277 is the H2O-linked amidine. The entire hydration layer is also 
quite dynamic. While a variety of classical AT specific compounds have had the structure of their 
DNA complexes determined by both NMR and X-ray, (25-28). this is the first compound in the 
heterocyclic cation family whose structure has been determined when bound to a mixed AT/GC 
sequence. The mechanism of GC binding is unique and illustrates new molecular recognition 
features that will be very useful for designing compounds to target specific sequences of DNA. 
3.5 Results 
 NMR 
In a previous 1D NMR study we reported the binding of DB2277 to a wide range of mixed DNA 
sequences containing a single, central G•C base pair, flanked by A•T bp tracts (14). The DNA 
sequence with an –AAGATA– binding site showed a selective binding orientation with DB2277 
at a 1:1 binding ratio and is, therefore, the sequence selected for high resolution NMR structural 
analysis presented here. The detailed NMR results including 1D and 2D 1H NMR spectra for both 
exchangeable and non-exchangeable protons, were obtained at 600 and 850 MHz. This complex 
gave excellent high-resolution spectra for structural insight into DB2277 binding in the minor 
groove of the mixed base pair DNA sequence. 31P 1D and 2D spectra were also obtained for 
assignment assistance and structural analysis. The detailed methods for these NMR results are 
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given in the supplementary material. The full sequence of the DNA hairpin used and the DB2277 
structure are shown in Figure 3.1 with their numbering schemes. 
 Imino proton spectra 
The –AAGATA– DNA hairpin complex with DB2277 displays well-resolved imino proton signals 
for 5 A•T and 4 G•C bp of DNA along with a broad upfield band for the unpaired T imino protons 
of the loop region (Figure 3.2). DB2277 was added up to a 1:1.4 DNA:DB2277 binding ratio into 
the solution containing DNA hairpin. After the addition of 0.4 equivalents of DB2277, free DNA 
signals start to disappear with the emergence of new peaks for the DB2277-DNA complex. This 
co-existence of free DNA and DB2277-DNA complex peaks demonstrates slow exchange between 
free DNA and the complex on the NMR chemical shift timescale. The absence of any free DNA 
peak at a 1:1 binding ratio also indicates tight binding of DB2277 with the DNA hairpin. Imino 
proton signals were assigned using 2D NOESY in 90% H2O/10% D2O. A single and selective 
binding orientation of the DB2277-DNA complex is observed in imino proton spectra with single 
resonance peaks for each base pair (Figure 3.2) (14). 1D proton NMR experiments of the DNA 
hairpin with 15N-labeled central G in the –AAGATA– binding site were conducted with DB2277 
and reported previously (14). The findings from this experiment along with 1D NOE experiments 
conducted on the DB2277-DNA complex allow the assignment of the peak at 11.5 ppm to a 
downfield shifted aza-benzimidazole-NH (BI -NH) proton signal of DB2277 (14).  
 2D NMR 
NOESY spectra in D2O buffer were collected to assign the free DNA and DB2277-DNA complex 
signals at 1:1 binding ratio. Assignments were confirmed by NOESY experiments conducted at 
both 600 and 850 MHz NMR at different mixing times (50 ms and 100 ms). NOESY experiments 
in 90% H2O/10% D2O were used to observe the specific binding of the exchangeable aza BI -NH 
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proton of DB2277 with DNA (14). Standard protocols for B-DNA assignment are used to assign 
DNA peaks (29,30). A sequential walk from the aromatic H6/H8 proton to the anomeric H1’ sugar 
protons of adjacent bases was used for the assignments (Figure 3.3 and 3.4). Protons of free DNA, 
free DB2277 and the DB2277-DNA complex in solution were assigned from the NOESY spectrum 
in D2O solution. These proton assignments were further confirmed and supported by employing 
2D TOCSY, 31P-correlated 2D spectra (HPCOR) and 13C-1H HSQC experiments (see details in 
the Methods section). A proton-decoupled 31P spectrum with phosphorus assignments for free 
DNA is shown in Figure 3.5 and chemical shifts of a 31P (δP in ppm) signal for both free DNA 
and DB2277-DNA complex are plotted in Figure 3.6. 
B1 and B1’ proton signals of DB2277 (Figure 3.1) were observed to resonate at the same 
chemical shift in the DNA-DB2277 complex spectra at a 1:1 binding ratio (as can be seen in Figure 
3.13 below). Similar degeneracy was observed for B2, B5 and B6 protons with B2’, B5’ and B6’ 
protons respectively. This suggests that these protons interchange due to the rapid flipping of the 
phenyl rings in bound DB2277. Despite their degeneracy, assignments of B1 versus B1’ 
overlapped proton pairs could be distinguished based on their location in the DB2277-DNA 
structure (as can be seen in the structure described below) and their vicinity to the specific DNA 
protons in the minor groove. For example, careful investigation of the structure of DB2277-DNA 
complex mentioned in detail below helps in assigning the phenyl proton in proximity to H2 protons 
of A3 and A4 as B1 whereas the phenyl proton close to the H4’/H5’/H5’’ proton of G5 and A6 as 
B1’. Other phenyl protons of DB2277 i.e. B2 vs. B2’, B5 vs. B5’ and B6 vs. B6’ were assigned 
similarly. Chemical shifts of NMR signals obtained from the free DB2277 protons and the DB2277 
protons bound to DNA are listed in Table 3.1. Assignments of free DNA and the DB2277-DNA 
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complex protons in the “NOE walk” of H6/H8 base-H1’ sugar region is shown in the 
supplementary Figure 3.4 and Figure 3.3 respectively.  
 Chemical shift perturbations and ring current effects 
The chemical shift differences between free DNA and DB2277-DNA complex for H1’, H2’ and 
H4’ sugar protons, H2 protons of adenine and methyl protons of thymine are shown in Figure 3.7. 
Chemical shift differences of H2’’, H3’ sugar protons, H6/H8 base protons and H5 proton of 
cytosine are shown in Figure 3.8, and imino proton shift differences are shown in Figure 3.9. 
Significant chemical shift differences are observed for the protons close to the central G in the 
minor groove of DNA as compared to the protons present in the flanking regions in the DB2277-
DNA complex (Figure 3.7).  
The significant upfield and downfield shifts can be explained by the ring current effect 
induced by the aromatic groups of DB2277 on DNA resonances. Nuclei present above and below 
the aromatic ring experience significant upfield shifts and nuclei in the plane of the ring experience 
significant downfield shifts. The significant upfield shift of H1’, H2’ and H4’ sugar protons is due 
to the mutual interaction of aromatic groups of DB2277 with DNA protons which depends upon 
their relative orientation in space. The upfield shifts of H1’ and H2’ sugar protons of G5, A6 and 
C18 in the binding site results from shielding from aromatic moieties in DB2277. The significant 
upfield shift (around 1.0 ppm) of H4’ sugar protons in the binding site of the DB2277-DNA 
complex is also evident in Figure 3.7. The H4’ proton of G5 is situated on top of the phenyl ring 
attached to the OCH2 group whereas the H4’ proton of its complementary base (C18) is situated 
below the phenyl ring attached to the aza BI moiety as evident in Figure 3.10. The upfield shift of 
H4’ protons of A6 and T7 is also due to their positioning in the plane of the aromatic moieties in 
DB2277.  
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The downfield shift of H2 protons of adenine (Figure 3.7) can be explained in a similar 
fashion by their position in the de-shielded region of conjugated systems in DB2277. The 
pronounced downfield shift effect experienced by the H2 proton of A6 in the binding site is due to 
the de-shielding caused by close positioning of this proton at the edge of a phenyl ring of DB2277 
(Figure 3.7). Small chemical shift differences were observed for protons in the flanking region of 
the DNA which are not in the vicinity of DB2277 (Figure 3.8 and Figure 3.9).   
A loss of connectivity through the H1’ sugar protons of T7 and T20 in the sequential walk 
from H1’ to base protons (Figure 3.3) is most likely due to the dynamics involved in the rapid 
flipping of phenyl rings of DB2277. The rapid flipping of phenyl rings of DB2277, as observed 
from NMR data (as can be seen in Figure 3.13 below), results in the interchange of phenyl ring 
protons as mentioned above. The observed loss of signals from these H1’ protons is supported by 
the induced ring current effects due to the relative orientation of the H1’ protons of T7 and T20 in 
relation to the aromatic rings of DB2277. Additionally, positioning of the H1’ proton of T7 right 
below the phenyl ring and the H1’ of T20 right above the aza BI group is evident in Figure 3.11.   
 NMR restraints 
Intramolecular NOEs of DNA and DB2277 along with the intermolecular NOEs between DNA 
and DB2277 were used for the structure calculations of DB2277-DNA complex. Intermolecular 
NOEs observed between the DB2277 protons and the DNA protons obtained from NOESY data 
are listed in Table 3.2. Strong intermolecular NOE contacts are observed for the DB2277 aromatic 
protons with A4, A6 and A16 protons of DNA and their assignments are listed in Table 3.2. The 
interactions of the DB2277 protons with DNA protons are also represented in the schematic model 
shown in Figure 3.12. 
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The aza BI -NH proton of DB2277 shows strong intermolecular contacts with the imino 
proton of G5 in the DNA-DB2277 complex at a 1:1 binding ratio (14). Similarly, B5 and B6 phenyl 
protons also show strong intermolecular NOE contacts with the imino proton of G5 in the DNA-
DB2277 complex (Table 3.2). The assignments for the strong intermolecular cross peaks observed 
between the H2 of adenine and phenyl protons of DB2277 in NOESY spectrum are shown in 
Figure 3.13.  Strong intermolecular NOEs are also observed between H1’ of G5 and B2 phenyl 
proton of DB2277 (Figure 3.3). The H1’ proton of C18 also shows strong intermolecular NOE 
contacts with B5 and B6 phenyl protons and NOEs are marked in the NOESY spectrum in Figure 
3.3. These important intermolecular contacts also localize the specific binding of DB2277 with the 
central G in the minor groove of DNA. 
The B1 and B2 phenyl protons of DB2277 show strong intermolecular contacts with the 
H2 protons of A3 and A4 and with the H1’ proton of G5. These NOEs reveal that the B1 and B2 
protons of the phenyl ring in DB2277 are pointed towards the floor of the minor groove (Figure 
3.13). The B1’ and B2’ phenyl protons show NOE with H5’ of A6 which reveals that these phenyl 
protons are facing more towards the top of the minor groove (Table 3.2). Intermolecular cross 
peaks observed between the B5’ and B6’ phenyl protons of DB2277 and the H4’/H5’ of C18 and 
T19 of DNA verify that these protons also face towards the top of the minor groove of DNA (Table 
3.2).  The intermolecular contacts of the B5 and B6 protons with H1’ of C18 and H2 of A6 show 
that these protons are pointing towards the floor (bases) of the minor groove of DNA (Figure 3.13 
and Table 3.2).  
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 Restrained Molecular Dynamics Simulations (rMD) 
MD simulations with NMR restraints were performed on both free DNA and the DB2277-DNA 
complex. An initial B form DNA model was generated in AMBER. The detailed methods for rMD 
calculations are given in the supplementary material. 
The parametrization of DB2277 is described in the supplementary section. The optimized 
geometry of DB2277 is used in the initial structure for the DB2277-DNA complex. Visual 
inspection of various docked conformations from autodock-vina 4.0 helped to select the orientation 
of DB2277 in relation to DNA based on NMR restraints. The strong intermolecular contacts of H2 
protons of adenine with phenyl protons of DB2277 obtained from NOESY, assisted in defining 
the initial orientation of DB2277 in relation to DNA (Figure 3.13). For example, H2 protons of 
A3 and A4 are located in proximity to the phenyl ring attached to the OCH2 group and H2 protons 
of A6 and A12 are located in the vicinity of the other phenyl ring which is attached to the aza BI.  
Distance restraints from NMR data were calculated and incorporated along with other 
restraints as described in the Methods section. rMD simulations were performed on the free DNA 
and DB2277-DNA complex and a rmsd plot for free DNA in the –AAGATA– binding site from 4 
ns of rMD simulation is shown in Figure 3.14. The heavy atom rmsd value for free DNA in the 
binding site is 1.7 Å (Figure 3.14). The average structure from the 4 ns rMD is used as a reference 
frame for the rmsd calculation. 
An rmsd plot for the DB2277-DNA complex is shown in Figure 3.15. A heavy atoms rmsd 
(root-mean-square deviation) value for the DB2277-DNA complex from 2 ns of rMD simulation 
is 0.6 Å (Figure 3.15). The rmsd value for DB2277-DNA is in good agreement with the values 
obtained from previous DNA minor groove complex studies (16,31). The average structure from 
the 2 ns rMD is used as a reference for rmsd fitting. Snapshots were obtained every 10 ps for the 
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last 100 ps of rMD calculations for both free DNA and the DB2277-DNA complex. Energy 
minimization with NMR restraints was subsequently performed on these converged conformers in 
explicit solvation to remove any random thermal fluctuations. Superimposition of these final ten 
converged structures is shown in Figure 3.16 for free DNA and in Figure 3.17 for the DB2277-
DNA complex. More fluctuations were observed for the terminal G•C bp for both free DNA and 
the DB2277-DNA complex. The increase in flexibility at the ends of the double helix is a common 
observation in MD simulations of oligonucleotides (32). The NMR refinement statistics are 
provided in Table 3.3. The free -AAGATA- DNA structure has been deposited with accession 
numbers 6ASF (PDB) and 30335 (BMRB). DB2277-DNA structure has been deposited with 
accession numbers 6AST (PDB) and 30336 (BMRB). 
The final structure for analysis is obtained by averaging all the production run snapshots 
for the last 100 ps rMD simulation for both free DNA and the DB2277-DNA complex. This 
structure was subsequently refined with energy minimization. A minor groove view of the 
minimized average structure of the DB2277-DNA complex is shown in Figure 3.18. Furthermore, 
the DB2277-DNA equilibrated structure from the rMD simulation was also used for 200 ns of MD 
simulations without NMR restraints. Findings from the free MD calculations suggest that the 
DB2277-DNA complex remains stable for the simulation time period and DB2277 stays tightly 
bound into the minor groove of DNA in a single selective binding orientation.  
 Analysis of helicoidal parameters of DNA from rMD simulations 
The minor groove widths for free DNA and the DB2277-DNA complex were calculated from 
trajectories for the last 100 ps of rMD simulations. A comparison of minor groove widths for free 
DNA and the DB2277-DNA complex is shown in Figure 3.19. The minor groove widths are 
similar for the free and complex DNA but there is a slight clamping down of the complex at the 
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GC bp where the aza BI has two H-bonds for strong binding and specific recognition. Plots for the 
roll and twist angles for free DNA and DB2277-DNA complex are shown in Figure 3.20 
respectively. These angles are similar to the ones for the free DNA and do not show any systematic 
changes.  
Epsilon (ε) and zeta (ζ) torsional angles differentiate BII backbone conformations (ε-ζ > 
0°) from the canonical BI conformations (ε-ζ < 0°) of DNA (33). The equilibrium ratios of BI and 
BII conformational states of DNA in solution by NMR have been extensively investigated (34,35). 
To evaluate possible BII states in the free –AAGATA– and complex sequence JH3’-P coupling 
constants were determined experimentally from NMR to calculate ε torsional angles (Table 3.4) 
(36). Calculated ε values were used for rMD simulations for both free DNA and the DB2277-DNA 
complex. ε-ζ values calculated for selected dinucleotide steps towards the 5’ end side of the DNA 
from the last 100 ps of rMD simulations for free DNA and DB2277-DNA complex are shown in 
Figure 3.21. Other bases also show little or no variation in their ε-ζ values from the standard BI 
state. Values for all dinucleotide steps fluctuate around -90° except the C2pA3 step that shows 
more variation in ε-ζ values (Figure 3.21) but remains in the BI region.  
3.6 Discussion 
Our initial results with DB2277 demonstrated strong and specific binding of the compound to 
single G•C bp DNA sequences with flanking A•T bps (13-15). The results also illustrated the 
dependence of the binding on the compound structure. Isomers and close analogs of DB2277 
bound much more weakly and with low specificity. What these results did not reveal was the 
molecular basis of the specific recognition of single G•C bp DNA sequences by DB2277, which 
is addressed by the NMR and MD structural analysis reported here.   
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The –AAGATA– DNA binding site gives a unique complex with DB2277 that is amenable 
for high-resolution NMR experiments (14). Significant chemical shift changes are observed for 
both DB2277 and DNA on complex formation. For DNA the largest shifts are in the –AAGATA– 
sequence in agreement with that sequence as the DB2277 binding site.  The 2D NMR results 
provided distances in both the free DNA and DB2277 as well as interatomic distances in the 
complex that were incorporated into restrained MD calculations to provide a structure for the 
complex.  The results from the rMD calculations clearly show that DB2277 fits tightly into the 
minor groove at the G•C bp in the –AAGATA– sequence (Figure 3.22A and 3.18).  
The first question that we wish to address from the structure model is how does DB2277 
selectively recognize a G•C bp in a DNA sequence? The experimental structure models shown in 
Figures 3.10, 3.11 and 3.22 and the schematic in Figure 3.12 provide a clear answer. In the NMR 
restrained molecular dynamics model the G5-NH in the minor groove of –AAGATA– forms a 
strong H-bond with the aza-N of the aza BI group with the H-bond distance of 2.1 Å. Since this 
interaction was part of the original design this observation is quite informative (13). The DB2277-
G•C interaction is locked down by formation of an –NH to C=O 2.1 Å H-bond between the aza BI 
–NH and the keto group of C18 in the minor groove based on the model shown in Figure 3.10. 
The downfield shift of the aza BI -NH proton due to the strong H-bond with O2 of C18 is also 
supported by an NMR study conducted by Leupin and co-workers on Hoechst 33258 with A•T 
sequences (14,17). These two H-bonds form strong and specific interactions between DB2277 and 
the G•C bp that accounts for the specific GC binding. The second question is how are the flanking 
AT sequences recognized? As can be seen in the rMD model in Figure 3.22C, the amidine on the 
phenyl-amidine attached to the aza BI group forms a direct H-bond to a T keto group (H-bond 
distance of 2.2 Å) in the minor groove (T=O ●●●●● H-N amidine). The model also suggests that 
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the amidine-DNA interaction is stabilized by an ensemble of dynamic H-bonds to water molecules 
in the minor groove. The amidine-phenyl-aza benzimidazole module, thus, forms very strong, 
specific and favorable interactions with the target DNA sequence. The amidine at the other end of 
DB2277 interacts much differently with the bases at the floor of the minor groove. The amidine –
NH groups are too far from the bases to form direct H-bonds. Instead, there is an interfacial water 
molecule as suggested by the model in Figure 3.22B that links an amidine-NH to a T=O at the 
floor of the minor groove (-NH ●●●●● O-H ●●●●● O=T). This amidine group is also stabilized 
by a dynamic extended water network in the minor groove (Figure 3.22B). Interfacial water 
molecules are a key component of many protein-DNA complexes (see for example Poon, G.M.K. 
et al., 2017 and references therein) but are quite rare in the minor groove complexes of small 
organic cations (37,38). 
Two other features of the DB2277 molecule provide significant assistance to the strong 
binding in the minor groove complex. The –O-CH2– linkage provides appropriate spacing and 
flexibility to the system to track along the shape of the minor groove and appropriately index the 
functional groups of DB2277 with those of DNA. Removal of this linker gives a molecule with 
lower affinity for single GC sequences (13). Another stabilizing feature of the complex is from the 
phenyl C-H protons that are near the floor of the minor groove. These aromatic protons carry a 
small positive charge and can form a stabilizing interaction with A-N3 and T=O groups in the 
minor groove (Figure 3.22C) (21). These DB2277-DNA interactions coupled to the dynamic 
stabilizing hydration network provide a very favorable complex for specific DNA recognition. 
3.7 Conclusion 
Our previous studies have shown specific recognition of a single G•C bp flanked by AT sequences 
by DB2277 in the minor groove of DNA. The DB2277 molecule shows a single and selective 
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binding orientation with the –AAGATA– binding site of DNA. The molecular basis of the specific 
recognition of a single G•C bp in the –AAGATA– binding site of DNA by DB2277 is clearly 
defined by high-resolution NMR. Molecular dynamics calculations using NOE restraints from 
NMR provide structural insight into the unique DB2277-AAGATA complex. This is the first NMR 
structure for the DNA complex of the heterocyclic cation family compounds with a mixed AT/GC 
sequence. The NMR restrained MD results indicate that the strong interactions of G5-NH with the 
aza-N of the aza BI group and C18-O2 with aza BI –NH of the aza BI group are responsible for 
the specific recognition and tight fit of DB2277 at the G•C bp in the minor groove of DNA. The 
results also indicate that the DB2277-AAGATA complex is further stabilized by dynamic 
hydration network and an interfacial water molecule that plays a crucial role in mediating the 
amidinium proton-DNA base pair interactions. This information will be very useful in future 
design efforts of sequence specific minor groove binders. 
3.8 Experimental procedures 
 Sample Preparation 
HPLC-purified DNA hairpin with the binding site 5’-AAGATA-3’ was purchased from Integrated 
DNA Technologies, Coralville, IA, USA. The DNA sample was dissolved in diluted NaCl 
solution, and its concentration was measured using the extinction coefficient at 260 nm with a 
Cary UV/Vis spectrophotometer at room temperature (39). The DNA sample was dialyzed three 
times against double deionized water by using a Spectra/Por (Spectrum Laboratories, Inc., Rancho 
Dominguez) dialysis membrane with a cutoff of 1000Da and lyophilized. Denaturing gel 
electrophoresis and NMR were used to confirm the purity of DNA samples. The heterocyclic 
diamidine, DB2277, was synthesized as previously reported (13). The stock solution of DB2277 
was prepared in ddH2O or 99.96% D2O.  
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 NMR Experiments 
Spectra were obtained at Bruker Avance 600 MHz NMR equipped with a 5mm QXI probe, a 
Bruker Avance III HD 600 MHz NMR equipped with triple resonance probe and an Avance III 
HD 850 MHz NMR with a TCI cryoprobe. DNA concentrations were used around 100 μM for 1D 
NMR experiments and in the range of 0.5 mM - 0.8 mM for 2D NMR experiments. The NMR 
experiments involving exchangeable protons were prepared with cacodylate buffer (10 mM 
cacodylic acid/NaOH at pH 7.0), NaCl (10 mM) ethylene diamine tetra-acetic acid (EDTA), and 
4, 4-dimethyl-4-silapentane-1-sulfonic acid (DSS) as an internal standard in 90% H2O-10% D2O 
at pH 6.7 (14). For 2D NMR experiments involving non-exchangeable protons, Tris-d11 buffer 
(10 mM in 99.996% D2O) with pH* around 6.3 was used in 99.996% D2O (40). Water suppression 
in 1D NMR spectra was obtained using 1-1 pulse sequence. 1D 31P spectrum was obtained on 
Bruker Avance 500 MHz NMR for both free DNA and DB2277-DNA complex. 85% Phosphoric 
acid in a capillary was used as an external reference. 
 2D NMR 
Phase-sensitive NOESY spectra were recorded for several mixing times (50 ms, 100 ms, 150 ms, 
300 ms), collected with 2048×512 data points in t2 and t1 dimension and a relaxation delay of 3.0. 
Spectra were recorded at 285 K and 298 K with the spectral width of 11 ppm. NOESY spectra 
were also recorded in H2O using 1-1 pulse sequence for water suppression, 150 ms mixing time 
and spectral width of 24 ppm. 1H, 31P-correlated 2D spectra (HPCOR) were used for the 
assignment of phosphorus resonances (41). Phase-sensitive TOCSY experiments were collected 
with 80 ms mixing time, 2048×1024 data points in t2 and t1 and 80 scans per t1 increment along 
with the spectral width of 11 ppm for the D2O sample. Phase-sensitive ROESY spectra were also 
recorded with a 100 ms spin-lock, a 2.5 s relaxation delay and 64 scans. 13C, 1H HSQC experiments 
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for the DNA-DB2277 complex were recorded for complete resonance assignment. CTNOESY 
(constant time NOESY) NMR was employed on [(5’-CCAAGCTTGG-3’)(5’-CCAAGCTTGG-
3’)). DNA to calculate epsilon torsional angles for this DNA sequence context. Data were 
processed with TOPSPIN (3.4 version, Bruker Biospin Inc., Billerica, MA). Spectra were zero-
filled during the processing to create a 2K × 2K matrix and apodized with shifted sine bell function 
(SSB = 2). 
 Distance Restraints 
Spectra of free DNA and DNA-DB2277 complex were assigned and integrated using SPARKY 
version 3.114 (42). Integration was performed using the Gaussian function with data used above 
the lowest displayed contour level for well-resolved peaks whereas data points within a selected 
rectangular box were used for partially-resolved peaks. NOESY data with 100 ms mixing time was 
used for integration of cross peaks volumes. Cytosine H5-H6 cross peak (2.45 Å), as a reference 
point, was used to calculate distance restraints from integrated cross peaks. NOEs were converted 
to interproton distances with the reference peak of known distance using the following equation: 
rij    = rref (Iij / Iref)-1/6  
where rij is inter-proton distance, Iij is NOE cross peak intensity between two protons i and j, rref is 
known distance of reference peak (Cytosine H5-H6) and Iref is the intensity of reference peak. 
Cross-peaks were classified as strong (< 3.5 Å), medium (< 4.0 Å) and weak (< 5.0 Å). 
Upper and lower error bounds of ± 25 %, ± 30 %, and ± 35 % respectively were used to derive 
distance restraints depending on their peak quality. For example, the percentage for upper error 
bound was increased for partially-overlapped peaks whereas 5.0 Å as an upper bound was used for 
well-assigned completely overlapped peaks and for long-range distances observed only in 300 ms 
mixing time NOESY data. 
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 DB2277 force field parametrization 
The initial geometry of DB2277 was optimized with an ab initio method (DFT/B3LYP theory with 
the 6-31+G* basis set) using Gaussian 09 (Gaussian, Inc., 2009, Wallingford, CT) with Gauss-
view 5.09 (43,44). Electrostatic potential calculations were performed for the DB2277 molecule 
using the DFT/B3LYP theory with the 6-31+G* basis set (45). Partial charges were derived using 
the RESP fitting method (Restrained Electrostatic potential) (46,47). Charge fitting to the 
electrostatic potential was calculated according to the Merz-Singh-Kollman scheme (48). 
All the parameters of the DB2277 molecule are required to run molecular dynamic 
simulations in the AMBER package. ANTECHAMBER, an AMBER tool, was used to generate 
force field parameter files using GAFF and parm99 force fields (49-51). The specific atom types 
adapted from the ff99 force field were used to assign atoms of the DB2277 molecule. Force field 
parameter files for the DB2528 molecule contains most of the parameters derived from the existing 
set of bonds, angles and dihedrals for the similar atom types in parm99 and GAFF force fields. 
The specified atom types used for the DB2277 molecule to generate the force field parameters are 
shown in Figure 3.23. The equilibrium bond length for CK-CA and the equilibrium bond angle 
for CA-CA-N2 were taken from the optimized geometry of DB2277 from Gaussian 09. Improper 
dihedrals were taken from the parm99 force field. Six torsional angles of DB2277 which are crucial 
in defining its conformation and its interaction with DNA, are as follows; 
1) N2-CA-CA-CA         
2) CA-CA-CT-H1    Need new parameters 
    CA-CA-CT-OS    Need new parameters 
3) CA-CT-OS-CA    Need new parameters 
4) CT-OS-CA-CA    Need new parameters 
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    CT-OS-CA-NC    Need new parameters 
5) N*-CK-CA-CA     Need new parameters 
6) NB-CK-CA-CA         
The values of torsional parameters for N2-CA-CA-CA and NB-CK-CA-CA dihedrals are already 
defined in previously reported parametrized data (52,53). The remaining dihedral angles (CA-CA-
CT-OS, CA-CT-OS-CA, CT-OS-CA-NC and N*-CK-CA-CA) (not defined in GAFF/Parm99 
force field) were re-parametrized. These dihedral angles specifically define the rotation around 
bonds connecting the phenyl group and aza-benzimidazole moiety.  Ab-initio calculations were 
performed using DFT/6-31+G (d) level of theory in Spartan 16 for defining the required 
parameters (54). Potential energy profiles for dihedral angles were obtained using constrained 
equilibrium calculations with dihedral angles varying from 0 to 180 degrees (52,53). The curves 
were fitted with the least square fitting in kaleidaGraph software using the following cosine 
function equation: 
∑ Vn/2 [1 + cos (nΦ – γ)]. 
where Vn is the torsional barrier, n is periodicity (0,1,2,3,4 or 6), and γ is phase angle. The frcmod 
file (force field modification) modified with these newly parametrized dihedral angles of DB2277 
is shown in Table 3.5.  
 Molecular Dynamics (MD) Simulations 
For molecular dynamic (MD) calculations the hairpin loop was not used and calculations were 
done on a double strand DNA. Hairpin loop doesn’t interfere in the complex formation (14). MD 
simulations were performed with Assisted Model Building with Energy Refinement (AMBER 14) 
(55). Canonical B-form dsDNA was built using a Nucleic Acid Builder (NAB) tool in the AMBER 
program (56).  
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The initial structure of the DNA-DB2277 complex was obtained using Autodock vina 
software (57). To perform simulations in explicit solvation conditions, free DNA and the DNA-
DB2277 complex were solvated in a truncated octahedron periodic box filled with TIP3P water. 
The box wall was extended to 10.0 Å distance from all the DNA or DNA-DB2277 complex atoms 
in each dimension. Counterions (Na+) were added to neutralize the system.  
The system was equilibrated with an AMBER14 package using “ff14SB” and 
ff14SB/chi/ez (i.e., parmbsc0_chiOL4_ezOL1) force field modifications for DNA (39,58). During 
the equilibration, the SHAKE algorithm was used to constrain all bonds involving hydrogen atoms. 
The Particle Mesh Ewald method with a 10.0 Å cutoff was used for electrostatic interactions. The 
ratio of peak heights of attenuated and reference spectrum obtained from CTNOESY spectra was 
used to obtain epsilon torsional values for ds[(5’-CCAAGCTTGG-3’)(5’-CCAAGCTTGG-3’)]. 
DNA (36). 
NOE restraints were applied as a potential with a flat bottom and parabolic sides with 
varying force constants as shown in the energy penalty plot in the Figure 3.24 (55). The restraint 
file also specifies the rk2 and rk3 values, the force constants for the lower and upper bounds, 
respectively. Standard backbone torsion angles for B-DNA (β, γ and χ) and sugar pucker restraints 
with a force constant of 50 kcal mol−1 Å−2 were used (59). Watson-Crick hydrogen bonding 
restraints were included using standard B-type DNA values and distance restraints from NMR 
were used with force constant of 20 kcal mol−1 Å−2 (59). ε torsion angles for both the DNA and 
DB2277-DNA complex were derived from experimentally determined values for ds[(5’-
CCAAGCTTGG-3’)(5’-CCAAGCTTGG-3’)). DNA. The restraint file containing all the above-
mentioned restraints was used for further molecular dynamic simulations.  In the first step of 
equilibration, the system was relaxed with 1000 steps of energy minimization using restraint file 
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for the DNA and DB2277-DNA complex. In the next step, the system was heated from 0 K to 300 
K over 10 ps using restraint file under constant-volume conditions. A production run on the system 
was subsequently performed for 4 ns for DNA and 2 ns for the DB2277-DNA complex in the NPT 
conditions (isothermal, isobaric ensemble) using restraints. The ensemble of final structures for 
DNA and the DB2277-DNA complex was obtained from every 10 ps for the last 100 ps of rMD 
calculations and subsequently minimized.  
The free MD simulation run in the explicit solvent was then performed without restraints 
for 200 ns for DNA and the DB2277-DNA complex on the PMEMD CUDA module of 
AMBER14. Analysis of helicoidal parameters of DNA was done using a CURVES+ program and 
cpptraj module (60,61). VMD 1.9 and UCSF Chimera molecular visualization software were used 
for graphics (62-64). 
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Figure 3.1 A) The molecular structure of DB2277, with numbering scheme for aromatic 
protons. B) DNA hairpin sequence used in the study. 
The structure of DB2120 is shown in the inset. 
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Figure 3.2 Imino proton spectra of DB2277 binding with DNA hairpin at several 
DNA:DB2277 binding ratios at 285 K. 
Assignment of the imino proton resonances was done using 2D NOESY. 
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Figure 3.3 NOESY spectrum of DB2277:DNA complex at 1:1 binding ratio at 285 K. 
 
Spectrum shows sequential walk through base proton to H1’ sugar protons (solid lines). 
Intermolecular NOEs are marked in green boxes and assigned as follows; a) C18 (H1’) - B5, b) 
C18 (H1’) - B6, c) G5 (H1’) - B2 and d) intramolecular DB2277 NOE, CH2O - B2. Missing peak 
(*) is connected through broken line. Additional peaks are assigned further in Figure 3.24. 
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Figure 3.4 NOESY spectrum of a free DNA hairpin at 285 K. 
Spectrum shows sequential walk through base protons to H1’ sugar protons. Additional peaks 
marked are assigned as follows: Cytosine H5-H6 (orange box), loop region (highlighted in 
brown). 
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Figure 3.5 1D proton-decoupled 31P spectrum with phosphorus assignments for free DNA at 
285 K. 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 The plot of chemical shifts of 31P (δP in ppm) for both free DNA and the DB2277-
DNA complex.  
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Figure 3.7 Chemical shift differences (Δδ in ppm) between free DNA and the DB2277-DNA 
complex for H1’, H2’ and H4’ sugar protons, H2 protons of adenine and methyl protons of 
thymine. 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Chemical shift differences (Δδ) between free DNA and the DB2277-DNA complex 
is shown in the chart for H2’’ and H3’ sugar protons, H5 of cytosine, H6/H8 base protons of 
the DNA. 
  
-1.5
-1
-0.5
0
0.5
1
C
h
e
m
i
c
a
l
 
S
h
i
f
t
 
D
i
f
f
e
r
e
n
c
e
 
 
(
Δ
δ
)
 
(
p
p
m
)
H1' H2' H2 H4' Methyl
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
C
h
e
m
i
c
a
l
 
S
h
i
f
t
 
D
i
f
f
e
r
e
n
c
e
 
(
Δ
δ
)
 
(
p
p
m
)
H2'' H3' H5 H6/H8
A
87 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Δδ between free DNA and the DB2277-DNA complex for imino protons of the 
DNA base pairs. 
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Figure 3.10 Specific interactions of G5 -NH2 with aza BI -N and C18-O2 with aza BI -NH 
moiety of DB2277. 
Ring current effects on H4’ protons of G5 bp in relation to phenyl rings of DB2277 (black 
circle). 
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Figure 3.11 Ring current effects due to the mutual interaction of H1’ protons of T7 and T20 
with phenyl rings of DB2277 (black circle). 
DB2277 is in ball and stick (C in magenta) and DNA is shown in stick representation (C in 
green). 
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Figure 3.12 Schematic model of interactions of DB2277 protons with DNA protons at the 
binding site. 
Strong/Medium interactions are shown in solid lines whereas weak interactions are shown in 
broken lines. •  represents the -NH2 group of amidine moieties. * NOE contacts observed in 90% 
H2O/10% D2O NOESY for exchangeable protons. 
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Figure 3.13 NOESY spectrum of the DB2277:DNA complex at 1:1 binding ratio at 285 K. 
Assignments of intramolecular DB2277 contacts are marked with green arrows whereas 
intermolecular NOEs of DB2277 with adenine of DNA are assigned and marked with red 
arrows. DB2277 protons are shown in green and H2 protons of adenine are shown in red. 
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Figure 3.14 An rmsd plot for heavy atoms of free DNA in binding site –AAGATA– 
Fitting applied to the average structure for 4 ns rMD. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 An rmsd plot for heavy atoms of the DB2277-DNA complex for the binding site –
AAGATA– 
Fitting applied to the average structure for 2 ns rMD.  
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Figure 3.16 NMR structure ensemble of free DNA. 
Snapshots were taken every 10 ps for the last 100 ps of rMD simulation and subsequently 
minimized. DNA is represented in new ribbon style (Ochre color). Hydrogen atoms and water 
molecules are omitted for clarity. 
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Figure 3.17 NMR structure ensemble of the DB2277-DNA complex. 
Snapshots were taken every 10 ps for the last 100 ps of rMD simulation and subsequently 
minimized. DNA is represented in new ribbon style (ochre) and DB2277 is shown in licorice 
(magenta). Hydrogen atoms, terminal bp and water molecules are omitted for the sake of clarity. 
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Figure 3.18 A) Minor groove view of final structure of the DB2277-DNA complex. B) Space-
fill representation of the DB2277-DNA complex. 
The DNA backbone is shown in ribbon style whereas the sugar and base region is shown in wire 
representation (gold color). DB2277 is shown in licorice (yellow for H, magenta for C, red for O 
and blue for N). Hydrogen atoms of DNA and water molecules are omitted for clarity. 
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Figure 3.19 Minor groove widths of free DNA and the DB2277-DNA complex. 
Free DNA (blue) and the DB2277-DNA complex (orange). Standard deviation calculated from 
last 100 ps trajectory of rMD. 
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Figure 3.20 A) Roll angles for free DNA and the DB2277-DNA complex. B) Twist angles for 
free DNA and the DB2277-DNA complex. 
Free DNA (blue) and the DB2277-DNA complex (orange). Standard deviations are calculated 
over all frames (each frame of 0.5 ps) for the last 100 ps trajectory of rMD. 
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Figure 3.21 Plots for ε-ζ dihedral angles vs time frames for the last 100 ps of the rMD 
simulation for the free DNA and DB2277-DNA complex. 
Free DNA (blue) and the DB2277-DNA complex (orange).  
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Figure 3.22 The rMD model with water molecules. 
A) Minor groove view of the DB2277-DNA complex with proximal water molecules. Inset: B) 
Dynamic water network with amidine-NH and an interfacial water molecule that forms an H-bond 
bridge between amidine-NH and T20-O2 at the floor of the minor groove (Upper circle), C) The 
strong H-bond interaction of amidine-NH with T17-O2 along with an ensemble of dynamic H-
bonds to water molecules in the minor groove of DNA. DNA backbone is shown in tube (tan) 
whereas sugar and base region are shown in stick representation. DB2277 is shown in ball and 
stick (yellow for H, magenta for C). Hydrogen atoms are omitted from DNA for clarity. H-bonds 
are reported in Å. 
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Figure 3.23 Molecular structure with specific atom types used for the DB2277 molecule. 
 
 
 
 
 
 
 
 
 
 
Figure 3.24 Energy penalty plot. 
The violation energy is a well with a square bottom between r2 and r3, with parabolic sides out 
to a defined distance (r1 and r4 for lower and upper bounds, respectively), and linear sides 
beyond that distance (55).   
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Figure 3.25 NOESY spectrum of the DB2277:DNA complex at 1:1 binding ratio at 285 K. 
The spectrum shows sequential walk through base protons to H1’ sugar protons (solid lines). 
Additional peaks marked are assigned as follows: Cytosine H5-H6 in orange box, loop region 
marked in brown. Remaining peaks marked in blue are assigned as e) C18 (H1’) - A6 (H2), f) C18 
(H5) - T17 (H6), g) A4 (H1’) - A4 (H2). Peaks from sugar H3’ protons marked in red boxes. 
Missing peak (*) is connected through broken lines. 
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Table 3.1 Chemical shifts (in ppm) of free DB2277 protons and DB2277 protons bound to 
DNA. 
 
DB2277 protons Free (ppm) Bound (ppm) 
B1/B1’ 7.77 8.21 
B2/B2’ 7.68 7.96 
B3 6.86 7.28 
B4 7.95 8.27 
B5/B5’ 8.11 8.41 
B6/B6’ 7.87 8.20 
OCH2 5.50 5.86 
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Table 3.2 Intermolecular NOEs of DB2277 protons with DNA are listed. 
 
 
 
 
 
 
 
 
 
 
 
 
a Intermolecular NOEs observed in NOESY spectrum collected in 90% H2O/10% D2O. 
b Weak 
NOEs or NOEs visible only at long mixing times. 
 
 
 
 
 
 
 
  
DB2277 
Proton 
H2 H1’ H4’ H5’/H5’’ Imino 
proton a 
B1  A4, A3 b   G5  
B1’     A6 b  
B2   A4, A3 b G5, T19 b  G5 b  
B2’     A6  
B3    T19 b   
B4   T19 b   
B5 A6 C18, A6 b  T7 b G5 
B5’    C18, T19 b   
B6  A6, A16 T17, C18   G5 
B6’    C18 C18 b  
BI -NH     G5 
OCH2  T19 b    
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Table 3.3 NMR refinement statistics for free DNA and the DB2277-DNA complex. 
 
 
Structure statistics calculated from final converged 10 snapshots taken every 10 ps for last 100 
ps of rMD simulation. Experimental details are provided in supplementary materials and 
methods. 
 
 
 
 
 
 
 
 
 
  
RESTRAINTS FREE DNA  DB2277-DNA COMPLEX 
Total NOEs 254 276 
Intra-residue 175 179 
Inter-residue (sequential) 78 64 
DB2277 intramolecular - 6 
DB2277-DNA intermolecular - 25 
Backbone  88 88 
Base pair 35 35 
Sugar pucker 18 18 
Structure statistics 
Total distance violation (kcal/mol) 21.47 ± 0.96 31.73 ± 2.35 
Total bond length penalty (kcal/mol) 0.023 0.023 
Total angle penalty (kcal/mol) 2.52 ± 0.06 2.53 ± 0.06 
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Table 3.4 JH3’-P coupling constant values determined from CTNOESY NMR for duplex DNA 
ds[(5’-CCAAGCTTGG-3’)(5’-CCAAGCTTGG-3’)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Value could not be measured due to extensive overlap with water signal. 
 
 
 
 
 
 
  
Duplex 
CCAAGCTTGG 
JH3’-P 
Coupling (Hz) 
C1 5.7 
C2 5.4 
A3 3.9 
A4 3.7 
G5* -- 
C6 3.7 
T7 3.0 
T8 4.8 
G9 4.5 
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Table 3.5 The frcmod file showing complete parameters for the DB2277 molecule. 
 
MASS 
N2 14.01         0.530               parm99 
H  1.008         0.161               parm99 
CA 12.01         0.360               parm99 
HA 1.008         0.167               parm99 
OS 16.00         0.465               parm99 
CB 12.01         0.360               parm99 
N* 14.01         0.530               parm99 
NB 14.01         0.530               parm99 
NC 14.01         0.530               parm99 
CK 12.01         0.360               parm99 
H1 1.008         0.135               parm99 
CT 12.01         0.878               parm99 
 
BOND 
CA-CA  469.0    1.400       parm99 
CA-CB  469.0    1.404       parm99 
CA-CT  317.0    1.510       parm99 
CA-NC  483.0    1.339       parm99 
CA-HA  367.0    1.080       parm99 
CA-N2  481.0    1.340       parm99 
CB-CB  520.0    1.370       parm99 
CB-NC  461.0    1.354       parm99 
CB-N*  436.0    1.374       parm99 
CB-NB  414.0    1.391       parm99 
CK-N*  440.0    1.371       parm99 
CK-NB  529.0    1.304       parm99 
CK-CA  469.0    1.460       force const:parm99,length;CA-CB:Gaussian  
H -N2  434.0    1.010       parm99 
CT-H1  340.0    1.090       parm99 
CT-OS  320.0    1.410       parm99 
CA-OS  372.4    1.3730      gaff, ca-os 
 
ANGLE 
N2-CA-N2    70.0      120.00    parm99 
H -N2-H     35.0      120.00    parm99 
CA-CA-N2    70.0      119.99    force const: parm99,CM-CA-N2:Gaussian  
CA-N2-H     50.0      120.00    parm99 
CA-CA-CA    63.0      120.00    parm99 
CA-CA-HA    50.0      120.00    parm99 
CA-CA-CT    70.0      120.00    parm99 
CA-CT-H1    50.0      109.50    parm99, CA-CT-HC 
H1-CT-H1    35.0      109.50    parm99 
H1-CT-OS    50.0      109.50    parm99 
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CA-CT-OS    60.0      109.50    parm99, C -CT-OS 
CT-OS-CA    62.3      119.76    force const: gaff,c3-os-ca:Gaussian 
CA-CA-OS    70.5      115.46    force const: gaff,ce-c2-os:gaussian  
NC-CA-OS    73.8      119.56    force const gaff, nd-cc-os:gaussian 
CA-CA-NC    69.2      122.63    gaff, ca-ca-nb  
CA-CA-CK    63.0      120.00    parm99, CA-CA-CN 
CA-NC-CB    68.6      115.86    gaff, ca-nb-ca 
CB-CB-NC    70.0      127.70    parm99 
CA-CB-CB    63.0      117.30    parm99 
CA-CB-NB    70.0      132.40    parm99   
CB-CB-NB    70.0      110.40    parm99 
CB-CB-N*    70.0      106.20    parm99 
N*-CB-NC    70.0      126.20    parm99 
CB-N*-CK    70.0      105.40    parm99    
CB-N*-H     50.0      125.80    parm99   
CK-N*-H     50.0      128.80    parm99 
CB-NB-CK    70.0      103.80    parm99 
N*-CK-NB    70.0      113.90    parm99  
CA-CK-NB    70.0      120.00    parm99, CC-CV-NB    
CA-CK-N*    70.0      120.00    parm99, CC-CW-NA    
       
DIHE 
N2-CA-N2-H     4    9.60        180.0          2.0    parm 99, X -CA-N2-X  
CA-CA-N2-H     4    9.60        180.0          2.0    parm 99, X -CA-N2-X    
N2-CA-CA-CA    4    0.789       327.000       -4.0    Cheatham  
N2-CA-CA-CA    4   -3.118         0.000       -2.0    Cheatham 
N2-CA-CA-CA    4    0.609        90.000        1.0    Cheatham 
CA-CA-CA-CA    4   14.50        180.0          2.0    parm99, X -CA-CA-X   
CA-CA-CA-CT    4   14.50        180.0          2.0    parm99 
CA-CA-CT-H1    6    0.72        180.0          2.0    New parameter 
CA-CA-CT-OS    6    0.72        180.0          2.0    New parameter 
CA-CT-OS-CA    3    6.88          0.0          1.0    New parameter 
CT-OS-CA-CA    2    3.29        180.000        2.000  New parameter 
CT-OS-CA-NC    2    3.29        180.000        2.000  New parameter 
OS-CA-CA-CA    4   14.50        180.0          2.0    parm99, X -CA-CA-X   
OS-CA-NC-CB    2    9.60        180.0          2.0    Parm99, X -CA-NC-X  
CA-CA-CA-CB    4   14.50        180.0          2.0    parm99, X -CA-CA-X  
CA-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X   
HA-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
HA-CA-CA-CT    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
CB-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
NC-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
OS-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
CK-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
CA-CA-CA-HA    4   14.50        180.0          2.0    parm99, X -CA-CA-X 
CA-CA-CB-CB    4   14.00        180.0          2.0    parm99, X -CA-CB-X  
HA-CA-CB-NB    4   14.00        180.0          2.0    parm99, X -CA-CB-X 
108 
HA-CA-CB-CB    4   14.00        180.0          2.0    parm99, X -CA-CB-X 
CA-CA-CB-NB    4   14.00        180.0          2.0    parm99, X -CA-CB-X   
CB-CB-NC-CA    2    8.30        180.0          2.0    parm99, X -CB-NC-X 
N*-CB-NC-CA    2    8.30        180.0          2.0    parm99, X -CB-NC-X  
NC-CB-N*-CK    4    6.60        180.0          2.0    parm99, X -CB-N*-X  
CB-CB-N*-CK    4    6.60        180.0          2.0    parm99, X -CB-N*-X  
CB-CB-N*-H     4    6.60        180.0          2.0    parm99, X -CB-N*-X    
NC-CB-N*-H     4    6.60        180.0          2.0    parm99, X -CB-N*-X      
CA-CB-CB-NC    4   21.80        180.0          2.0    parm99, X -CB-CB-X   
CA-CB-CB-N*    4   21.80        180.0          2.0    parm99, X -CB-CB-X   
CA-CB-NB-CK    2    5.10        180.0          2.0    parm99, X -CB-NB-X 
N*-CK-NB-CB    2   20.00        180.0          2.0    parm99, X -CK-NB-X 
CA-CK-NB-CB    2   20.00        180.0          2.0    parm99, X -CK-NB-X   
NB-CK-N*-CB    4    6.80        180.0          2.0    parm99, X -CK-N*-X 
CA-CK-N*-CB    4    6.80        180.0          2.0    parm99, X -CK-N*-X 
CA-CK-N*-H     4    6.80        180.0          2.0    parm99, X -CK-N*-X  
N*-CK-CA-CA    4    3.42        180.0          2.0    New parameter 
NB-CK-CA-CA    4   -0.6         180.0         -4.0    DB921 
NB-CK-CA-CA    4    3.1         180.0         -2.0    DB921 
NB-CK-CA-CA    4   -0.7         360.0          1.0    DB921  
 
IMPROPER 
CA-CA-CA-HA         1.1          180.0         2.0          parm99 
CA-CA-CA-CA         1.1          180.0         2.0          parm99 
CA-N2-CA-N2         1.1          180.0         2.0          parm99 
CA-NC-CA-OS         1.1          180.0         2.0          parm99 
CB-N*-CB-NC         1.1          180.0         2.0          parm99 
CB-CK-N*-H          1.1          180.0         2.0          parm99 
CA-N*-CK-NB         1.1          180.0         2.0          parm99 
CK-CA-CA-CA         1.1          180.0         2.0          parm99 
CA-CA-CA-HA         1.1          180.0         2.0          parm99 
CA-CA-CA-HA         1.1          180.0         2.0          parm99 
CA-CA-CA-CA         1.1          180.0         2.0          parm99 
CA-N2-CA-N2         1.1          180.0         2.0          parm99 
CB-CA-CB-NB         1.1          180.0         2.0          parm99 
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My contribution to this chapter was molecular dynamics studies, and writing. 
4.1 Abstract  
DB2277, a heterocyclic diamidine, is a successful design for mixed base pair (bp) DNA sequence 
recognition. The compound has a central aza-benzimidazole group that forms two H-bonds with a 
GC bp that has flanking AT bps. The nuclear magnetic resonance structure of the DB2277−DNA 
complex with an AAGATA recognition site sequence was determined, and here we report 
extended molecular dynamics (MD) simulations of the structure. DB2277 has two terminal phenyl-
amidine groups, one of which is directly linked to the DB2277 heterocyclic core and the other 
through a flexible -OCH2- group. The flexibly linked phenyl is too far from the minor groove floor 
to make direct H-bonds but is linked to an AT bp through water-mediated H-bonds. The flexibly 
linked phenyl-amidine with water-mediated H-bonds to the bases at the floor of the minor groove 
suggested that it might rotate in time spans accessible in MD. To test this idea, we conducted multi-
microsecond MD simulations to determine if these phenyl rotations could be observed for a bound 
compound. In a 3 μs simulation, highly dynamic torsional motions were observed for the -OCH2-
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linked phenyl but not for the other phenyl. The dynamics periodically reached a level to allow 
180° rotation of the phenyl while it was still bound in the minor groove. This is the first observation 
of rotation of a phenyl bound to DNA, and the results provide mechanistic details about how a 
rotation can occur as well as how mixed bp recognition can occur for monomer compounds bound 
to the minor groove. 
4.2 Introduction 
We are systematically designing entirely new heterocyclic amidine derivatives with the goalof 
recognizing a range of biologically important DNA sequences that is much broader than what has 
been previously possible with these and related agents (1−8). Additional goals, which are 
addressed in the research described in this paper, are to better understand the dynamics of bound 
minor groove complexes and the roles that waters of interaction play in the structure, binding 
selectivity, and energetics of complex formation. Heterocyclic amidine cations, such as 
pentamidine, furamidine, and berenil, whose DNA complexes have been extensively investigated, 
are uniformly specific for binding to AT DNA sequences. To also recognize G·C base pairs (bps), 
it is necessary to incorporate H-bond acceptor units, as noted many years ago by Dickerson and 
Lown (9−12). To broaden the applications of heterocyclic amidines, particularly in therapeutic 
applications, it is essential to expand their sequence recognition abilities (1−8). It should be noted 
that pentamidine and berenil are already used in human and animal therapy, and furamidine has 
recently reached Phase III clinical trials against human parasitic diseases. These therapeutic 
successes suggest that the heterocyclic amidines are excellent prospects for expanded uses, and 
this has recently been confirmed in leukemia (13). 
The compounds listed above have H-bond donors for recognition of A·T base pair AN3 
and T2 C O groups but no available acceptors. DB2277 (Figure 4.1) is a member of a new class 
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of designed heterocyclic diamidines that specifically recognize a single G·C bp with a broad range 
of flanking AT sequences (1,2,5,7). There are quite a large number of nuclear magnetic resonance 
(NMR) and crystal structures of heterocyclic amidines binding to pure AT DNA sequences but no 
previous structures with a centrally bound GC base pair (14−20). To begin to understand GC 
recognition by the new agents, a number of mixed sequence DNAs were used in NMR studies to 
understand DNA sequence-dependent eﬀects of GC recognition by DB2277 in a minor groove 
complex (5). The formation of a unique 1:1 complex for NMR studies was achieved with a DNA 
sequence that has a central -AAGATA-binding site (7). 
The structure of the AAGATA−DB2277 complex was determined by two-dimensional 
NMR and found to be quite unusual. The aza-benzimidazole-phenyl-amidine end of the complex 
fits tightly into the minor groove with numerous van der Waals contacts, H-bonds, and solvent 
interactions. The experimental structure models (Figure 4.2) show that the G5-NH in the minor 
groove of AAGATA forms an excellent H-bond with the aza-N of the aza-BI group, as expected 
from the compound design (7). The DB2277−G·C interaction is further locked down by the 
unexpected formation of an H-bond between the aza-BI-NH group and the C14-O2 group (cytidine 
at position 14) in the minor groove (7). The flanking AT sequences also strongly interact with 
DB2277. The amidine on the phenyl-amidine attached to the aza-BI group forms a direct H-bond 
in the minor groove to an AT base pair (T O···H−N-amidine). The amidine−DNA interaction is 
additionally stabilized by an ensemble of dynamic water H-bonds in the minor groove (7). The 
complex is also stabilized by phenyl C−H protons that are near the floor of the minor groove. 
These aromatic protons carry a small positive charge and can form stabilizing interactions with 
the A-N3 and T O groups. The DB2277−DNA interactions coupled to the dynamic stabilizing 
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hydration network and van der Waals interactions provide a very favorable complex and specific 
DNA recognition for the aza-BI-phenyl-amidine module. 
The other phenyl-amidine of the complex is connected by a flexible -OCH2- to the aza-
benzimidazole (Figure 4.1). As a result of the overall complex structure, this terminal phenyl-
amidine rises away from the floor of the minor groove such that it cannot form direct interactions 
with the A·T bps at the floor of the groove. Instead, there is an interfacial water molecule that links 
the inner facing amidine-NH to T16-O2 (Figure 4.1) at the floor of the groove (−NH···O−H···O 
T). This water molecule, unlike the other waters that are well-known to externally stabilize minor 
groove complexes (21, 22) is an integral part of a trimeric DB2277−DNA−water complex. Both 
amidines are also stabilized by a dynamic, external, extended water network in the groove (Figure 
4.2). Similar waters of stabilization are seen in essentially all minor groove complexes that have 
been determined at suﬃcient resolution and are clearly a common feature of DNA minor groove 
interactions (23, 24). The unique feature of the DB2277−water interactions is the interfacial water 
interaction that is a very rare feature of small molecule−DNA complexes. It should be emphasized 
that the complexes that we are designing for GC bp recognition bind to the DNA minor groove as 
monomers and are quite diﬀerent from the extensively studied polyamides that form stacked dimer 
or hairpin binding units (25−28). 
To better understand the binding of DB2277 to a mixed base pair DNA sequence, we have 
conducted long time scale MD investigations for several reasons: (i) to investigate the local 
dynamics of both AT and GC bp interactions of DB2277 to better characterize the critical design 
features that are essential for strong, specific complex formation with mixed base pair DNA 
sequences; (ii) to determine whether the water-linked phenyl could rotate while DB2277 was 
bound tightly in the minor groove and, if so, determine what changes in the bound molecule, 
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interfacial water, and DNA are required to allow the flip; (iii) to determine whether in long MD 
simulations rotation of the other, directly H-bonded phenyl in DB2277 could be observed; and (iv) 
to investigate the influence on complex structure and stability of water molecules that are external 
to bound DB2277. By conducting multi-microsecond MD calculations starting with the NMR-
restrained DB2277 structure, we were able to observe the rotation of the flexible-linked phenyl as 
well as how this rotation aﬀects the interfacial water component of the complex. To the best of 
our knowledge, this is the first observation of rotation of an aromatic group bound to the DNA 
minor groove, and the mechanistic characteristics of the dynamic transitions are described here. 
4.3 Material and Methods 
Molecular dynamics (MD) simulations for 3.0 μs were performed without any restraints on the 
DB2277−AAGATA complex. All energy minimizations and molecular dynamics (MD) 
simulations were conducted on the PMEMD CUDA module of the Assisted Model Building with 
an Energy Refinement (AMBER14) program (29). The initial structure of the DB2277−DNA 
complex used in MD simulations was based on the restrained MD NMR structure [Protein Data 
Bank (PDB) entry 6AST] (7). 
To conduct the molecular dynamics simulations of the DB2277 complex in the AMBER 
package, all the parameters of the molecules are required. Amber contains the parameters for 
DNA; however, the parameters of DB2277 used for MD simulation must be determined, and the 
values are reported in detail below. The procedure used is similar to that described by the 
Cheatham group (30) and our group for minor groove binders (31)       
Force fields are key foundations of molecular mechanics with the fundamental assumption 
of Born-Oppenheimer approximation (32), where the energy of a system is described as a function 
of nuclear coordinates only. The accuracy of force fields further depends on the validity of 
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additional assumptions; additivity and transferability (32). Additivity corresponds to the 
expression of the potential energy of any system as a sum of different potentials and transferability 
refers to the development of the potential energy functions on a small set of molecules which can 
be applied to a much wider range of molecules with similar chemical groups. However, there is 
the limited availability of parameters for organic molecules in AMBER force fields (33). The 
equation to represent the additive form of force fields is as follows:                                                                                                                                                                                                                                                                                                                                                                                               
 
 
 
 
 
The force field involving separation of potential energy terms in the equation 1 is empirical and 
provides useful insight into the determination of molecular structure and dynamics. The energy 
terms used in the functional form of the force field are described below: 
The first term in the equation 1 represents the bond stretching and is denoted with a 
harmonic potential. Kr represents the force constant of the bond (generally very high), is an 
indication of the amount of energy required to stretch or compress a chemical bond significantly. 
r0 represents the reference bond length, defined by the value of the bond length when all other 
terms in the potential energy function are zero. 
The second term in the above equation 1 represents the change in potential energy in 
relation to deformation of bond angles. Kφ represents the force constant for the bond angle with 
values typically less than for bond stretching and is an indication that it takes less energy for a 
bond angle to deviate from its reference value.  
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The third term in the above equation 1 is referred to as the torsional term and is represented 
as the change in the potential energy of the molecular system as a function of the rotation about 
each dihedral angle. The energies involved here are significantly lower than for bond stretching 
and angle bending. Vn represents the barrier height, n represents the number of minima in the 
energy function (multiplicity) and γ is the phase factor, which determines the position of the 
minima. 
The fourth term in the above equation 1 is represented by the non-bonded interactions 
involving atoms in the molecule separated by 3 or more bonds and between atoms in the different 
molecule. This term includes both the electrostatic interaction through the Coulombic potential, 
and the van der Waals interaction using the Lennard-Jones 12-6 potential. The van der Waals 
potential contains an attractive and a repulsive term. The attractive part represents the dispersion 
forces generated between instantaneous dipoles, which arise from fluctuations in electronic charge 
distributions in all molecules. The repulsive term reflects the observation that atoms repel each 
other below a certain distance (typically close to 0.3 nm). The electrostatic potential term is 
represented by the sum of electrostatic potentials generated by charges placed on atomic nuclei, 
i.e., partial atomic charges where rij is the distance between the nuclei i and j. 
The foundation of classical force fields assumes that that similar chemical groups in 
different molecules interact in the same way (34). Therefore, the development of a force field is 
based on reproducing the energy surfaces for a set of small molecules that are typically well-
characterized and contain the functional groups that occur in all biomolecules. This assumption 
gives a force field very broad applicability. Thus, force field parametrization expansion for new 
atom and bond types plays a very important role in molecular mechanics. For the internal terms in 
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the force field function, equilibrium bond length and equilibrium bond angles are mostly obtained 
from the experiment and high-level ab-initio calculations (33). 
The first step in the generation of force field parameters includes specification of atom 
type of the molecule. Usage of more specific atom types helps in describing the chemical 
environment of molecule more accurately at the cost of burdening the parametrization (35). 
Selection of the consistent or appropriate charge approach is necessary to accurately fit the 
conformational and non-bonded energies in a transferable way. Default charge scheme used in the 
AMBER force fields (or GAFF parametrization), RESP “Restrained electrostatic potential” at 
HF/6-31G* works well with the small molecules (36-38). 
 Force Field Parameters for DB2277 
Most of the parameters in the force field parameter files for the DB2277 molecule were derived 
from the existing set of bonds, angles and dihedrals for the similar atom types in parm99 and 
GAFF force fields (35, 39). The assignment of specifying atom types for the DB2277 molecule 
used in generating the force field parameters are shown in previously reported NMR structure of 
DB2277-DNA complex (7). Optimized geometry of DB2277 from Gaussian 09 (40) was used to 
obtain the equilibrium bond length for CK-CA and the equilibrium bond angle for CA-CA-N2. 
Torsional angles of DB2277 listed below play a significant role in defining its conformation and 
its interaction with DNA; 
1) NB-CK-CA-CA and N2-CA-CA-CA: Obtained from previously reported parameters for DAPI 
and DB921 molecules (30, 31). 
2) N*-CK-CA-CA, CT-OS-CA-CA, CT-OS-CA-NC CA-CT-OS-CA, CA-CA-CT-H1 and CA-
CA-CT-OS: Obtained from previously reported parameters for DB2277 in DB2277-DNA NMR 
structure (70). 
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Since the dihedral angles, CA-CA-CT-OS, CA-CT-OS-CA, CT-OS-CA-NC and N*-CK-
CA-CA are not defined in GAFF/Parm99 force field, therefore these dihedrals were re-
parametrized and were reported earlier. These dihedrals define the rotation around bonds 
connecting the phenyl group and aza-benzimidazole moiety and are crucial in predicting the 
dynamic rotational movements of the phenyl and amidine moieties. Spartan16 (41) was used to 
perform ab-initio calculations using DFT/6-31+G (d) (42) level of theory for defining the above-
mentioned torsional angle parameters. Potential energy profiles were obtained for dihedral angles 
varying from 0 to 180 degrees (30, 31) and were fitted with the least square fitting in kaleidaGraph 
software using the following cosine function equation: 
∑ Vn/2 [1 + cos (nΦ – γ)] 
where Vn is the torsional barrier, n is periodicity (0,1,2,3,4 or 6), and γ is phase angle. The frcmod 
file (force field modification) modified with these newly parametrized dihedral angles of DB2277 
can be found in the previously published NMR structure of DB2277-DNA complex.  
The AMBER14 package was used to equilibrate the DB2277−DNA complex system using 
“ﬀ14SB” and ﬀ14SB/chi/ez (i.e., parmbsc0_chiOL4_ezOL1) force field modifications for DNA 
(43) Significant improvement in the development of empirical force fields and MD simulation 
methods has helped to describe the structure, energetics, and dynamics of nucleic acids more 
accurately (44−46) The parm94−99 force field was parametrized for simulation on the 1−10 ns 
time scale, but severe distortions of DNA structure were found in 50 ns simulations due to 
irreversible transitions in α and γ torsion angles. Thus, parmbsc0 (39) contains the reparametrized 
α and γ dihedral terms using the high-level quantum mechanical (QM) calculations on models of 
sugars and phosphates. Similarly, the χ distribution using relevant model systems was 
subsequently improved using various levels of theory in QM methods. The most tested χ 
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modifications are the “OL” modifications used in ﬀ14SB. Therefore, the combination of ﬀ14, 
ε/ζOL1, and χOL4, which includes ε/ζOL1 and χOL4 modifications to the ﬀ14 force field, is 
suitable to use for DNA (47). 
MD simulation of the complex was performed under explicit solvation conditions using a 
truncated octahedron periodic box filled with TIP3P water. The box wall was extended to a 
distance of 10.0 Å from any solute atom in each dimension. The system was neutralized by sodium 
cations using the LEAP module of AMBER. The particle mesh Ewald method with a 10.0 Å cutoﬀ 
was used for the correct treatment of electrostatic interactions. During the equilibration, the 
SHAKE procedure was applied to constrain all bonds involving hydrogen atoms to their correct 
values. The system was relaxed with 1000 steps of energy minimization in the initial phase of 
equilibration. Then the system was heated from 0 to 300 K over 10 ps under constant-volume 
conditions. A production run on the system was subsequently performed for 3.0 μs for the 
DB2277−DNA complex under NPT conditions (isothermal, isobaric ensemble). For the detailed 
investigation of the dynamic motions of the phenyl rings of DB2277, the time interval for each 
frame was decreased to 0.25 ps during the 1020−1021 ns period of the MD simulation. Helical 
analysis of the DNA was done using the CURVES+ module (48) and analysis of trajectories was 
performed using various scripts in the cpptraj module (49). All of the molecular graphics were 
generated using VMD 1.9 and UCSF Chimera molecular visualization software (50−52). 
4.4 Results and Discussion 
NOESY spectra obtained for the DB2277−AAGATA complex in D2O buﬀer show degeneracy in 
the chemical shift (δ) observed for all B1/B1′, B2/B2′, B5/B5′, and B6/B6′ phenyl proton pair 
signals of DB2277 as labeled in Figure 4.1 (7). Observed averaging of chemical shifts of phenyl 
proton signals could be caused by rapid phenyl rotation or by an unlikely complete chemical shift 
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overlap of all four sets of phenyl protons on the NMR chemical shift time scale. NMR data reported 
by Embrey and Searle et al. for Hoechst 33258 indicate that the similar overlap observed for phenyl 
protons of that molecule is caused by rotational averaging of the signals (53, 54). Intramolecular 
exchange rate calculations from EXSY NMR between the two opposite binding orientations of 
DB2277 in the DB2277−AAGTTT complex (5′−3′ and 3′− 5′) at a 1:1 binding ratio are 6.8 s−1 at 
303 K and 2.8 s−1 at 285 K (5). The half-life observed for the exchange between major and minor 
binding species is around 100 ms as determined by NMR, whereas the half-life for dissociation of 
the DB2277− AAGTTT complex is in the range of 30−60 s as determined by surface plasmon 
resonance. Therefore, the long rate of dissociation of DB2277 from the complex allows 
microscopic exchange between major and minor binding species of DB2277 while bound to DNA 
(5). It is also clearly evident from all of these observations that internal phenyl dynamics of 
DB2277 in the bound state are much faster than the exchange of DB2277 between binding 
orientations, end to end rotation, in the more symmetric minor groove complexes. With the -
AAGATA-sequence, only one favored bound form of DB2277 is observed, and this allowed 
determination of the DB2277− DNA complex structure (7).  
The initial conformation of the DB2277−AAGATA complex for MD simulations was 
based on the restrained NMR structure (7). The equilibrated structure obtained after 2 ns of MD 
with restraints obtained from NMR was used as an initial conformation for MD (Figure 4.1) (7). 
The three aromatic groups of DB2277 were initially very close to one plane, while the amidine 
groups are twisted ∼30° out of the phenyl plane due to a steric clash of protons on the phenyls and 
amidines (7).  
The DNA sequence used in the restrained NMR structure was retained in the MD 
calculations, and the DB2277 complex is shown in a schematic graphic in Figure 4.1. Because of 
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the labeling the DB2277 atoms in the 3.0 μs MD simulations, it was obvious that the phenyl at the 
top of Figure 4.1 (Ph1), attached to the flexible -CH2O-, had rotated 180° several times while no 
rotation of Ph2 was observed in this time span. The two phenyl-amidine groups of DB2277 are 
both H-bonded to T-O2 groups at the floor of the minor groove; however, the Ph1 phenyl-amidine 
(Figure 4.1) is coupled through an interfacial water that is an integral part of the complex, and the 
MD results show that it is very dynamic (Figure 4.2). The observation that the phenyl amidine 
rotates 180° during the MD simulation is the first observation of this type for a small molecule 
bound to DNA and allows us to evaluate the mechanism of flipping. 
The lower phenyl (Ph2), linked to BI, is constrained in the complex through an optimum 
H-bond of the inner-facing -NH2 group of the amidine (Am2) with T7-O2, as well as strong van 
der Waals interactions with the walls and floor groups of the minor groove (Figure 4.3). Because 
of these constraints, no 180° rotational motion was observed for phenyl Ph2 throughout the MD 
simulations. Beginning and ending views of the flipped structures of Ph1 (C1 and C2 point out in 
frame 1218, while C3 and C4 point out in frame 3763) and the constant orientation of Ph2 (C17 
and C19 are pointed out) are seen in Figure 4.3A. Clearly, the dynamics of these two phenyls are 
very diﬀerent. The average values calculated for torsional angles Ø2 and α2 (Figure 4.3B and 
Table 4.1) show no major fluctuations from the standard geometry of the conformation in the 
DB2277−DNA complex with Ø2 close to 17° and α2 at 43° (average). Figure 4.4 shows major 
fluctuations in torsional angles for Ph1, and these are discussed below. 
 Dynamic Internal Motions of Phenyl Ph1 
Ph1 was investigated in detail to understand the interplay of water, DB2277, and DNA in the 
flipping motion of this phenyl. The 180° rotation of Ph1 attached to -OCH2- is observed 16 times 
through the MD simulation. To analyze the flipping mechanism of the Ph1 phenyl, the MD 
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simulation frames related to a typical flip, 180° rotation, at ∼1 μs in the simulations, of Ph1 were 
observed in detail. Similar mechanisms of phenyl rotation in DB2277, however, were observed for 
all phenyl rotations in the simulation. Interestingly, the rotations observed for phenyl Ph1 were 
observed to happen in <1 ns, and the results shown here are captured for the rotation of Ph1 in 1 
ns time period between 1020 and 1021 ns of the MD simulation. 
For a high-resolution investigation of the rotational motion of Ph1, the time interval for 
each frame was decreased from our standard, 2 ps, to 0.25 ps. Up to frame 1218 of the observed 
nanosecond, the DB2277−AAGATA complex (Figure 4.2) stays close to the initial low-energy 
conformation that is similar to the published NMR structure of the complex (PDB entry 6AST) 
(7). In this conformation, N2 of the planar amidine, Am1, points above the plane of the aromatic 
groups of DB2277 (Figure 4.2) to facilitate the water-mediated H-bond with O2 of T16 
(N2−H···O−H···O−T16). C1 and C2 Ph1 phenyl atoms (Figure 4.2) project out of the minor 
groove in this structure. 
As a buildup to full phenyl rotations, substantial dynamic changes in Ø1 and α1 torsion 
angles of Ph1 phenyl are observed within a few picoseconds, i.e., around the 304.5−310 ps range, 
which relate to frames starting from frame 1218 and ending at frame ∼1240 (highlighted in orange 
bars in Figure 4.4 and shown in Figure 4.2) while maintaining H-bonds of the Am1 group in the 
optimum range with DNA (Table 4.1). A large change in the α1 torsional angle observed at the 
305 ps time step in the 1 ns flip region, i.e., from ∼40° to ∼137° (averaged), is highlighted by a 
red arrow in Table 4.1 and Figure 4.4. Concerted flexible twists of the highly dynamic Ø1 and α1 
torsions, in this time range, play a key role in maintaining the water-mediated H-bond contact with 
DNA that must be released before a 180° rotation can occur. The perpendicular position of Ph1 
with respect to other aromatic rings of DB2277 caused by dynamic thermal motions of the atoms 
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at 309.75 ps in frame 1238 is shown in Figure 4.2 with the large phenyl Ø1 twist of −73° and Am 
close to ∼150°. Highly dynamic states of Ø1 and α1 torsion angles of Ph1 between 305.25 and 
∼800 ps are evident in Table 4.1 and Figure 4.4. This dynamic range is well illustrated by frames 
1238, 1660, and 2700 in Figure 4.2, where a water-mediated H-bond contact of Am1 with T16-
O2 (T16-O2···H−O···H−N-Am1) helps to stabilize the complex energetics in frames 1660 and 
1238. The configuration of the DB2277−DNA complex in frame 2700 is stabilized by a dynamic 
H-bond water network of the amidine and T-O2 in the minor groove of DNA (Figure 4.2B). These 
large motions of Ph1 clearly set it up for a complete rotation, while no such motions are observed 
for Ph2 (Figures 4.3 and 4.4). 
 Role of Am1 Twist in the Ph1 Flip 
Role of Am1 Twist in the Ph1 Flip. Dynamic internal motions of the Am1 group play a vital role 
in stabilizing Ph1 in DB2277. The α1 torsion angle of amidine Am1 remains stable around −50° 
for almost 500 ps in the 1 ns trajectory as reported in Table 4.1 (highlighted in green) and Figure 
4.4 before a transition in amidine group rotation. As a result of the large torsional fluctuations, the 
H-bond to the interfacial water is lost (Figure 4.5A) and Ph1 rapidly flips so that C3, C4, and N2 
are pointed out of the minor groove in frame 3244 as compared to the orthogonal position of Ph1 
relative to other aromatic moieties in the molecule in frame 1238 as shown in Figure 4.2. The total 
time span from frame 1238 to 3244 is around 500 ps. In the conformation shown in frame 3238 in 
Figure 4.5, N1 points inside the minor groove but is placed below the plane of Ph1 with no possible 
H-bond or water-mediated contact with DNA. Although the three aromatic rings of DB2277 are 
roughly planar in this structure, there is no H-bond stabilization of the Am1 group, and this 
structure has an energy that is higher than the optimum energy. The Am1 amidine rotates to a 
position in the plane of Ph1 in frame 3244, and a water molecule forms an H-bond with T16-O2; 
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however, there is still no H-bond contact of amidine Am1 with DNA (Figure 4.5). Significant 
rotation of the α1 torsion angle of Ph1 of DB2277 [frames 3244−3248 (Figure 4.5)] helps to place 
Am1 in an optimal position to form a water-mediated H-bond contact of Am1 with T16-O2. 
Between frames 3244 and 3248 (Figure 4.5), the structure moves to a lower energy by forming 
the water-mediated H-bond contact of the amidine group with T16-O2 (T16-O2···2.2 Å···H-
O···1.9 Å···H−N-Am1). The three aromatics are close to planar, and water-mediated H-bond 
contacts help to stabilize this conformation. The dramatic transition of the α1 torsion angle from 
approximately −50° to approximately 40° within 0.5 ps (frames 3244 and 3245) is evident in the 
reported 810.75−811.25 ps time span marked with a red arrow in Table 1. This large twist observed 
in α1 of the Am1 group (Table 4.1 and Figure 4.4) facilitates the full 180° rotation in Ph1 as seen 
in frame 3763 at 940.75 ps (Figure 4.3A) which is quite similar to frame 3248 (Figure 4.5). C3 
and C4 atoms of the flipped phenyl point out of the minor groove after rotation in Figure 4.5. This 
low-energy con-formation of DB2277 is similar to the initial structure and remains stable for 
several hundred nanoseconds when Ph1 undergoes a reverse 180° rotation back to the initial state. 
Two key H-bonds responsible for the specificity and stability of the DB2277−DNA complex 
(Figure 4.3A) remain in an optimal range in the flipped phenyl conformations of DB2277 during 
rotation of Ph1: G5-NH2 with N of aza-BI (3.2 Å) and C14-O2 (cytidine at position 14) with NH-
aza-BI (3.2 Å). The lower phenyl Ph2 remains tightly bound in the minor groove of DNA with an 
H-bond contact of Am2-NH with T7-O2 (2.9 Å). 
The variations in the relative motions of the base pairs in the DB2277−DNA complex over 
the 1 ns trajectory of the Ph1 flip are represented in terms of their helical parameters (minor groove 
width, roll, and twist angles) displayed in Figure 4.6. Dynamic motions of the minor groove as 
the bound DB2277 phenyl-amidine undergoes large torsional fluctuations cause increases in the 
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minor groove width of DNA (Figure 4.6). Thus, transient breathing motions of the complex assist 
in the dynamic flipping of Ph1. Helical twist calculations for DNA are consistent with the 
published helical analysis of the NMR structure of the DB2277−DNA complex. 
In summary, we have shown how the flexible -OCH2- linker in DB2277 provides freedom 
for the Ph1 phenyl to project away from the floor of the minor groove of DNA. The flexibility of 
-OCH2- Ph1 helps DB2277 to track along the minor groove curvature by forming indirect and 
dynamic water-mediated H-bond contacts of Am1 with the bases at the floor of the minor groove. 
The flexibility and water-mediated contact allow Ph1 to rotate several times in a microsecond so 
that we are able to observe the rotation in a bound compound for the first time. During these flips 
of Ph1, the aza-benzimidazole H-bonds to G-NH2 and C-O2 (cytidine) of the central GC bp, which 
account for the mixed sequence recognition by DB2277, and H-bonds of the amidine of Ph2 remain 
quite constant. Neither the aza-BI nor Ph2 shows the large dynamic motions as seen with Ph1 or a 
180° rotation. 
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Figure 4.1 Molecular structure of DB2277 with the target DNA sequence. 
Abbreviations for aromatic rings are listed along with their torsion angles. Brown lines represent 
the nuclear Overhauser eﬀect interactions of DB2277 protons with specific DNA protons in the 
minor groove (7). Dashed lines illustrate the H-bond interactions of amidines with T-O2 in the 
minor groove of DNA. 
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Figure 4.2 Minor groove views of the DB2277−DNA complex. 
Ø1 and α1 torsion angles are shown at several key times (frame number at the top left) along with 
water-mediated H-bonds (yellow, angstroms). Panel A shows larger twists for α1 and Ø1, via 
comparison of frame 1218 with the orthogonal position of Ph1 relative to other aromatic groups 
of bound DB2277 in frame 1238. Starting at frame 1218 with C1 and C2 pointed out in panel A 
and end at the frame 2700 with C3 and C4 pointed out in panel B. The DNA backbone is 
represented as orange sticks with khaki space fill. The DB2277 molecule is shown as sticks (green, 
C). Water molecules are shown as balls and sticks. 
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Figure 4.3 Minor groove views of the DB2277−DNA complex with torsion angle plot for Ph2 
phenyl. 
(A) Minor groove views of the DB2277−DNA complex with reported Ø2 and α2 torsion angles of 
phenyl Ph2 and amidine Am2, respectively, for the initial frame and the end frame for a 1 ns 
trajectory of the Ph1 flip. Colors as in Figure 4.2. (B) Torsion angle plot of Ø2 and α2 angles of 
Ph2 in the bound DB2277 molecule for a 1 ns trajectory. The time interval for each frame in the 
plot is 0.25 ps of a 1 ns trajectory (1020− 1021 ns of the 3 μs MD simulation). 
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Figure 4.4 Torsion angle plot of Ø1 and α1 angles of phenyl Ph1 and amidine Am1, 
respectively, of the bound DB2277 molecule. 
1 ns trajectory of the Ph1 flip. Major transitions of Ø1 and α1 torsions are highlighted and 
illustrated in time frames in Figures 4.2 and 4.5. The time interval for each frame in the plot is 
0.25 ps of a 1 ns trajectory (1020−1021 ns of the 3 μs MD simulation). 
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Figure 4.5 Minor groove views of the DB2277−DNA complex capturing the concerted motions 
of water molecules and Am1 twist to facilitate the Ph1 flip. 
Frames captured within a few picoseconds (frames 3238−3248). Flipped Ph1 in complex with 
C3 and C4 atoms pointed out of the minor groove. (B) The water-mediated H-bond network of 
the Am1 group with the minor groove of DNA helps to stabilize the structure in frame 3248 as it 
approaches the minimum energy compared to other frames. Water-mediated H-bonds (yellow) 
between T16-O2 and NH of Am1 at the floor of the minor groove are reported in angstroms in 
diﬀerent frames. Ø1 and α1 torsion angles are also reported. Colors as in Figure 4.2. 
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Figure 4.6 Minor groove width, Roll angles and Twist angles of bound DNA in comparison to 
the NMR structure of DB2277-DNA complex. 
A) Minor groove width (in Å) of bound DNA for 1-ns trajectory (blue) in comparison to the minor 
groove width of DNA in the NMR structure of DB2277-DNA complex (orange). B) Roll angles and 
C) Twist angles at inter-base pair level for the bound DNA in 1ns Ph1-flip trajectory compared to 
roll and twist angles of DNA in NMR structure of DB2277-DNA complex (orange). Standard 
deviation calculated from all time steps in 1-ns trajectory of Ph1 flip. 
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Table 4.1 Phenyl and Amidine Torsion Angles Ø1, Ø2, α1, and α2 of the Bound DB2277 
Molecule during the 1 ns Trajectory of the Ph1 Flipa 
 
 
aFrame numbers are shown in parentheses below the time steps (in picoseconds) where each frame 
is 0.25 ps. The 0 ps point of the flip period points at the 1020 ns point of the 3 μs MD simulations. 
Significant shifts in the α1 value are marked with red arrows, and the time range that shows a 
stable α1 value is highlighted in green. The standard deviation is calculated using all the frames 
within the time range mentioned in the table. Ø2 and α2 stay in a limited structure for the entire 
simulation. Torsional plots using these values are also shown in Figures 4.3 and 4.4. 
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5 CONCLUSIONS 
In this dissertation, the molecular recognition of the mixed base pair (bp) sequences of DNA by 
small molecules has been systematically investigated. DB2277, a novel heterocyclic cation 
specifically recognizes a single GC bp flanked by AT sequences in the minor groove of DNA. The 
NMR spectroscopy was used to illustrate the highly dynamic nature of DB2277 binding with 
AAAGTTT type of mixed bp sequences. The strong binding efficiency allows the compound to 
form two reverse-oriented microstructures in the minor groove of DNA of relatively symmetric 
DNAs such as AAAGTTT. Comparison of NMR exchange rate dynamics with the much longer 
dissociation off-rate from surface plasmon resonance (SPR) has shown that DB2277 rapidly flips 
back and forth between the two opposite minor groove orientations before its complete dissociation 
from the target DNA. Examination of over-thirty mixed bp DNA hairpin sequences using NMR 
and thermal melting resulted in the finding of a unique DNA sequence with AAGATA binding 
site that showed a single and selective binding orientation with DB2277.  
This dissertation has also illustrated the first solution structure of the heterocyclic cation, 
DB2277, with an AT/GC mixed DNA sequences in a 1:1 complex. The molecular basis of the 
specific recognition of a single GC bp in AAGATA binding site by DB2277 has been well 
described in the high-resolution NMR structure of the complex. The structural insight into the 
specific interactions involved in the DB2277-DNA complex was obtained using NOE (Nuclear 
Over Hauser effect) restraints from NMR in conjunction with molecular dynamics (MD) 
simulations. The NMR-restrained MD structure has specified the strong interactions of G-NH and 
C-O2 of the central bp in mixed-sequence DNA with aza-N and aza BI -NH of the aza-BI (aza-
benzimidazole) group of DB2277, respectively.  These two key interactions indicate how a small 
molecule like DB2277 is able to selective recognize mixed bp DNA sequences. 
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Extended MD calculations on the NMR structure of the DB2277-DNA complex reported 
further stabilization of the complex through a dynamic hydration network and interfacial water 
molecules that play a vital role in mediating the interactions between amidinium protons and DNA 
bps. The flexibility imparted to the phenyl, which is linked to the heterocyclic core of the DB2277 
via a flexible linker (-OCH2- group), and interfacial water molecules allow this phenyl to undergo 
180° rotations in the bound compound in the multi-microsecond MD simulations. This is the first 
time that phenyl rotations have been reported in the DNA bound state of a compound along with 
the mechanistic details on the rotation. Structural and dynamic aspects of DB2277 in complex with 
the mixed bp DNA sequences studied here are very useful in designing additional compounds to 
bring more diversity in the sequence-specific DNA recognition field. Therefore, designing 
additional heterocyclic compounds to target a wide range of sequence-specific DNAs will be very 
useful in extending the use of small molecules in various therapeutic applications for future use. 
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Appendix A.1 Abstract 
The design and synthesis of compounds that target mixed, AT/GC, DNA sequences is described. 
The design concept connects two N-methyl-benzimidazole-thiophene single GC recognition units 
with a flexible linker that lets the compound fit the shape and twist of the DNA minor groove while 
covering a full turn of the double helix. 
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Appendix A.2 Introduction 
Small, synthetic molecules that selectively target biological macromolecules in cells and induce 
specific responses, such as changes in gene expression, are a central goal of biomolecular 
compound design and synthesis research as well as therapeutic development (1-8). While there is 
significant progress in this area with proteins, there is limited progress in the variety of compound 
designs to target mixed base pair (bp) DNA sequences. Approaches for compounds that can target 
the DNA component of DNA-protein complexes, for example, would help remove this block to 
progress and provide an important step forward in the area (9-12). In order to effectively target 
DNA in cells, compounds with appropriate physical properties must be designed along with the 
development of synthetic approaches that are reasonable in cost and effort. 
Heterocyclic-cation, minor-groove binders that can selectively bind to DNA have become 
a valuable resource in therapeutics, and compounds that successfully act on specific cancers, 
parasitic organisms and bacteria are now in animal and clinical testing as well as therapeutic use 
(1,13-15). These successful agents have provided proof of concept that selective and functional 
recognition of the DNA minor groove with a set of modules, combined in different ways for 
different sequences, is possible. The relatively simple agents available, however, primarily 
recognize only A·T bp sequences and have off-target effects (16). 
Our approach to overcome this limitation is design and preparation of modular minor-
groove, sequence-specific compounds that can recognize G·C in addition to A·T bp in longer DNA 
sequences than most current agents. The design strategy starts with heterocyclic cationic molecular 
modules that have effective DNA binding affinity in AT sequences, cell and nuclear uptake, 
reasonable syntheses, relatively low human toxicity and a range of physical properties to increase 
the chances of finding active compounds for the treatment of a variety of diseases (11). Using this 
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approach a thiophene-N-methylbenzimidazole (thiophene-N-MeBI) compound (DB2429, Figure 
A.1A) was designed according to the “σ-hole” preorganizing principle for macromolecular 
targeting (17). This effect is based on the presence of low-lying C−S σ* orbitals on the thiophene 
S that possess positive electrostatic potential for interaction with electron donating atoms such as 
the unsubstituted N in N-MeBI (18,19). Such rational control of the conformation of small 
molecules is a key concept of optimized molecular design for targeting macromolecules and can 
lead to significantly improved binding affinity and specificity that is independent of 
compound−DNA contacts. Compounds with furan or pyridine in place of the thiophene in DB2429 
bind with less affinity and selectivity in support of the role of σ-hole interactions with the thiophene 
(17). 
The critical question at this point, which is addressed in this report for the first time, is how 
to extend relatively simple compounds, such as DB2429, to selectively recognize longer, more 
complex DNA sequences with additional G·C bp. Our approach combines modular GC recognition 
units to prepare agents that can selectively recognize two G·C bps in DNA sequences such as 
(A/T)3-(G/C)-(A/T)n-(G/C)-(A/T)3 where “n” can be 0-5 bps (Figure A.1). For the initial test of 
this approach, a flexible linker, –O-(CH2)3-O-, for DB2429-type GC recognition molecular 
modules was used. The design strategy includes enough flexibility to match the shape and 
curvature of the DNA minor groove and an appropriate length with modules spaced to bind to the 
GAAAC DNA sequence and a full turn of the DNA helix. 
Our first transcription factor (TF)-DNA complex for targeting was the PU.1 TF that is of 
critical importance in the development of acute myeloid leukemia (AML). Compounds that bind 
AT or single G·C bp sequences have been successful at targeting the PU.1 promoter and inhibiting 
AML in cells (20). To increase the effectiveness of the TF-promoter DNA targeting approach, we 
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wish to target additional TFs, such as the Blimp-1 TF protein that impairs T cell function and is 
correlated with AML progression (21). Blimp-1 binds to a consensus GAAAC/G promoter 
sequence, (22,23) and agents that bind strongly to that sequence have the potential to inhibit the 
TF and provide new anti-AML activity. Scheme A.1 shows a retrosynthetic analysis which allows 
modular assembly of small molecules designed to bind to DNA sequences with two G·C bps. The 
target bis-amidino-N-methylbenzimidazolethiophenes are prepared from amidino-N-
methylphenylenediamines by coupling with the appropriate bis-thiophenecarboxaldehydes in the 
presence of selected oxidizing agents. The required bis-aldehydes are obtained by linking the 
protected 5-(4-hydroxyphenyl) thiophene-2-carboxaldehdyes with 1, 3-dibromopropane 
employing standard Williamson Ether synthesis methodology. The protected 5-(4-hydroxyphenyl) 
thiophene-2-carboxaldehdyes are readily accessible using standard Suzuki coupling reactions 
between various substituted bromothiophenes and 4-hydroxyphenylboronic acid. A set of related 
compounds prepared using this approach are shown in Figure A.1B. Their synthesis routes are 
shown in Supporting Information, Scheme A.2. The resulting agents are particularly striking 
because relatively simple changes in chemical groups in AT specific compounds, the addition of 
specific H-bond accepting groups for G·C bp recognition, converts them into compounds (Figure 
A.1B) that strongly and specifically recognize mixed bps sequences of DNA much more strongly 
than the original AT sequences. This is the first example where heterocyclic cations linked in this 
manner have been systematically designed and prepared to recognize G·C bp in complex DNA 
sequences. 
Appendix A.3 Material and Methods 
All commercial reagents were used without purification.  Melting points were determined on a 
Mel-Temp 3.0 melting point apparatus, and are uncorrected. TLC analysis was carried out on silica 
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gel 60 F254 precoated aluminum sheets using UV light for detection. 1H and 13C NMR spectra 
were recorded on a Bruker 400 MHz spectrometer using the indicated solvents. Mass spectra were 
obtained from the Georgia State University Mass Spectrometry Laboratory, Atlanta, GA. The 
compounds reported as salts contain waters of hydration and in each case a water signal was noted 
in the 1H-NMR spectra. Elemental analyses were performed by Atlantic Microlab Inc., Norcross, 
GA.  
In the DNA thermal melting (Tm), circular dichroism (CD), fluorescence anisotropy, and 
electrospray ionization mass spectrometry (ESI-MS) experiments, the hairpin oligomer sequences 
were used as shown in Table A.1. In SPR experiments, 5′-biotin labeled hairpin DNA oligomers 
were used. All DNA oligomers were obtained from Integrated DNA Technologies, Inc. (IDT, 
Coralville, IA) with reverse-phase HPLC purification and mass spectrometry characterization. 
The buffer used in Tm, CD, and fluorescence experiments was 50 mM Tris-HCl, 100 mM 
NaCl, 1 mM EDTA, pH 7.4 (TNE 100). The biosensor-surface plasmon resonance (SPR) 
experiments were performed in filtered, degassed TNE 100 with 0.05% (v/v) surfactant P20. 50 
mM ammonium acetate buffer with 10% MeOH was used in ESI-MS experiments.  
Appendix A.3.1 UV-vis Thermal Melting (Tm) 
DNA thermal melting experiments were performed on a Cary 300 Bio UV-vis spectrophotometer 
(Varian). The concentration of each hairpin DNA sequence was 3 μM in TNE 100 using 1 cm 
quartz cuvettes. The solutions of DNA and ligands were tested with the ratio of 2:1 [ligand] : 
[DNA]. All samples were increased to 95 °C and cooled down to 25 °C slowly before each 
experiment. The spectrophotometer was set at 260 nm with a 0.5 °C/min increase beginning at 25 
°C, which is below the DNA melting temperature and ending above it at 95 °C. The absorbance of 
the buffer was subtracted, and a graph of normalized absorbance versus temperature was created 
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using KaleidaGraph 4.0 software. The ΔTm values were calculated using a combination of the 
derivative function and estimation from the normalized graphs. 
Appendix A.3.2 Biosensor-Surface Plasmon Resonance (SPR) 
SPR measurements were performed with a four-channel Biacore T200 optical biosensor system 
(GE Healthcare, Inc., Piscataway, NJ).  A streptavidin-derivatized (SA) CM5 sensor chip was 
prepared for use by conditioning with a series of 180 s injections of 1 M NaCl in 50 mM NaOH 
(activation buffer) followed by extensive washing with HBS buffer (10 mM HEPES, 150 mM 
NaCl, 3 mM EDTA, and 0.05% P20, pH 7.4).  Biotinylated-DNA samples (AAAATTTT, 
AAAAGTTTT, GAAG, GAAAC, GAAAAC, and GAAAAAC hairpins, Table A.1) of 25-30 nM 
were prepared in HBS buffer and immobilized on the flow cell surface by noncovalent capture as 
previously described (24). Flow cell 1 was left blank as a reference, while flow cells 2−4 were 
immobilized separately by manual injection of biotinylated-DNA stock solutions (flow rate of 1 
μL/min) until the desired amount of DNA response units (RU) was obtained (250−300 RU). 
Ligand solutions were prepared with degassed and filtered TNE 100 with 0.05% (v/v) surfactant 
P20 by serial dilutions from a concentrated stock solution. Typically, a series of different ligand 
concentrations (2 nM to 500 nM) were injected over the DNA sensor chip at a flow rate of 100 
μL/min for 180 s, followed by buffer flow for ligand dissociation (600−1800 s). After each cycle, 
the sensor chip surface was regenerated with a 10 mM glycine solution (pH 2.5) for 30 s followed 
by multiple buffer injections to yield a stable baseline for the following cycles. RUobs was plotted 
as a function of free ligand concentration (Cfree), and the equilibrium binding constants (KA) were 
determined either with a one-site binding model, where r = (RUobs/RUmax) represents the moles of 
bound compound/mol of DNA hairpin duplex and K is macroscopic binding constant.  
                                       𝒓 =  𝑲 ∗ 𝑪𝒇𝒓𝒆𝒆 𝟏 + 𝑲 ∗ 𝑪𝒇𝒓𝒆𝒆⁄    (1) 
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RUmax can be used as a fitting parameter, and the obtained value compared to the predicted 
maximal response per bound ligand can also be used to independently evaluate the stoichiometry 
(25). Kinetic analyses were performed by globally fitting the binding results for the entire 
concentration series using a standard 1:1 kinetic model with integrated mass transport-limited 
binding parameters as described previously (26).  
Appendix A.3.3 Fluorescence anisotropy  
Fluorescence spectra were recorded on a Cary Eclipse Spectrophotometer, with excitation and 
emission slit width typically fixed at 10, 10 nm. The free compound solutions at different 
concentrations were prepared in TNE 100, and DNA sequence aliquots were added from a 
concentrated stock. Titration spectra were collected after allowing an incubation time of 10 min.  
The excitation wavelength is based on molecular absorbance from UV-vis spectroscopy. Emission 
spectra were monitored at the fluorescence excitation wavelength at 25 °C. 
Fluorescence anisotropy (r) measures the extent of polarization of the fluorescence 
emission of a system in solution when excited with polarized light. It is directly related to the 
rotational diffusion of the system and is low for small and flexible molecules (higher 
depolarization), and increases when larger complexes are formed (slower rotational movement, 
smaller depolarization) (27). Therefore, the change in fluorescence anisotropy can be used to 
monitor a binding reaction (28). This is particularly convenient for systems where no or small 
changes in fluorescence intensity is observed between the free and bound states. The fluorescence 
anisotropy is defined in the equation:  
                                  𝒓 =  
𝑰𝒗𝒗−𝑮𝑰𝒗𝒉
𝑰𝒗𝒗+𝟐𝑮𝑰𝒗𝒉
 , 𝑮 =  
𝑰𝒉𝒗
𝑰𝒉𝒉
                                          (2)                             
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where Ivv is the fluorescence emission intensity measured for vertically polarized excitation and 
vertically polarized emission. Ivh is the intensity measured for vertically polarized excitation and 
horizontally polarized emission, and G is a correction factor. 
Depending on the parameters achieved from the previous step, add an appropriate 
concentration of ligands until the total intensity of emission wavelength is ~ 400. Record that 
concentration. Place blank cuvette containing TNE 100 in the instrument. Collect the spectrum 
using parameters obtained from the previous part, double check the emission spectra. The polarizer 
(Agilent Technologies, Manual Polarizer Accessory) was installed to the system and set the 
excitation and emission wavelength of compound same as the previous scan spectrum. The slit 
width fixed same as [10, 10 nm] and the average time of reading was set as 50 s. Read Ivv, Ivh of 
the buffer as a blank sample. The Ihh, Ihv of ligand only solution with the concentration same as the 
record was read to calculate the G of ligand. The Ivv and Ivh of each titration sample including 
ligand only were read to be made into scatter plot and fit the data to get the KD value in 
KaleidaGraph 4.0 software.  
Appendix A.3.4 Circular Dichroism (CD) 
Circular dichroism experiments were performed on a Jasco J-810 CD spectrometer in 1 cm quartz 
cuvette at 25 °C. A buffer scan as a baseline was collected first in the same cuvette and subtracted 
from the scan of following samples. The hairpin DNA sequence GAAAC or AAAATTTT (5 
µM),Table A.1, in TNE 100 was added to the cuvette prior to the titration experiments and then 
the compound was added to the DNA solution and incubated for 10 min to achieve equilibrium 
binding for the DNA-ligand complex formation. For each titration point, four spectra were 
averaged from 500 to 220 nm wavelength with scan speed 50 nm/min, with a response time of 1 
s. Baseline-subtracted graphs were created using the KaleidaGraph 4.0 software. 
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Appendix A.3.5 Competition Electrospray Ionization Mass Spectrometry (ESI-MS) 
Electrospray Ionization Mass Spectrometry (ESI-MS) analyses were performed on a Waters Q-
TOF micro Mass Spectrometer (Waters Corporate, Milford, MA) equipped with an electrospray 
ionization source (ESI) in a negative ion mode. DNA sequences AAAATTTT, AAAAGTTTT, 
GAAC, GAAAC, GAAAAC and GAAAAAC, Table A.1, for ESI-MS experiments were purified 
by dialyzing it in 50 mM ammonium acetate buffer (pH 6.7) at 4 ºC with 3x buffer exchange. Test 
samples were prepared in 50 mM ammonium acetate with 10% v/v methanol at pH 6.7 and 
introduced into the ion source through direct infusion at 5 µl/min flow rate. The competitive 
experiments were done by mixing a ligand and DNAs with different sequences at different ratios. 
The instrument parameters were typically as follows: capillary voltage of 2800 V, sample cone 
voltage of 30 V, extraction cone voltage of 1.0 V, desolvation temperature of 70 °C, and source 
temperature of 100 °C. Nitrogen was used as nebulizing and drying gas. A multiply charged spectra 
were acquired through a full scan analysis at mass range from 300-2500 Da and then deconvoluted 
to the spectra presented.  MassLynx 4.1 software was used for data acquisition and deconvolution.  
Appendix A.3.6 Ab-Initio Calculations and Molecular Dynamic (MD) Simulation 
Optimization and electrostatic potential calculations were performed for the DB2528 molecule 
using DFT/B3LYP theory with the 6-31+G* basis set in Gaussian 09 (Gaussian, Inc., 2009, 
Wallingford, CT) with Gauss-view 5.09 (29). Partial charges were derived using the RESP fitting 
method (Restrained Electrostatic potential) (30,31). 
AMBER 14 (Assisted Model Building with Energy Refinement) software suite was used 
to perform molecular dynamic (MD) simulations using “ff14SB” and ff14SB/chi/ez (i.e., 
parmbsc0_chiOL4_ezOL1) force field modifications for DNA (32). Canonical B-form ds[(5’-
CCAAAGAAACTTTGG-3’)(5’-CCAAAGTTTCTTTGG-3’)] DNA was built in Nucleic Acid 
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Builder (NAB) tool in AMBER. AMBER preparation and force field parameter files required to 
run molecular dynamic simulations for DB2528 molecule were produced using ANTECHAMBER 
(33). Specific atom types assigned for DB2528 molecule were adapted from the ff99 force field. 
Most of the force field parameters for DB2528 molecule were derived from the existing set of 
bonds, angles and dihedrals for the similar atom types in parm99 and GAFF force fields. Some 
dihedral angle parameters were obtained from previously reported parametrized data (34,35). 
AutoDock Vina program was used to dock the DB2528 in the minor groove of DNA to 
obtain the initial structure for DB2528-DNA complex (36). MD simulations were performed in 
explicit solvation conditions where the DNA-DB2528 complex was placed in a truncated 
octahedron box filled with TIP3P water using xleap program in AMBER. Sodium ions were used 
to neutralize the system. A 10 Å cutoff was applied on all van der Waals interactions. The MD 
simulation was carried out using the Sander module with SHAKE algorithm applied to constrain 
all bonds. Initially, the system was relaxed with 500 steps of steepest-descent energy minimization. 
The temperature of the system was then increased from 0 K to 310 K for over 10 ps under constant-
volume conditions. In the final step, the production run on the system was subsequently performed 
for 300 ns under NPT (constant-pressure) conditions. Coordinate file of DB2528-DNA complex 
along with water molecules in proximity is also attached (terminal bp is not included due to fraying 
at the ends of DNA). 
Appendix A.4 Results and Discussion 
Thermal melting (Tm) provides a rapid, evaluation screen of compounds with selected DNA 
sequences (Table A.1, A.2) (37,38)  Binding to DNA gives an increase in the melting temperature 
that is related to binding affinity. Hairpin DNA oligomers, which have monomolecular melting 
transitions, were chosen for the screen. DB2429 (Figure A.1A) shows our approach of design of 
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single G recognition compounds and for linking these modular units to recognize more complex 
sequences. DB2528 and analogs are the first test of this concept and Tm results are shown in Table 
A.2. DB2528, which combines two DB2429 units with a flexible –O-(CH2)3-O- linker (Figure 
A.1B), does not bind well to a single G segment (AAAAGTTTT, ΔTm = 2℃) but binds with a ΔTm 
of 9℃ with the target two G·C bps sequence, GAAAC. It has lower Tm with longer, GAAAAC 
and GAAAAAC sequences (6℃). It is very encouraging that it shows no significant binding with 
an all AT sequence (ΔTm = 1℃), and closer G·C bps (GC, GAC, GAAC), all with ΔTm <2℃ (Table 
A.1, A.2, Figure A.2). The ΔTm for GAAAC and CAAAG are essentially identical but the less 
symmetrical sequence GAAAG gives a 3℃ lower ΔTm (Figure A.2). Modification of the amidine 
(DB2604 and 2614) or thiophene (DB2612 and 2614) groups can enhance interactions with the 
minor groove in cases where self-association limits DNA interactions, but the additions did not 
enhance binding with DB2528 (Figure A.1B, Table A.2). The replacement of N-MeBI in DB2528 
with benzimidazole (BI) gives a more classical minor groove binder that shows strong binding 
with the AT sequences and weaker binding to the G sequences (not shown). This result clearly 
confirms the crucial importance of N-MeBI to the G·C bp recognition. Circular dichroism (CD) 
results with DB2528 and the GAAAC sequence show a strong positive induced CD peak at the 
compound absorption wavelength (Figure A.3). This result clearly indicates that the compound is 
a minor groove binder. Addition of a pure AT sequence to DB2528 results in very little spectral 
change in agreement with quite weak binding to pure AT sequence. 
Biosensor-SPR methods provide an excellent way to quantitatively evaluate the interaction 
of small molecules with immobilized biomolecules (24).  SPR provides sensitive, real-time 
progress of the binding reaction with binding affinity, kinetics, and stoichiometry of complex 
formation (25,39)  Based on the Tm results, the interactions of DB2528 were evaluated by SPR 
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with G·C bp sequences (Table A.3). As can be seen in Figure A.4, DB2528 binds strongly with 
GAAAC and global kinetics fitting yielded a single binding site with a KD of 5 nm, a rapid on-rate 
(ka = 2.83±0.5×10
6 M-1s-1) and a very slow off-rate (kd = 1.7±0.4×10
-2 s-1). The association and 
dissociation of DB2528 with the shorter GAAG sequence are quite fast with a high KD = 149 nM. 
Pure AT and single G sequences were also studied by SPR, and it is encouraging that DB2528 has 
no detectable binding with either of them. These results indicate excellent selectivity and strong 
binding for a two G sequence that has a specific distance between the two G·C bps. As a test of 
the SPR binding results, the KD was determined by a fluorescence anisotropy titration of the 
compound with the GAAAC DNA, and the KD value is in agreement with the results from SPR 
(Table A.3, and Figure A.5) and validates the SPR results for binding affinity. Clearly, the 
combination of thiophene-N-MeBI and a flexible –O-(CH2)3-O- linker creates an effective module 
for strong two G·C bps specific recognition of a full turn of the DNA helix. 
Competition ESI-mass spectrometry (MS) provides a direct analysis of relative binding 
affinity, stoichiometry and specificity for small molecule DNA complexes (40,41).  The use of 
several DNA sequences simultaneously mixed with a compound creates a competitive binding 
environment for direct comparison of DNA interactions. The competition ESI-MS analysis results 
of DB2528 with DNA sequences AAAATTTT, AAAAGTTTT, and GAAAC, are shown in Figure 
A.6 A, B. The upper plot shows three peaks for the three DNA sequences. On addition of DB2528, 
the peak for GAAAC (9773) decreases with the simultaneous appearance of a new peak at 
m/z=10510 that is characteristic of a 1:1 GAAAC-DB2528 complex (Figure A.6B). There is no 
appearance of any complex peak with the other DNA sequences. Results for competition ESI-MS 
analysis of DB2528 with sequences GAAC, GAAAC, GAAAAC, and GAAAAAC are shown in 
Figure A.6 C, D to test the sequence specificity. The upper plot shows four peaks for the four 
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sequences. With the addition of DB2528, only the peak for GAAAC (9773) decreases with the 
simultaneous appearance of a new peak at m/z=10510 for a 1:1 GAAAC-DB2528 complex. There 
is no significant complex peak with any of the other tested sequences. In agreement with the 
binding results, the competition ESI-MS results clearly indicate that DB2528 binds with GAAAC 
very strongly and specifically in a 1:1 complex. 
DB2528 was designed to H-bond with two G·C bps separated by three A·T bp and for 
terminal amidines H-bonds with AT. The compound binds strongly and specifically to this 
sequence but how does it fit to the minor groove and A·T/G·C bps? To answer this question, the 
molecular dynamics structures for the DB2528 complex with the minor groove of AGAAACT 
(Figure A.7) were determined with the AMBER 14 software suite and the ff99 force field. Force 
constants for DB2528 were added and the structure determined as previously described (34,35,42). 
The full view in Figure A.7A and Figure A.7A show DB2528 is able to match the curvature of the 
DNA minor groove and can cover a full turn of the double helix. The same view is shown in space 
filling model in Figure A.8B and shows the excellent contacts and van der Waals interactions that 
the compound makes with the minor groove molecular walls. A view of the complex structure at 
the upper part of the model is shown in Figure A.7B. This view shows strong H-bond between the 
N of N-MeBI and the G-NH that points out into the groove. There is also an H-bond between the 
amidine-NH that points to the floor of the groove and a T=O. The view in Figure A.7C shows the 
same H-bond pattern with the other end of the complex. The amidine-N-MeBI-thiophene-phenyl-
O- can easily be seen tracking along the minor groove. Again, there are strong H-bonds from the 
G-NH to the N of N-MeBI and from the amidine to a T=O. As can be seen, both amidines are 
strongly hydrated and this certainly contributes to the energetics of binding and the fit to the groove 
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(Figure A.7A and Figure A.8). The compound curves around the groove and there is an exact 
indexing of two N-MeBI-G-NH and amidine-A·T bp.  
In conclusion, the initial goal of this work was to link previously designed single G·C bp 
binding modules with a flexible linker for recognition of two G·C bps in the core sequence 
AGAAACT that has functional significance. With optimized design, synthesis and analysis a 
linked heterocyclic-diamidine has been obtained that has an excellent match to the DNA minor 
groove shape and registry of the compound with DNA functional groups. These results show, for 
the first time, what can be accomplished with modular compounds of this type in selective targeting 
of complex DNA. The compound has synthesis that is reasonable in cost and time and offers a 
promising route to develop a broad array of modular agents for control of gene expression. 
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Scheme A.1 Retrosynthetic analysis for bis-amidine-N-Methylbenzimidazole-thiophene 
compounds from bis-thiophenecarboxaldehydes that are prepared by linking 
arylthiophenecarboxaldehydes. Full synthetic details are in Supplementary Materials. 
 
 
 
 
 
 
 
 
 
 
Scheme A.2. Synthesis of two G·C bps binders. Reagents and conditions: a) i. 4-hydroxyphenyl-
boronic acid, Pd(PPh3)4, 2 M aqueous K2CO3, EtOH, reflux ii. HCl, H2O. b) dibromoalkane, 
K2CO3, DMF, 80 °C. c) 3-amino-4-(methylamino)benzamidine or 3-amino-4-(methylamino)-N-
isopropylbenzamidine, 1,4-benzoquinone, DMF, EtOH, reflux. 
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Figure. A.1 A) The compound DB2429 with best binding affinity and selectivity for a single 
G·C bp sequence found in our initial research. B) Chemical structure of new compounds 
designed to link two GC recognition modules. Red: G·C bp recognition module. 
 
  
Figure A.2. Comparisons of thermal melting results (ΔTm, °C) of DB2528 with pure AT and 
mixed DNA sequences. ΔTm = Tm (the complex) - Tm (the native DNA). 3 µM DNA sequences 
were studied in TNE 100 with the ratio of 2:1 [ligand]:[DNA]. An average of two independent 
experiments with a reproducibility of ±0.5 °C.  
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Figure A.3. Circular dichroism titration spectra of DB2528. DB2528 was titrated into 5 µM 
sequence A) AAAGAAACTTT; B) AAAATTTT (Table A.1). Arrow indicates the ligand induced 
spectral changes in DNA during titration. 
 
Figure. A.4 Representative SPR sensorgrams for DB2528 in the presence of GAAAC DNA, 
concentrations of DB2528 from bottom to top are 10, 15, 30, 50, and 100 nM. The solid black 
lines are best-fit values for the global kinetic fitting of the results with a single site function. 
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Figure A.5. Fluorescence Anisotropy (FA) binding curve between 20 nM DB2604 and sequence 
GAAAC in TNE 100. Exmax = 365 nm; Emmax = 468 nm; slit width: [10, 10 nm]. The FA 
collection concentration points are 0, 1, 5, 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 250, 300 nM.  
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Figure. A.6 ESI-MS negative mode spectra of the competition binding of sequences A), B) 
AAAATTTT, AAAAGTTTT and GAAAC(10 µM each) ; C), D) GAAC, GAAAC, GAAAAC and 
GAAAAAC (10 µM each); with 40 µM DB2528 in buffer (50 mm ammonium acetate with 10% 
methanol(v/v), pH 6.8). A), C) The ESI-MS spectra of free DNA mixture. B), D) The ESI-MS 
spectra of DNA mixture with DB2528. The ESI-MS results shown here are deconvoluted spectra 
and molecular weights are shown with each peak. Full DNA sequences are in Table A.1. 
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Figure. A.7. A) Minor groove view of the DB2528-DNA complex with proximal water molecules. 
B) Hydrogen bonding the upper G-NH and an opposite strand T-O2 with N of N-MeBI and NH 
of an amidine of DB2528 respectively are shown in yellow circles (in Å). C) View of hydrogen 
bonding of the lower G-NH and an opposite strand T-O2 with N of N-MeBI and NH of an 
amidine of DB2528, respectively is shown in yellow circles. Upper and lower are with respect to 
the model in A. DNA is represented in ribbon style (in blue) whereas G and T involved in H-
bonding are shown in stick representation (B and C in green). DB2528 is shown in the ball and 
stick representation (B and C in magenta).   
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Figure A.8: A) Full view of the DB2528-DNA complex along with the water molecules in 
vicinity of complex. B) Space fill representation of DB2528-DNA complex. C) Upper part of the 
complex with H-bond of G6-NH and T26-O2 of DNA with N of N-MeBI and NH of amidine of 
DB2528 respectively is market in green (in Å). D) Lower part of the complex with H-bond 
interaction of G21-NH and T11-O2 of DNA with N of N-MeBI and NH of amidine respectively, 
is marked in the green (in Å). 
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Table A.1. All sequences used in this paper. a 
 
 
 
 
 
 
 
 
 
 
aThe loop circle is shown underlined. The 5’-biotin labeled sequences were used in SPR 
experiments. 
 
 
 
 
 
Name Sequences 
AAAATTTT 5’-CCAAAATTTTGCTCTCAAAATTTTGG-3’ 
AAAAGTTTT 5’-CCAAAAGTTTTGCTCTCAAAACTTTTGG-3’ 
GC 5’-CCAAAAGCTTTTGCTCTCAAAAGCTTTTGG-3’ 
GAC 5’-CCAAAGACTTTGCTCTCAAAGTCTTTGG-3’ 
GAAC 5’-CCAAAGAACTTTGCTCTCAAAGTTCTTTGG-3’ 
GAAG 5’-CCAAAGAAGTTTGCTCTCAAACTTCTTTGG-3’ 
GAAAC 5’-CCAAAGAAACTTTGCTCTCAAAGTTTCTTTGG-3’ 
GAAAG 5’-CCAAAGAAAGTTTGCTCTCAAACTTTCTTTGG-3’ 
GATAC 5’-CCAAGATACTTGCTCTCAAGTATCTTGG-3’ 
CAAAG-1 5’-CCAAACAAAGTTTGCTCTCAAACTTTGTTTGG-3’ 
CAAAG-2 5’-CCAACAAAGTTGCTCTCAACTTTGTTGG-3’ 
GAAAAC 5’-CCAAAGAAAACTTTGCTCTCAAAGTTTTCTTTGG-3’ 
GAATTC 5’-CCAAGAATTCTTGCTCTCAAGAATTCTTGG-3’ 
GAAAAAC-1 5’-CCAAGAAAAACTTGCTCTCAAGTTTTTCTTGG-3’ 
GAAAAAC-2 5’-CCAAAGAAAAACTTTGCTCTCAAAGTTTTTCTTTGG-3’ 
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Table A.2. Thermal melting studies ΔTm (℃) of studied compounds with pure AT and mixed 
DNA sequences.a 
 
ΔTm 
(℃) 
 
DNA 
Tm (℃)b 
AAA
A 
TTTT 
 
64 
AAA
A 
G 
TTTT 
67 
AAA
A 
GC 
TTTT 
69 
AA
A 
GA
C 
TTT 
70 
AAA 
GAA
C 
TTT 
71 
AAA 
GAAA
C 
TTT 
69 
AAA 
GAAAA
C 
TTT 
70 
AA 
GAAAAA
C 
TT 
70 
DB252
8 
1 2 1 2 1 9 6 6 
DB260
4 
2 3 1 2 2 9 6 6 
DB261
2 
1 <1 1 1 1 2 1 1 
DB261
4 
2 2 1 1 2 6 5 5 
 
aΔTm=Tm (the complex)-Tm (the native DNA). 3 µM DNA sequences were tested in TNE 100 with 
the ratio of 2:1 [ligand] : [DNA]. An average of two independent experiments with a 
reproducibility of ±0.5 ℃. Full DNA sequences can be seen in Table A.1. 
bThe values are the melting temperature of DNAs only used to calculate the relative data. 
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Table A.3. Summary of binding affinity (KD, nM) for the interaction of all test compounds with 
biotin-labeled DNA sequences using biosensor-SPR method. a 
 
 
 
 
 
 
aAll the results in this table were investigated in TNE 100 with 0.05% P20 at a 100 µL min-1 flow 
rate. “--” experiment not done, “NB” no binding. The listed binding affinities are an average of 
two independent experiments carried out with two different sensor chips and the values are 
reproducible within 10% experimental errors. 
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Appendix B.1 Abstract 
AT specific heterocyclic cations that bind in the DNA duplex minor groove have had major 
successes as cell and nuclear stains and as therapeutic agents which can effectively enter human 
cells.  Expanding the DNA sequence recognition capability of the minor groove compounds could 
also expand their therapeutic targets and have an impact in many areas, such as modulation of 
transcription factor biological activity. Success in the design of mixed sequence binding 
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compounds has been achieved with N-methylbenzimidazole (N-MeBI) thiophenes which are 
preorganized by a σ-hole interaction to fit the shape of the DNA minor groove and H-bond to the 
–NH of G·C base pairs that projects into the minor groove.  Initial compounds bind strongly to a 
single G·C base pair in an AT context with a specificity ratio of 50 (Kd AT-GC/Kd AT) or less and 
this is somewhat low for biological use.  We felt that modifications of compound shape could be 
used to probe local DNA microstructure in target mixed base pair sequences of DNA and 
potentially improve the compound binding selectivity.  Modifications were made by increasing the 
size of the benzimidazole N-substituent, for example, by using N-isobutyl instead of N-methyl, 
and by changing the molecular twist by introducing substitutions at specific positions on the 
aromatic core of the compounds.  In both cases we have been able to achieve a dramatic increase 
in binding specificity, including no detectible binding to pure AT sequences, without a significant 
loss in affinity to mixed base pair target sequences. 
Appendix B.2 Introduction 
Design and preparation of agents that can recognize mixed base pair (bp) sequences of DNA 
containing combinations of A·T and G·C bps have been of long term interest. Starting in the mid-
1980s, this took a step forward with work in the Dickerson and Lown laboratories to redesign the 
minor groove binding polyamides netropsin (Nt.) and distamycin (Dst.), which specifically 
recognizing AT bp, into synthetic compounds that could also bind to a G·C bp (1,2). They 
proposed doing this by replacing one or more pyrrole groups in Nt and Dst with an imidazole 
group. The extra N in imidazole relative to pyrrole allows the imidazole group to form an H-bond 
with the G-NH2 in the minor groove of a G·C bp (1-3). The proposal attracted attention in several 
additional laboratories and success in GC recognition was achieved by connecting two recognition 
units to make a hairpin polyamide (4-6). Although several groups have worked with these synthetic 
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polyamides, solution difficulties, aggregation, and poor cell uptake have limited their applications 
(7-9).  
In contrast to netropsin (Nt) and distamycin (Dst), other types of AT specific heterocyclic 
cations, such as, Hoechst dyes, furamidine, DAPI, pentamidine, as well as numerous compounds 
that covalently attach to the minor groove, have had major successes as cell / nuclear stains and 
therapeutic agents (10-15). Interestingly, however, no systematic effort to redesign these agents 
into mixed bps recognition compounds, as with the polyamides, has been made. We felt that these 
promising and successful agents could potentially be redesigned to have significantly expanded 
use with broadened sequence recognition capability. We have now had considerable success in the 
design of agents that can recognize G·C bps as well as AT (16-18). Such new agents would have 
broad applications, for example, in targeting transcription factors to modulate gene expression 
(19,20).  
For genes controlling critical cell functions, modifications of transcription factor (TF) 
activity, either directly or indirectly through steps such as enhancer activity, diseases such as 
leukemia or other cancers can result (20-22). Given the variety of functions and diseases controlled 
by TFs, a strong interest in targeting and controlling this activity with small molecules has 
developed (20). The problem is that TFs have evolved to bind high molecular weight nucleic acids, 
and not, in general, small molecules (23,24). This has made finding binding sites on TFs to interact 
strongly and specifically with small molecules, a difficult task. As a result, TFs are often defined 
as “undruggable” (23). Our concept is to target TF-DNA complexes by binding of designed agents 
to specific DNA sequences. To do this, we must design new types of DNA binding agents with 
broader sequence recognition capabilities than the classical AT-specific agents. 
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Incorporating the N-MeBI thiophene module into the heterocyclic cations, as in Figure 
B.1, initially gave DB2429 which specifically binds to a target G·C bp with flanking AT bps (18). 
DB2429 was expanded to DB2457 better cover the AT bps that flank the central GC. These 
compounds are a significant step forward in our molecular design and synthesis project for 
recognition of mixed bp DNA sequences (16,17,25). Analysis of the importance of the N-MeBI-
thiophene module to binding specificity and selectively clearly shows that both the N-MeBI and 
thiophene are necessary for a strong, specific interaction (18). Replacing the thiophene with a furan 
or pyridine, for example, reduced both binding strength and specificity.  The same was true for 
replacing the N-MeBI with a benzoxazole group which in principle has the same H-bonding 
capability as N-MeBI. Compounds with the N-Me substitution replaced by an NH group bind much 
more strongly to pure AT DNA sequences than to any sequence with a G·C bp (18,26). The 
remarkable reversal of binding specificity with a relatively small change in the overall compound 
structure is an important observation in new ideas for the design of agents to recognize specific 
DNA sequences. 
The specificity ratio for binding to the single G·C bp sequence versus the pure AT sequence 
is about a factor of 10 for DB2429 while it is about 50 for the larger DB2457 which binds more 
strongly to all sequences (18). As described above, the strong decrease of binding affinity and 
selectivity for most structural changes with DB2429 and DB2457 raised the question of whether 
the selectivity ratio of these structures could be enhanced by different types of substitutions. 
Because of the critical importance of selectivity in targeting DNA, we have investigated new 
modifications of these initial compounds that have the potential to increase the selectivity. Initial 
synthetic modifications and DNA binding studies have been conducted with derivatives of the 
larger, stronger binding compound, DB2457. From the first crystal structures of a minor groove 
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binder to extensive structures of heterocyclic diamidines by the Neidle group, the wider minor 
groove in GC versus AT sequences has been observed (27).  Based on these observations, the 
concept for the compound modifications is to target DNA microstructural variations, such as the 
wide minor groove in G·C bp containing regions. We reasoned that compounds with increased 
bulk might favor the wider, mixed bp sequences over pure AT. To test this idea the following 
general changes in the compound structure and functional groups were made with the goal of 
increasing specificity: (i) by increasing compound bulk primarily by replacing the N-Me group of 
N-MeBI with groups of increased size and (ii) by modifying the overall twist in the compound 
linked aromatic core structure by adding appropriate substituents (Figure B.1).   
As we move to design new compounds to inhibit specific transcription factors, two things 
are very important:  the selectivity ratio and the ability of the compounds to enter different cell 
types.  At least some substituent changes at the N-BI position should have positive effects on both 
of these critical factors. We were able to successfully synthesize compounds with a wide variety 
of substituents at the N-BI position and three compounds with substituents on the aromatic groups 
of DB2457 that modified the effective steric bulk of the compounds.  With these modifications, 
we were able to make significant improvements in compound specificity without a decrease in 
binding affinity, no increase in KD. 
Appendix B.3 Compound Design 
The first set of compounds that were prepared had modifications at the N-BI position of DB2457 
(Table B.1 and B.2).  We wanted to increase the length and complexity of the alkyl group, for 
example, methyl – ethyl – isopropyl (i-Pr) – isobutyl – neopentyl substituents. There are also linear 
groups with more polar substituents as in DB2728.  To significantly change the shape of the alkyl 
group, compounds with cyclobutyl (DB2726), cyclopentyl (DB2714) and cyclohexyl (DB2727) 
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substituents were prepared.  Finally, the chemistry of the substituent was changed dramatically 
with different phenyl (Ph) substituents on the BI group, N-Ph (DB2740) and N-ortho-methyl 
phenyl (DB2747).  A control compound without an N-BI substituent, a benzimidazole, was also 
prepared. Such compounds have N-H groups pointed into the DNA minor groove and found to 
have very strong selectivity for pure AT sequences, relative to the compounds described above 
(26). Two compounds, with an N-MeBI and an N-i-Pr-BI were prepared with the thiophene S 
replaced by Se to evaluate the effect of size and changes in polarizability at that position (28,29). 
Four additional compounds were prepared with substitutions designed to increase the twist of the 
aromatic rings of the core structure. DB2754 has a Me on the thiophene, DB2753 has a Me on the 
Ph attached to the BI while DB2759 has a chloro and DB2762 has a trifluoromethyl group adjacent 
to the amidine on the same phenyl ring.  We were unable to synthesize a compound with a Me 
adjacent to the amidine.  Brief synthetic details are given here for the synthesis of the new 
compounds along with Scheme B.1.  Full synthetic details for all compounds are given in the 
Supporting Information. 
Appendix B.4 Materials and Methods 
In the DNA thermal melting (Tm), circular dichroism (CD) experiments, the hairpin oligomer 
sequences were used as shown in Figure B.1. In SPR experiments, 5′-biotin labeled hairpin 
DNA oligomers were used. All DNA oligomers were obtained from Integrated DNA 
Technologies, Inc. (IDT, Coralville, IA) with reverse-phase HPLC purification and mass 
spectrometry characterization. 
The buffer used in Tm and CD experiments was 50 mM Tris-HCl, 100 mM NaCl, 1 mM 
EDTA, pH 7.4 (TNE 100). The biosensor-surface plasmon resonance (SPR) experiments were 
performed in filtered, degassed TNE 100 with 0.05% (v/v) surfactant P20.  
175 
Appendix B.4.1 UV-vis Thermal Melting (Tm) 
DNA thermal melting experiments were performed on a Cary 300 Bio UV-vis spectrophotometer 
(Varian). The concentration of each hairpin DNA sequence was 3 μM in TNE 100 using 1 cm 
quartz cuvettes. The solutions of DNA and ligands were tested with the ratio of 2:1 [ligand] / 
[DNA]. All samples were increased to 95 °C and cooled down to 25 °C slowly before each 
experiment. The spectrophotometer was set at 260 nm with a 0.5 °C/min increase beginning at 25 
°C, which is below the DNA melting temperature and ending above it at 95 °C. The absorbance of 
the buffer was subtracted, and a graph of normalized absorbance versus temperature was created 
using KaleidaGraph 4.0 software. The ΔTm values were calculated using a combination of the 
derivative function and estimation from the normalized graphs. 
Appendix B.4.2 Biosensor-Surface Plasmon Resonance (SPR) 
SPR measurements were performed with a four-channel Biacore T200 optical biosensor system 
(GE Healthcare, Inc., Piscataway, NJ).  A streptavidin-derivatized (SA) CM5 sensor chip was 
prepared for use by conditioning with a series of 180 s injections of 1 M NaCl in 50 mM NaOH 
(activation buffer) followed by extensive washing with HBS buffer (10 mM HEPES, 150 mM 
NaCl, 3 mM EDTA, and 0.05% P20, pH 7.4).  Biotinylated-DNA samples (AAATTT, 
AAAGTTTand AAAGCTTT hairpins, Figure B.1) of 25-30 nM were prepared in HBS buffer and 
immobilized on the flow cell surface by noncovalent capture. Flow cell 1 was left blank as a 
reference, while flow cells 2−4 were immobilized separately by manual injection of biotinylated-
DNA stock solutions (flow rate of 1 μL/min) until the desired amount of DNA response units (RU) 
was obtained (250−300 RU). Ligand solutions were prepared with degassed and filtered TNE 100 
with 0.05% (v/v) surfactant P20 by serial dilutions from a concentrated stock solution. Typically, 
a series of different ligand concentrations (2 nM to 500 nM) were injected over the DNA sensor 
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chip at a flow rate of 100 μL/min for 180 s, followed by buffer flow for ligand dissociation 
(600−1800 s). After each cycle, the sensor chip surface was regenerated with a 10 mM glycine 
solution (pH 2.5) for 30 s followed by multiple buffer injections to yield a stable baseline for the 
following cycles. RUobs was plotted as a function of free ligand concentration (Cfree), and the 
equilibrium binding constants (KA) were determined either with a one-site binding model, where 
r = (RUobs/RUmax) represents the moles of bound compound/mol of DNA hairpin duplex and K is 
macroscopic binding constant.  
                                       𝒓 =  𝑲 ∗ 𝑪𝒇𝒓𝒆𝒆 𝟏 + 𝑲 ∗ 𝑪𝒇𝒓𝒆𝒆⁄    (1) 
RUmax can be used as a fitting parameter, and the obtained value compared to the predicted 
maximal response per bound ligand can also be used to independently evaluate the stoichiometry. 
Kinetic analyses were performed by globally fitting the binding results for the entire concentration 
series using a standard 1:1 kinetic model with integrated mass transport-limited binding parameters 
as described previously (30,31). 
Appendix B.4.3 Circular Dichroism (CD) 
Circular dichroism experiments were performed on a Jasco J-810 CD and Jasco J-1500 CD 
spectrometer in 1 cm quartz cuvette at 25 °C. A buffer scan as a baseline was collected first in the 
same cuvette and subtracted from the scan of following samples. The hairpin DNA sequence 
AAAGTTT (5 µM), Figure B.1, in TNE 100 was added to the cuvette prior to the titration 
experiments and then the compound was added to the DNA solution and incubated for 10 min to 
achieve equilibrium binding for the DNA-ligand complex formation. For each titration point, four 
spectra were averaged from 500 to 230 nm wavelength with scan speed of 50 nm/min, with a 
response time of 1 s. Baseline-subtracted graphs were created using the KaleidaGraph 4.0 
software. 
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Appendix B.4.4 Structural Calculations 
Molecular torsional angle map calculations of the compounds were performed in the Spartan’16 
software. The “constrain dihedral” command was used with selected compounds to restrain four 
atoms to define the middle rotation bond and two terminal bonds which formed the dihedral as the 
calculation targets. The calculation range was set from 0° to 100° or 180° through 11 or 19 steps. 
Calculations were carried out with the energy profile method at ground state with density 
functional B3LYP/6-31G* in vacuum. After the calculations, the relative energy (rel. E) (kJ/mol) 
was displayed in a spreadsheet. The torsional angle map can be created with the constraint of the 
torsional angle as the X-axis and rel. E as the Y-axis by using KaleidaGraph 4.0 software. 
Appendix B.4.5 Ab-initio Calculations and Molecular Dynamic (MD) Simulation 
Optimization and electrostatic potential calculations were performed for the DB2708 molecule 
using DFT/B3LYP theory with the 6-31+G* basis set in Gaussian 09 (Gaussian, Inc., 2009, 
Wallingford, CT) with Gauss-view 5.09 (32). Partial charges were derived using the RESP fitting 
method (Restrained Electrostatic potential) (33,34). AMBER 14 (Assisted Model Building with 
Energy Refinement) software suite was used to perform molecular dynamic (MD) simulations 
(35). Canonical B-form ds[(5’-CCAAAGTTTGG-3’)(5’-CCAAACTTTGG-3’)] DNA was built 
in Nucleic Acid Builder (NAB) tool in AMBER. AMBER preparation and force field parameter 
files required to run molecular dynamic simulations for DB2708 molecule were produced using 
ANTECHAMBER (36). Specific atom types assigned for DB2708 molecule were adapted from 
the ff99 force field. Most of the force field parameters for DB2708 molecule were derived from 
the existing set of bonds, angles and dihedrals for the similar atom types in parm99 and GAFF 
force fields (25). Some dihedral angle parameters were obtained from previously reported 
parametrized data (37,38). Parameters of DB2708 in frcmod file are also listed. 
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AutoDock Vina program was used to dock the DB2528 in the minor groove of DNA to 
obtain the initial structure for DB2708-DNA complex (39). MD simulations were performed in 
explicit solvation conditions where the DNA-DB2708 complex was placed in a truncated 
octahedron box filled with TIP3P water using xleap program in AMBER. Sodium ions were used 
to neutralize the system. A 10 Å cutoff was applied on all van der Waals interactions. The MD 
simulation was carried out using the Sander module with SHAKE algorithm applied to constrain 
all bonds. Initially, the system was relaxed with 500 steps of steepest-descent energy minimization. 
The temperature of the system was then increased from 0 K to 310 K for over 10 ps under constant-
volume conditions. In the final step, the production run on the system was subsequently performed 
for 500 ns under NPT (constant-pressure) conditions. Coordinate file of DB2708-DNA complex 
along with water molecules in proximity is also attached. 
Appendix B.5 Results and Discussion 
Appendix B.5.1Chemistry 
The general synthetic approach to the target diamidine compounds 7 is outlined in Scheme 1. 
Nucleophilic aromatic substitution reactions between 4-bromo-1-fluoro-2-nitrobenzene 1 and 
various aliphatic and aromatic amines yields the 4-bromo-N-alkyl and N-aryl-2-nitrobenzenes 2 in 
reasonable yields (41-79%), which ultimately leads to the N-alkyl and N-aryl benzimidazoles. The 
nucleophilic aromatic substitution reaction with aliphatic amines was achieved at room 
temperature in ethanol whereas the less basic aryl amines required heating in dimethylacetamide 
in the presence of Cs2CO3 at 160
oC. Suzuki-Miyaura coupling of 4-cyanophenylboronic acids with 
the various 4-bromo-N-alkyl and N-aryl-2-nitrobenzenes under standard conditions provides the 
nitro biphenyl analogues 3 in good yields (51-79%). The arylphenylene diamines 4 required for 
formation of the N-substituted benzimidazoles were obtained by stannous chloride reduction of 
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the nitro groups of 3 and were subsequently allowed to react directly without characterization. 
Sodium metabisulfite mediated the oxidative condensation and cyclization of the phenylene 
diamines 4 with the previously reported (18) 5-(cyanophenyl)-2-formylthiophenes 5 to yield the 
bis-nitriles 6 in acceptable yields (39-76%).  Lithium bis(trimethylsilyl)amide in THF reacts with 
the bis-nitriles 6 at room temperature to yield, after acidic work-up, the diamidines 7 generally in 
acceptable yields (30-79%). 
Appendix B.5.2 DNA thermal melting: Screening for mixed sequence binding 
Changes in DNA thermal melting temperature (Tm) provide a rapid way for initial ranking of 
compounds for binding affinity with different DNA sequences. We have used the three selected 
sequences shown in Figure B.1 for comparative experiments. Most heterocyclic cations prepared 
to this time have been pure AT sequence binders and a DNA with the binding site -AAATTT- was 
used to test for pure AT sequence binding affinity. The target DNA of primary interest has a single 
G·C bp with the binding sequence –AAAGTTT-. The third sequence with two G·C bps was also 
used to test for binding affinity and selectivity versus AAAGTTT. 
The reference compound, DB2457, with an N-Me substituent was previously reported (18) 
and has preferential binding to the single G·C bp sequence, the ΔTm is 14℃, with lower ΔTm and 
weaker binding to the pure AT and two G·C bps sequences, 6 and 5℃, respectively. The 
compounds with the N-ethyl and N-i-Pr substituents had similar binding to AAAGTTT and weaker 
binding to the pure AT sequence for improved selectivity as desired. At the level of evaluation of 
Tm, most of the other derivatives at the N-X position had very weak binding to the pure AT 
sequence but variable binding to the single and double G·C bps sequences. The t-butyl derivative, 
for example, had significantly weaker binding to AAATTT but slightly weaker binding to 
AAAGTTT. DB2753 and DB2754, methyl-substituted aromatic compounds, had much weaker 
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binding to all sequences. A –Cl substituent ortho to an amidine group, DB2759, on the other hand, 
gave stronger binding to AAAGTTT than the aromatic methyl compounds and very low binding 
to the pure AT sequence. A trifluoromethyl substituent in the same position had significantly 
weaker binding to both the single G·C bp and pure AT sequences.  Two compounds were prepared 
with S in thiophene replaced with Se, but they showed no significant improvement in KD for 
AAAGTTT or in selectivity. The compounds will be of a long term interest, however, in cell 
uptake studies. 
Appendix B.5.3 Biosensor-SPR: Methods for quantitative binding  
A biacore sensorchip (CM5) was functionalized with streptavidin and used to immobilize 5’-biotin 
labeled DNA sequences (Figure B.1) in flow cells 2-4 and flow cell 1 was left as a blank, for 
background subtraction. With different compounds in the flow solution, we were able to determine 
comparative binding constants for all of the derivatives (Table B.2). Example sensorgrams are 
shown for representative compounds with the different DNAs in Figure B.2. With the AAATTT 
and AAAGCTTT sequences, all compounds showed significantly weaker AAATTT binding than 
with AAAGTTT with generally fast on and off rates. No kinetics and limited KD values could be 
accurately determined for those DNA sequences. With the AAAGTTT sequence, however, 
excellent sensorgrams were obtained at low concentrations for most derivatives (Figure B.2). 
Kinetics fits with a one site model were excellent and allowed a determination of KD values (Table 
B.2). Kinetics fits were generally required to determine KD values since many sensorgrams did not 
reach a steady-state level, especially at the lower concentrations.  
DB2429, the original compound (Figure B.1), has a KD for AAAGTTT of 50 nM with 10 
fold higher KD value for AAATTT and 20 fold higher KD value for AAAGCTTT (18). The parent 
N-Me compound in this study, DB2457, has a 10-fold lower KD value for AAAGTTT of 4 nM 
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with 50 fold higher KD values for AAATTT and AAAGCTTT relative to DB2429. The N-ethyl 
and N-i-Pr compound have similar KD values for single G·C bp sequence but a higher value for 
AAATTT with a selectivity ratio of KD s of near 250. They have similar selectivity for GC to the 
N-Me compound. The N-isobutyl (DB2711) has slightly weaker binding to the single G·C bp 
sequence (KD = 13 nM) but high selectivity with no measurable binding to AAATTT and 
AAAGCTTT sequences. This compound with its high selectivity in binding validates the idea of 
N-substitution to enhance selectivity, a key feature for designing any new potential drug molecules 
in this series. The n-butyl compound (DB2715) has a 10 nM KD with AAAGTTT and a 100 times 
weaker value to AAAGCTTT. Increasing the size of the N-alkyl substituent to N-neopentyl 
(DB2718), decreased affinity for binding to the AAAGTTT sequence with a 31 nM KD and lower 
selectivity to the GC sequence. Surprisingly, when an O atom was introduced into the alkyl group 
(DB2728 and DB2764), similar binding to the single G·C bp sequence was observed, relative to 
the butyl compound, but with stronger binding to the GC sequence. Several cyclic alkyl substituted 
compounds were studied with quite variable selectivity ratios. The N-cyclopentyl compound 
(DB2714) has slightly weaker binding to the single G·C bp sequence (KD = 9 nM) but with high 
selectivity, near 150 for GC and negligible binding to AAATTT that was too weak to evaluate 
accurately (see Figure B.2). The cyclobutyl compound, DB2726, with a relatively small cyclic 
substituent, however, has lower selectivity and behaves in a similar manner to the i-Pr derivative.  
DB2727 and DB2738 with larger cyclic alkyl groups also have weaker binding to the single G·C 
bp sequence but improved selectivity. The two N-aromatic compounds have excellent binding to 
AAAGTTT with no detectable binding to AAATTT but surprisingly strong binding to the 
AAAGCTTT sequence. According to the selectivity ratios shown in Table B.2, DB2711 and 
DB2759 have the best binding selectivity for the sequence AAAGTTT comparing to AAATTT 
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and AAAGCTTT and maintain relatively strong binding to AAAGTTT (KD < 15nM). Moreover, 
DB2714 and DB2715 show AAAGTTT selectivity ratios all more than 100 fold higher for 
AAAGCTTT. These four compounds with the modifications based on DB2457 have good binding 
with AAAGTTT and excellent sequence specificity. Excitingly, except for the N-Me substituted 
compound DB2457 and DB2673, other compounds show very high selectivity (at least 250 fold) 
for AAAGTTT comparing to the pure AT sequence. 
As with the Tm results, the Se compounds did not have the best KD for AAAGTTT or the 
best selectivity. The four compounds with substitutions on the aromatic core system and an N-i-Pr 
substituent have weaker binding than the parent N-i-Pr but no detectible binding to the AAATTT 
and GC sequences.  These results make the chloro derivative, DB2759, and the N-isobutyl, 
DB2711 very attractive for further development since they have relatively favorable binding to 
AAAGTTT with a KD of around 14 nM and high selectivity with no detectible binding to the pure 
AT or two G·C bps sequences. 
The increasing size of the N-alkyl groups results in similar or decreasing binding affinity 
with sequence AAAGTTT. Fortunately, the binding to reference pure AT and AAAGCTTT 
sequences decreased to a larger extent with many of the compounds (Table B.2). A moderate size 
of N-substituted groups can give the best target sequence binding and selectivity. Since the micro-
environment such as width and depth of DNA minor groove change according to the different A·T 
and G·C bp combinations, (40-42) the size and stereo structure of binding ligands can strongly 
affect sequence specificity. Regarding the width of the minor groove of three studied sequences, 
the order is AAAGCTTT > AAAGTTT > AAATTT at the center sequence (40-42). Moderately 
sized substitutions such as i-Pr, cyclopentyl can target the single G·C bp sequence specifically. 
The aromatic substitutions may match the two G·C bps sequence microstructure. Although they 
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bind to AAAGTTT strongly but in many cases also with stronger binding to AAAGCTTT. Each 
of the compounds can also induce change in the minor groove structure of each DNA and at this 
time an experimental analysis is the best way to find the optimum compound for affinity and 
selectivity. The most important finding, however, is that modification of DB2457 can dramatically 
increase binding selectivity. 
Appendix B.5.4 Biosensor-SPR Kinetics 
A selection of compounds with a range of KD values and a variety of chemical substitutions and 
structures was used to evaluate the kinetics of association, ka, and dissociation, kd, for the 
AAAGTTT sequence. As can be seen in Figure B.2, the binding kinetics were generally too rapid 
to fit accurately with the AAATTT and AAAGCTTT sequences. The kinetics results for 
AAAGTTT are summarized in Table B.3 and Figure B.3. For the N-substituted compounds with 
an unsubstituted aromatic system, the KD values with AAAGTTT in Table B.3 cover a narrow 
range, from around 4 to 13 nM with only two compounds above 10 nM. The kinetics values also 
cover a relatively small range for ka, from around 2 to 5 x 10
6 m-1s-1. The kd values cover a 
somewhat larger range, from 0.008 to 0.05 s-1 but as seen in Figure B.3, a general correlation of 
the sets of values accounts for the small variation in KD. The N-methyl (DB2457) and N-Ph 
(DB2740) compounds have similar low ka values, around 2 x 10
6 m-1s-1. They also have similar 
low kd values that give them strong binding affinity. Within the compounds in Table B.3, DB2715 
with n-butyl and DB2711 with isobutyl represent the fastest association and disassociation rates, 
4.6 x 106 m-1s-1 and 0.0444 s-1, 4.1 x 106 m-1s-1 and 0.0516 s-1, respectively. Moreover, they show 
the weakest binding (12.6 and 9.6 nM) to AAAGTTT among the compounds with an unsubstituted 
aromatic system. These results suggest that the butyl substitutions interfere with binding in the 
minor groove giving them fast but weak association and rapid dissociation with a relatively high 
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KD. DB2764 with substitution of 2-methoxyethyl, which is the approximately same length as n-
butyl (DB2715), shows a similar KD value, 11 nM. DB2708 with N-i-Pr has similar on and off-
rates as the parent, DB2457, to result in the same binding strength with AAAGTTT. DB2728 (3-
methoxypropyl), is one methylene longer than DB2764 and shows a faster on-rate than DB2764. 
It has nearly the same off-rate and slightly stronger binding ability with single G·C bp sequence. 
The Se N-i-Pr derivative DB2712 has a ka value similar to the thiophene but a higher kd and as a 
result, a KD that is around 2 fold weaker. Clearly, the larger, more polarizable Se offer no 
advantage. The cyclic alkyl substitution, cyclopentyl (DB2714), has moderate kinetics and KD 
values (Table B.3). A methyl-substituted phenyl, N-i-Pr derivative, DB2753, has much weaker 
binding, KD > 100nM, that is due to a very low ka of 0.073 x 10
6 m-1s-1. The kd for this compound, 
however, is in the range of other compounds in Table B.3. The core aromatic system of 
significantly twisted due to repulsion between the –methyl substituent and the adjacent phenyl 
ring. To bind into the minor groove, the twist must be reduced at an energy cost that slows 
association with lowering of ka and an increase in KD. Once bound it appears that the compound 
can form interactions similar to the compounds with an unsubstituted aromatic system to give kd 
in the same range. 
To help compare the kinetics data of the selected compounds, the relationship between on-
rates (ka) and off-rates (kd) is plotted in Figure B.3. Green dash lines show the binding affinities 
(KD). The parent compound DB2457 and the strongest binding compounds, DB2740 and DB2708, 
are located in a KD line with a slope around 4 nM. DB2708 with N-i-Pr substitution has slightly 
faster association and disassociation because of its optimum structure matching the AAAGTTT 
minor groove. We can clearly see six compounds with different, but similar sized N-alkyl 
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substitutions that are distributed around the 10 nM green dash line. The on-rates and off-rates are 
all in a limited range.  
Appendix B.5.5 CD binding mode 
CD titration experiments are an effective and convenient method of evaluating the binding mode 
and the saturation limit for compounds binding with DNA sequences. CD spectra monitor the 
asymmetric environment of the compounds binding to DNA and therefore can be used to obtain 
information on the binding mode (43). There are no CD signals for the free compounds but on the 
addition of the compounds into DNA, substantial positive CD signals (ICD) arose in the absorption 
region between 300 and 450 nm. These positive ICD signals indicate a minor groove binding mode 
by these ligands, as expected from their structures. A monotonic increase of ICD signals at the 
range of 330 to 440 nm was observed upon an incremental addition of DB2708, DB2740, DB2759 
and DB2754 to the AAAGTTT sequence. As can be seen from Figure B.4, all studied compounds 
from strong to moderate binders bind in the minor groove of the AAGTTT sequences with a 1:1 
stoichiometry, in agreement with SPR results. In summary, the CD titration results confirm a minor 
groove binding mode for the compounds studied in Figure B.1. 
Appendix B.5.6 Molecular Structure: Calculations 
To help to understand the large differences in binding affinities between the control compound 
DB2708, with no substitutions on the core aromatic system, and the substituted compounds 
DB2753, DB2754, DB 2759 and DB2762, torsional angle maps were constructed in the SPARTAN 
16 software package (44). (Figure B.5).  DB2708 has the lowest energy difference between the 
minimum energy torsional angle and 0° for both the Ph-amidine, the Ph-BI bond and the 
thiophene-Ph. DB2759 with a Ph-Cl substituent adjacent to the amidine has a slightly higher 
energy difference between the minimum energy torsional angle and 0° than the Ph-amidine bond 
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of DB2708 and this results in a slightly higher KD. However, DB2762 with CF3-Ph substitution 
shows a higher energy difference between the minimum energy torsional angle and 0°, up to 2.5 
times higher than DB2708, and much weaker binding with the target sequence compared to 
DB2708. DB2753 with a methyl-Ph substituent adjacent to BI has the highest KD value of the 
entire set of compounds and the highest energy difference between the minimum energy torsional 
angle and 0° for the Ph-BI bond. The torsional map of the thiophene-Ph bond of DB2708 shows 
0° as the lowest energy state which is reasonable for the 5-atom and 6-atom ring contacts. DB2754 
with a methyl-thiophene substituent adjacent to Ph-Am shows a higher KD value and a higher 
energy difference for the thiophene-Ph. If we assume that the maximum torsional angle for 
optimum binding to DNA should be around 10° or less, these angles and energy differences are 
very important. To reduce the Ph-amidine bond to near 10° in DB2759 requires around 7 kJ/mol 
while to reduce the Ph-amidine bond to near 10° in DB2762 requires about twice as much energy. 
For the Ph-BI bond of DB2708 and DB2753, the energy of reducing to near 10° in DB2753 is 
about 5 times higher than with DB2708. It seems highly likely that these conformational energy 
costs are responsible for a least part of large binding constant differences for DB2708, DB2759, 
DB2762, DB2753, and DB2754.  It should be noted that choosing another minimum torsional 
angle, such as 0° or 5°, leads to the same conclusions. 
Appendix B.5.7 Molecular Structure: Molecular Dynamics 
To help understand the basis of molecular recognition of DNA sequences with a single G·C bp in 
an AT context, molecular dynamics (MD) simulations for the representative compound, DB2708, 
were conducted in the AMBER 14 software suite (35). Force constants for DB2708 were 
determined as described in the methods section and added to the ff99 force field for the 
simulations. After 500ns of MD simulation, 25 PDB structures for the complex of DB2708 in the 
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AAAGTTT binding site (Figure B.6) were collected. Structures were evaluated in detail every 
20ns (25 structures for 500ns) to determine what major features of the DB2708-DNA complex are 
primarily responsible for the excellent stability (KD) and specificity ratios (KD of AAAGTTT/ KD 
of AAATTT). There are three optimum H-bonds in the complex. Both amidine groups form –N-
H to T=O H-bonds (Figure B.5B) that are an average of 2.8Å in length (SD = 0.1Å). The amidines 
also form numerous highly dynamic H-bonds to water molecules that move in and out of the minor 
groove (45). These water molecules frequently also form H-bonds with AT bps at the floor of the 
minor groove and help link the compound to the specific binding site in the groove. The third 
strong H-bond is from the central G-NH that projects into the minor groove to the imidazole N in 
the BI group of DB2708, Figure B.5C, to account for much of the binding selectivity of DB2708. 
Additional selectivity in binding is provided by the –CH group of the six-member ring of BI that 
points into the minor groove. This -CH forms a dynamic close interaction with the –C=O of the 
dC base of the central G·C bp as well as to a T=O on an adjacent AT bp (Figure B.5C). 
Additional direct stabilizing interactions are formed by –CH groups that point to the floor 
of the minor groove from the two phenyls of DB2708. These –CH groups form significant dynamic 
interactions with A-N3 groups on the bases at the floor of the groove (see Figure B.5B for an 
example). DB2708 tracks optimally along the minor groove with appropriate twist to match the 
minor groove curvature. Extensive interactions are formed by the conjugated aromatic-system of 
DB2708 with the sugar-phosphate walls of the minor groove. In addition to H-bonds with the AT 
bps, the amidines of DB2708 also form electrostatic interactions with the backbone phosphates 
that result in Na+ release and an entropy increase that is another stabilizing component, along with 
water release from the minor groove, on complex formation. The sum of these numerous, relatively 
weak, stabilizing interactions results in strong binding of DB2708, a KD of 4nM (Table B.2) with 
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a ΔG of binding of 11.5 kcal/mol. The i-Pr group of DB2708 forms a tight interaction with the 
DNA backbone in the G·C bp region. In an AAATTT sequence, the i-Pr group would have 
increased steric hindrance to increase the KD for AAATTT binding.   The KD for binding to an 
AAATTT sequence without the G·C bp, for example, increases from around 200nM with DB2457, 
the N-methyl derivative, to around 1000nM with the i-Pr compound DB2708 (Table B.2) to 
provide a significant increase in selectivity. Clearly, many of the N-X derivatives of this compound 
in Table B.2 can match the minor groove microstructure in AAAGTTT better than with AAATTT. 
Simulation of additional N-X derivatives and more detailed analysis will be presented in a future 
paper.  
Appendix B.6 Conclusions 
Here we have synthesized a series of DNA sequence-specific recognition ligands based on the 
structure of DB2457 with N-MeBI-thiophenes which are preorganized by a σ-hole interaction to 
fit the shape of the DNA minor groove and H-bond to the –NH of G·C bps that project into the 
minor groove. In order to improve their potential biological applications, modifications have been 
made to the initial structure to increase the binding specificity. We increased the size of N-
substitution of BI to match the DNA microstructure in target mixed base pair sequences and in 
successfully (Table B.2) improving the compound binding selectivity. We also changed the core 
structure twist of the compounds by introducing substitutions at specific positions on the aromatic 
core of the compounds.  In both ways, we have been able to achieve a significant increase in 
binding specificity, including no detectable binding to pure AT sequences, without a significant 
loss of binding affinity to target mixed base pair sequences.  
Various biophysical experiments have been performed to support our results: DNA thermal 
melting and biosensor-SPR were used to detect the binding affinity and kinetics between 
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compounds and target mixed base pair DNA sequences. The binding mode was determined by CD 
experiments along with the 1:1 minor groove binding. Structural calculations were performed to 
compare the different influence of modified groups at the same position of the compounds. 
Molecular dynamics was used to help explain the binding details and mechanism. Three H-bonds 
around the central G·C bp as BI(3)-C-H---O=dT(7), BI(3)-C-H---O=dC(15) and BI(4)-N---H-N-
dG(6) help determine  the strong binding affinity and high binding specificity of the representative 
N-i-Pr compound, DB2708, to an AAAGTTT sequence. These structural modifications provide 
ideas to produce significant improvements of the binding specificity of G·C bp sequences. The 
key compounds in this project should help improve the biological applications of small molecule 
DNA minor groove sequence-specific binders in projects such as the inhibition of transcription 
factors. 
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Figure B.1. A) Chemical structures of reported σ–hole single G·C bp binders and the modified 
compounds from DB2457 used in this study. B) The DNA sequences used in this study; DNA 
sequences used for SPR studies were labeled with 5’-biotin. 
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Figure B.2. Representative SPR sensorgrams for A-C, DB2714, D-F, DB2753 in the presence 
of AAATTT, AAAGTTT and AAAGCTTT hairpin DNAs. In A, C, D, F, the concentrations of 
sensorgrams is 2-500 nM of each compound from bottom to top. In B, the concentrations of 
DB2714 from bottom to top are 15, 20, 30, 50, and 100 nM; In E, the concentrations of DB2753 
from bottom to top are 30, 70, 100, 200, and 500 nM. In B and E, the solid black lines are best-
fit values for global kinetic fitting of the results with a single site function. 
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Figure B.3. Circular dichroism spectra for the titration of representative compounds, A) 
DB2708, B) DB2740, C) DB2759 and D) 2754 with a 5 µM AAAGTTT sequence in Tris-HCl 
buffer (50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.4) at 25℃. Arrows indicate the 
changes. 
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Figure B.4. Kinetic plot showing the relationship between on-rates (ka), off-rates (kd) and 
binding affinities (KD) (Green dash line) represented on the diagonal axis for compounds in 
Table B.3, and determined by SPR. On-rates and off-rates and are plotted as logarithmic 
values.  
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Figure B.5. (A, B, C) Torsional angle maps of the Ph-Am bond for DB2708, DB2759, and 
DB2762; and (D, E) of the Ph-BI bond for DB2708 and DB2753; and (F, G) of the Thiophene-
Ph bond for DB2708 and DB2754. All calculations are performed at the B3LYP/6-31G* level 
of theory. The range of dihedral calculations is from 0°-100°. The scanned dihedral is shown 
as the bold red line at 0°in the compound structures. 
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Figure B.6. Molecular Dynamics (MD) model of DB2708 with an AAAGTTT sequence: (A) A 
space-filling model viewed into the minor groove of the A3GT3 binding site with bound DB2708. 
The DNA bases are represented in tan-white-red-blue-yellow(C-H-O-N-P) color scheme and 
DB2708 is light pink-white-blue-yellow (C-H-N-S) color scheme with the N-i-Pr is facing out of 
the minor groove in a brighter-pink. The important interactions between different sections of 
DB2708-DNA are illustrated in (B) and (C). The terminal amidine group forms a strong 
hydrogen bond with the carbonyl  group  of dT(8) (yellow dashed lines), and another direct 
stabilizing interaction is observed from the Ph(6) –CH group which points to N3 of dA (14) at 
the floor of the minor groove (B). In (C), the imidazole (4)-N makes a strong hydrogen bond 
interaction with the exocyclic NH of dG(6). The BI(3)-C-H forms strong interactions with the 
carbonyl group of dT(7) in the minor groove and this unit also points towards the  carbonyl 
group of dC(15) with close distance. 
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Table B.1. Thermal melting studies (ΔTm, ℃) of DB2457 and analogues with pure AT and 
mixed DNA sequences. a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a ΔTm = Tm (the complex) - Tm (the free DNA). 3 µM DNA sequences were studied in Tris-HCl 
buffer (50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.4) with the ratio of 2:1 [ligand]/[DNA]. 
An average of two independent experiments with a reproducibility of 0.5 ℃.                                
Full DNA sequences: AAATTT: 5’-CCAAATTTGCCTCTGCAAATTTGG-3’;                      
AAAGTTT: 5’-CCAAAGTTTGCTCTCAAACTTTGG-3’;                                                
AAAGCTTT: 5’-CCAAAGCTTTGCTCTCAAAGCTTTGG-3’. 
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Table B.2. Summary of binding affinity (KD, nM) for the interaction of all test compounds 
with biotin-labeled DNA sequences using biosensor-SPR method a 
 
 
 
a All the results in this table were investigated in Tris-HCl buffer (50 mM Tris-HCl, 100 mM 
NaCl, 1 mM EDTA, 0.05% P20, pH 7.4) at a 100 µL min-1 flow rate. NB means no binding. The 
listed binding affinities are an average of two independent experiments carried out with two 
different sensor chips and the values are reproducible within 10% experimental errors. 
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Table B.3. Comparison of SPR Kinetics Results of Binding to the AAAGTTT DNA Sequencea 
 
 
 
 
 
 
 
 
 
a Kinetics analysis was performed by global fitting with a 1:1 binding model. ka is the association 
rate constant, while kd is the dissociation rate constant. KD was calculated through global fitting 
of the kinetic data obtained for various concentrations of the compounds; KD is given by kd / ka. 
 
Scheme B.1. The general synthetic approach to the target diamidine compounds 
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